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i 
 
Abstract 
 
Campylobacter jejuni is one of the leading causes of food borne illness worldwide; the 
main cause of infection is the consumption of undercooked, contaminated poultry. Motility, 
mediated by single polar flagella, is necessary for Campylobacter virulence. The flagellin 
proteins are extensively glycosylated in C. jejuni with pseudaminic acid and related 
derivatives; glycosylation is required for flagella filament formation. The flagellin 
glycosylation locus in C. jejuni NCTC11168 comprises 50 genes, 50% are potentially 
involved in glycan biosynthesis and others are hypothetical; the regulatory mechanism(s) of 
flagellin glycosylation remain unclear. The response to nitric oxide stress in C. jejuni is 
regulated by NssR, which also regulates a small number of genes in the flagellin 
glycosylation locus; an nssR mutant has defective motility. This work aims to elucidate the 
mechanisms by which NssR regulates these genes and investigate the consequences of nssR 
mutation. Transcriptional organisation of the affected genes was deduced and chromatin 
immunoprecipitation (ChIP) used to map NssR binding to six potential locations in the region. 
Methods to measure bacterial motility were assessed and used to document the defective 
motility of the nssR mutant, which was found to be due to truncated, sometimes asymmetric, 
flagella. Finally, mass spectrometry was used to examine flagellin glycosylation in all strains. 
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Chapter I: Introduction 
 
1.1 A brief history of Campylobacter 
Whilst campylobacters were not widely recognised as human pathogens until the 
1970’s, they were probably first observed in 1886 by German bacteriologist Theodor 
Escherich, who described spiral bacteria in the colons of infants who had died from enteric 
disease (Escherich, 1886). Escherich was unable to cultivate these bacteria on solid media 
and, despite observing that these organisms were more frequently found in stool specimens 
from infants with enteric disease, thought that they played no aetiological role (Kist, 1985). In 
the following years several reports were made of non-culturable bacteria with similar 
characteristics, but the lack of suitable selective media made further investigation difficult. 
However, in 1909, two veterinary surgeons reported the discovery of an unknown vibrio-like 
organism, which could be frequently isolated from the aborted foetuses of ewes (McFadyean 
and Stockman, 1913). In 1919 Smith and Taylor isolated a bacterium they described as a 
‘spirillum’ from aborted bovine foetuses and concluded that this bacterium was identical to 
the vibrio-like bacterium of McFadyean and Stockman; consequently the name ‘Vibrio fetus’ 
was proposed for these organisms. In 1931, Jones et al. connected winter dysentery in calves 
with a ‘Vibrio’ they called ‘Vibrio jejuni’; in 1944 a similar organism associated with 
dysentery in swine was reported (Doyle, 1944).  
Whilst the role of campylobacters as veterinary pathogens was already quite well 
established, the first well documented instance of human Campylobacter infection did not 
occur until 1938. This involved a milk-borne outbreak of enteritis, while microscopy only 
positively identified ‘V. jejuni’ in 10% of the cases, organisms resembling ‘V. jejuni’ were 
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grown in liquid cultures of the blood of 3.5% of those infected (Levy, 1946). In 1963 the 
genus Vibrio underwent a major taxonomic change. Sebald and Véron (1963) proposed 
Campylobacter (Greek, campylo: ‘curved’) as a new genus, to incorporate those ‘vibrios’ 
already known to differ from the rest of the genus, most notably by low DNA base 
composition and microaerophilic growth requirement. Immediately after its inception the 
genus Campylobacter contained two species, ‘C. fetus’ and ‘C. bubulus’. The number of 
species increased dramatically in the following years, especially following the development of 
a filtration technique by Dekeyser et al. in 1972 that allowed the first isolation of 
Campylobacter from faeces. The development of a selective medium by Skirrow (1977) was 
another revolution in Campylobacter research, as was the increased availability and 
sophistication of equipment and methods for generating microaerobic environments. The 
relative simplicity of the isolation procedure allowed the isolation of Campylobacter and 
Campylobacter-like organisms by less specialised diagnostic microbiology laboratories and, 
for the first time, allowed the importance of campylobacters as infectious agents in humans to 
be identified.  
 
1.2 Taxonomy 
Campylobacter is included, together with the genera Arcobacter and Sulfurospirillum 
in the family Campylobacteraceae (Vandamme et al., 1991; Stolz et al., 1999), which has 
been shown by partial 23S rRNA analysis to be part of the delta-epsilon subdivision of 
Proteobacteria (Trust et al., 1994). Following the above mentioned development of a 
selective medium by Skirrow (1977), interest in the genus increased considerably as the 
importance of Campylobacter in human disease began to be realised; this led to the 
description of many new species of campylobacters from varying sources.  The greater 
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number of species and the ever-increasing sophistication of methods used to classify bacteria 
lead to re-arrangement within the genus itself. In 1987 studies of 16S rRNA gene sequence 
divergence in Campylobacter  by Lau et al. (1987) demonstrated the diversity of the genus as 
then defined; the genus Helicobacter was created by Goodwin et al. (1989) by the 
reassignment of ‘C. pylori’ and ‘C. mustelae’, as these species were seen to possess sheathed 
flagella, differing cellular fatty acid composition and a divergence in 16S rRNA sequences 
from the other members of the Campylobacter genus. Former campylobacters have also been 
reassigned into Arcobacter, which contains the ‘aerotolerant’ campylobacters and 
Sulfurospirillum, which contains only free living environmental strains. Comparative genome 
analysis has also been carried out on the 25 genomes, of various levels of completeness, 
which are available for the Campylobacteraceae and related bacteria, including Helicobacter. 
The species tree generated using this method compares well with the phylogenetic tree 
derived from 16S rRNA gene sequences (Debruyne et al., 2008). 
Currently the genus Campylobacter contains 17 species and six subspecies, together 
with several named biovars which have clinical or economic importance (Debruyne et al., 
2008; On, 2005); Campylobacter fetus is the type species of the genus. Two species, C. jejuni 
and C. coli, are in particular the most likely to cause human Campylobacter infections. C. 
jejuni is believed to account for approximately 90% of all cases of human Campylobacter 
infections, with C. coli, which is usually associated with pigs, accounting for 3-4% of cases 
(Frost et al., 1999). 
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1.3 Campylobacter jejuni 
1.3.1 Morphology 
Campylobacter jejuni cells are slim (0.2 - 0.8 µm wide and 0.5 - 5 µm long), spiral 
shaped, Gram-negative, non-sporulating rods that exhibit a characteristic rapid ‘darting’ 
motility, by means of a single unsheathed polar flagellum at one or both ends of the cell. The 
spiral morphology is useful for identification in a clinical context, as few bacteria of any 
clinical importance are spiral in shape; the morphology of C. jejuni is probably an adaptation 
to aid motility in viscous environments, such as that of the intestinal mucosa.   
Having entered stationary phase or following exposure to suboptimal conditions or 
stressors C. jejuni has been proposed to enter a viable but nonculturable state (VBNC; Moore, 
2001; Pearson et al., 1993). This state is characterised by the alteration of the cellular 
morphology from the usual spiral shaped rod to a coccoid form, alterations in cell wall 
structure leading to changes in Gram staining (Moran and Upton, 1986; Ng et al., 1985) and a 
decrease in metabolic activity. Whether campylobacters can reverse those changes which 
occur upon entry into the VBNC state, and so use this state as a means of avoiding stress, is 
not entirely clear. Some studies report that cells in a VBNC state are unable to revert to a form 
which is culturable and able to colonise (Hald et al., 2001; Ziprin et al., 2003). Others report 
that passage through the intestines of chicks (Talibart et al., 2000) or mice (Baffone et al., 
2006) is sufficient to produce viable cells capable of colonisation. The ability of 
campylobacters to survive stress by entering a VBNC state, if this is in fact the case, could 
help to explain the prevalence and routes of transmission of this pathogen. 
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1.3.2 Growth requirements  
Campylobacter spp. are fastidious, strictly microaerophilic organisms, requiring an O2 
concentration of 3 - 15% and a CO2 concentration of 3 - 5% (Ketley, 1997); as such an 
atmosphere of 5% O2, 10% CO2 and 85% N2 is commonly used when culturing 
campylobacters. C. jejuni is thermophilic and has an optimum growth temperature of 42C, a 
characteristic that may reflect an adaptation to the temperatures found in the intestines of 
mammals and particularly birds, which are usual habitats of Campylobacter spp; however a 
temperature of 37°C is commonly used when culturing pathogenic Campylobacter species. C. 
jejuni has a respiratory metabolism and is not able to ferment or oxidise carbohydrates, 
instead it obtains energy from amino acids and intermediates of the tricarboxylic acid cycle 
(Mohammed et al., 2004). C. jejuni and C. coli both encode only one gene for catalase, katA, 
which catalyses the breakdown of H2O2 to H2O and O2 (Grant and Park, 1995). C. jejuni also 
has only a single superoxide dismutase (SOD) gene, which catalyses the breakdown of 
superoxide to H2O2 and O2; E. coli harbours multiple SOD genes (Cabiscol et al., 2000). 
Despite the presence of these enzymes campylobacters are generally highly sensitive to both 
free radicals and superoxides. 
 
 1.3.3 Epidemiology 
Campylobacter enteritis is the most common form of acute bacterial enteritis in the 
developed world; it affects people of all ages, but most particularly children aged less than 4 
years and adults aged 15-44 years (Tauxe, 2005). There was a steady increase in 
Campylobacter infections in England and Wales up to a peak of 58,059 reported cases in 
1998. Since this peak cases have declined slowly, although with significant variation in the 
number of cases in a given year, the general decreasing trend is believed to be due to better 
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control of infection and contamination in animals, particularly in poultry (Tam, 2001). In 
England and Wales during 2008 there were 49,800 laboratory confirmed cases of 
campylobacteriosis (Anon, 2009). It is believed that the true number of cases of 
Campylobacter infections is as much as 10 times greater than that recorded due to under-
reporting, as many of those suffering from food-borne campylobacteriosis do not seek 
medical assistance. In temperate climates infection is seasonal, with twice the number of 
infections occurring in summer than in winter (Anon, 2006). The natural reservoir of 
Campylobacter spp. consists of both wild and domestic animals, with poultry having the 
greatest potential for causing human infection.  
Campylobacteriosis is usually a food-borne infection and foods of animal origin play 
an important role in infection; raw and inadequately treated milk and untreated water have 
also been implicated as sources of infection (Frost et al., 2002). However, food- borne 
outbreaks from a common source are unusual, and sporadic (i.e. single individual) food-borne 
infections make up the majority of cases. Despite the presence of large numbers of motile 
organisms in the faeces of infected persons and an apparently low infectious dose of between 
500 and 800 organisms (Black et al.,1988; Robinson, 1981), person-to-person transmission is 
rare. Many cases of campylobacteriosis are linked to foreign travel and the consumption of 
contaminated food or water in the areas visited.   
In developing countries campylobacters are often hyper-endemic and C. jejuni 
infection is almost ubiquitous in children under 2 years old; there is often significant mortality 
associated with C. jejuni in these populations. Campylobacter enteritis is rarely seen in adults 
in areas where campylobacters are hyper-endemic as immunity is usually acquired early in 
life due to frequent exposure (Coker et al., 2002). 
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1.3.4 Motility 
Campylobacter is characterised by a rapid, darting motility mediated by bi-polar 
flagella. Lee et al. (1986) have also shown that the motility of C. jejuni increases with the 
viscosity of the solution, with a maximum reported speed of 75µm.s
-1
 under highly viscous 
conditions. This ability to move quickly in viscous conditions could facilitate movement into 
and through the mucus covered and hence highly viscous lining of the intestinal tract.  
Structurally the flagellum consists first of the basal body, which connects the 
flagellum to the cell and also interacts with the flagellar motor. The hook links the basal body 
to the flagellar filament, which is composed of thousands of copies of two proteins, FlaA and 
FlaB. The genes encoding FlaA and FlaB are adjacent to one-another and share >93% 
sequence homology, and are independently transcribed, flaA from a σ28 promoter and flaB 
from a σ54 promoter (Guerry et al., 1990). Mutants in flaA have been shown to be poorly 
motile and to possess only short, truncated flagella; mutants in flaB however possessed near-
normal length flagella and were almost as motile as the parent strain but did show some 
reduction in pathogenic potential (Guerry et al., 1991; Wassenaar et al., 1993). This would 
appear to suggest that FlaA is the major flagellin, whilst FlaB forms a minor part of the 
flagellar structure and is possibility not expressed under all conditions. Whether this is in fact 
the case is uncertain as is the exact location or function of FlaB in the flagellar filament. The 
presence of two homologous fla genes may confer an advantage in the event of a mutation 
occurring in one copy, such that the organism can still maintain at least a certain level of 
motility, Wassenaar et al., (1991). 
The flagellin from C. jejuni 81-176 is predicted from its amino-acid sequence to be 
59.5kDa in size, however flagellin from this strain is actually approximately 65KDa in 
apparent (i.e. Mr) size. The additional 10% mass consists of glycosyl groups which are 
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attached by an O-linkage to 19 serine and threonine resides in the central, surface exposed 
region of the flagellin of strain 81-176 (Thibault et al., 2001). At least some glycosylation of 
flagellin is required in order to form a functional flagellar filament (Linton et al., 2000); 
although the exact function(s) of flagellin glycosylation is as yet unclear, flagellin 
glycosylation is covered in greater detail in Section 1.8.  
 
1.3.5 Biofilm formation 
 As previously stated C. jejuni is one of the leading causes of bacterial gastroenteritis 
worldwide and as such it is very widespread. Paradoxically its microaerobic growth 
requirements, together with its inability to tolerate atmospheric oxygen concentrations, mean 
that it is unable to multiply in the aerobic environment.  Transmission of C. jejuni between 
hosts, particularly livestock hosts, is likely to involve a period of exposure of Campylobacter 
to the hostile external environment; the methods used by Campylobacter to survive in the 
aerobic environment are not well understood. It has been suggested by Buswell et al. (1998) 
that C. jejuni is able to maintain itself in the environment by forming a biofilm.  
Biofilms are usually defined as multi layered bacterial populations enclosed in a 
matrix composed of extracellular polysaccharide substances; these bacteria may be adherent 
to each other and to surfaces or interfaces (Costerton et al., 1995). Aggregations of bacteria 
attached to each other, but not to a surface, are usually termed ‘flocs’ and have many 
properties in common with surface attached biofilms (Hall-Stoodley et al., 2004); aggregates 
of bacterial cells that form at an air-liquid interface are termed  ‘pellicles’ (Friedman and 
Kolter, 2004). Biofilms exist in a wide variety of ecological niches and are of considerable 
economic importance in the food industry, waste water treatment plants and in medicine. 
Monospecies biofilms are formed by a number of human pathogens, including 
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Staphylococcus epidermidis (Mack et al., 2000) Vibrio cholerae (Nesper et al., 2001) and 
Pseudomonas aeruginosa, the latter in the lungs of cystic fibrosis patients (Whiteley et al., 
2001). Bacteria in biofilms are often less susceptible to antibiotics than their free-living 
counterparts (Nichols, 1991); protection against other stresses, including desiccation, nutrient 
starvation and the host immune system, may also be conferred by biofilms (Davies, 2003; 
Miller and Bassler, 2001), allowing bacteria to survive what would otherwise be lethal 
environments. 
Whilst there have been no reports of C. jejuni biofilm formation in vivo this strain has 
been found in biofilms with several other bacterial species (Trachoo et al., 2002). There is 
considerable variation in the ability of strains of C. jejuni to form mono-species biofilms. 
Several strains, including NCTC 11168 and 81-176 have been shown to form biofilms on a 
variety of surfaces including stainless steel, glass, poly-vinyl chloride and nitrocellulose 
membranes (Kalmokoff et al., 2006), although some clinical isolates seem to be impaired in 
biofilm formation (Joshua et al., 2006). C. jejuni has been shown to form the three distinct 
forms of biofilm when in monoculture; it can form a true biofilm by attaching to a glass 
surface, a pellicle at an air-liquid interface when grown in stationary liquid culture, and 
unattached cellular aggregates, or flocs, in the culture medium (Joshua et al., 2006). It was 
also demonstrated that, unlike free-living cells, the bacteria in the attached biofilm and 
pellicle retained their characteristic spiral morphology and were viable under atmospheric 
oxygen conditions for several weeks.  
Kalmokoff et al. (2006) demonstrated that during growth in a biofilm, C. jejuni cells 
express genes involved in energy generation, such as succinyl-CoA synthase, and in 
biosynthesis (riboflavin synthase) at higher levels than their free-living counterparts; these 
expression differences are commensurate with those seen in other bacteria (Hefford et al., 
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2005; Lazazzera, 2005). However, a particular group of proteins present at higher levels in the 
biofilm inhabiting C. jejuni cells, the motility related proteins, were unusual and are not 
normally identified as up-regulated in other biofilm-grown bacteria (Kalmokoff et al., 2006). 
The motility related proteins with enhanced expression included the flagellin structural 
proteins, hook, basal body proteins, filament cap and the chemotaxis protein CheA. It is 
known that flagella are important in the initial attachment phase of biofilm formation (Kirov 
et al., 2004), but in some genera motility genes are commonly repressed after the attachment 
phase has been successfully completed (Lazazzera, 2005). This makes the enhanced 
expression of motility-related proteins in C. jejuni inhabiting mature biofilms unusual and 
thus far inexplicable. It was confirmed by Reeser et al. (2007) that an aflagellate ΔflaAB 
mutant in C. jejuni M129 was deficient in its ability of form biofilms. Joshua et al. (2006) 
also reported that an aflagellate maf5 mutant (now annotated pseE; Cj1337), which appears to 
have an as yet unclear role in the assembly and transfer of glycans to flagellin monomers 
(McNally et al., 2006a), and fliS mutants in C. jejuni NCTC 11168 did not attach to surfaces 
and so were unable to form biofilms or pellicles; these strains were however able to form 
flocs in the body of the media. 
 
1.3.6 The Nitrosative stress response in C. jejuni  
At elevated levels nitric oxide (NO) reacts easily with a variety of targets within a 
bacterial cell including thiols and metal centres, such as haem centres and Fe-S clusters (Poole 
and Hughes, 2000); therefore NO can have a strong bactericidal activity. NO from a variety of 
sources can be encountered by bacteria, both in the environment, where NO is present as an 
intermediate of denitrification, and also in the mammalian host, where NO is present due to 
the reaction of salivary nitrite with stomach acid (Lundberg et al., 2004) and as a prominent 
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agent in macrophage killing. The primary source of NO in the mammalian host are nitric 
oxide synthases, particularly inducible NO synthase 2, which is expressed primarily in 
macrophages after induction by cytokines or bacterial products, including 
lipooligosaccharides (Ding et al., 1988; Iovine et al., 2008). Both systemic (C. jejuni 84-25) 
and diarrhoeal (C. jejuni 81-176) Campylobacter were shown by Iovine et al. (2008) to be 
killed by cytokine or LOS stimulated macrophages in an inducible NO synthase dependant 
manner. NO is lipophilic and able to diffuse freely, so it is able to enter cells without 
restriction. Bacteria have a variety of responses to NO exposure, most of which are designed 
to detoxify NO and its associated redox products (Poole, 2005) and can modulate expression 
of these responses according to NO exposure.  
 C. jejuni is thought to encounter increased levels of NO during the course of a human 
infection, as the synthesis of NO in patients with infective bacterial gastroenteritis is 
significantly increased (Forte et al., 1999), including following an infection with 
Campylobacter (Enocksson et al., 2004). Elvers et al. (2004) demonstrated that the single 
domain globin Cgb performs the major NO scavenging and detoxification function in C. 
jejuni. Expression of cgb is minimal in laboratory media but is upregulated strongly and 
specifically upon exposure to nitrosative stress. The NO-sensing regulator of cgb expression 
in C. jejuni is NssR (nitrosative stress-response regulator) encoded by Cj0466, which is the 
only member of the Crp-Fnr transcriptional regulator superfamily present in C. jejuni (Elvers 
et al., 2005; Parkhill et al., 2000); the mechanism by which NssR senses NO is unclear. NssR 
regulates the expression of a small nitrosative stress response regulon of at least four genes, 
which include cgb and ctb, a truncated globin the physiological function of which is unclear, 
and two genes of unknown function, Cj0761 and Cj0830. The genes cgb and ctb also appear 
to be positively regulated by oxygen, which may indicate a role for oxygen in either NO 
Introduction  Chapter I 
  12 
 
detoxification or NssR activity (Monk et al., 2008).  The study by Monk et al. (2008) also 
indicated that the Campylobacter response to NO stress is more general than previously 
thought, as several heat shock associated proteins, including HrcA, GrpE and DnaK, were 
upregulated in response to NO stress, potentially these proteins are involved in the response to 
the accumulation of unfolded proteins following NO exposure. Also upregulated following 
NO stress were several proteins involved in iron uptake, as NO attacks proteins with haem 
centres or Fe-S clusters the increased uptake of iron may be required for restoration of normal 
protein function.  
 The promoter regions of those genes regulated by Crp-Fnr superfamily members 
usually contain distinctive recognition motifs, such as the inverted repeat sequence TTGAT-
N4-ATCAA recognised by FNR family proteins (Eiglmeier et al., 1989). Elvers et al. (2005) 
discovered a similar motif, which has the consensus sequence TTAAC-N4-GTTAA, upstream 
of all of the NssR-dependent genes that they identified; this sequence is therefore predicted to 
be the NssR-binding motif under conditions of nitrosative stress; whether it is still used in 
conditions where nitrosative stress is not present is unknown. 
 
1.4 Clinical manifestations of C. jejuni infection 
C. jejuni can cause a broad spectrum of diseases ranging from gastroenteritis, 
septicaemia, meningitis and abortion, to autoimmune diseases such as reactive arthritis and 
Guillain-Barŕe syndrome. However, the most common result of human infection with C. 
jejuni is an acute, self-limiting gastrointestinal illness; symptoms usually include diarrhoea, 
fever and abdominal cramps, although the variation of symptoms between individuals is 
common (Young and Mansfield, 2005).  The incubation period after ingestion of C. jejuni 
varies from one to five days (Allos 2001), although this can be dependant on the number of 
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cells ingested. The symptoms are often indistinguishable from other acute bacterial 
gastrointestinal infections such as salmonellosis and shigellosis and a definitive diagnosis is 
only made after detecting C. jejuni in the faeces. 
 The clinical manifestations of C. jejuni infection vary between developed and 
developing countries. In developed countries primary infection usually results in 
inflammatory diarrhoea, which is characterised by prominent fever, abdominal pain and stools 
containing leukocytes, mucus and gross or microscopic blood. This form of gastroenteritis 
tends to be self-limiting and is usually resolved within a week (Black et al., 1988). In 
developing countries a spectrum of disease exists, ranging from severe inflammatory illness to 
mild non-inflammatory diarrhoea and an asymptomatic carrier state (Young and Mansfield, 
2005). Infants and young children tend to be the only groups that have symptomatic disease 
and within these groups non-inflammatory, watery diarrhoea is most common (Blaser et al., 
1980). In these circumstances adults rarely have symptomatic disease and it is in these groups 
that the asymptomatic shedding of C. jejuni has been observed (Pazzaglia et al., 1991). 
 
1.4.1 Complications arising from C. jejuni infection. 
The majority of Campylobacter infections resolve naturally, without the need for 
antibiotic treatment, but complications tend to arise if the organism spreads from the 
gastrointestinal (GI) tract. Local infections, within the GI tract area, such as appendicitis, 
cholecystitis and pancreatitis can occur together with gastrointestinal haemorrhaging (Allos, 
2001). More rare are extra-intestinal infections such as meningitis, endocarditis, septic 
arthritis, osteomylitis and neonatal sepsis. Bacteraemia is also rare, reported in less than 1% of 
cases of Campylobacter infection (Allos, 2001) and these patients are likely to be at the 
extremes of age or have an underlying immune compromise. There are also several late-onset 
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complications following Campylobacter infection which are auto-immune in nature including, 
reactive arthritis, Miller Fisher syndrome, and Guillain-Barŕe syndrome. Recently irritable 
bowel syndrome (IBS), characterised by abdominal pain and altered bowel habit, has been 
associated as a post-infectious manifestation, with enteric C. jejuni infection (Spiller, 2007). 
Thornley et al. (2001) demonstrated that IBS was occurring in individuals who had suffered 
Campylobacter enteritis at a greater rate than expected, given the control data. This study also 
found that C. jejuni isolates that were toxic to Hep-2 cells were more frequently isolated from 
those individuals who went on to develop IBS. 
 
1.4.1.1 Guillain-Barŕe syndrome (GBS) 
GBS is the most common and most serious sequela of infection of C. jejuni and, since 
the eradication of polio in most areas of the world, has become the most common cause of 
acute neuromuscular paralysis (Nachamkin et al., 1998). GBS is an autoimmune disorder of 
the peripheral nervous system and is characterised by muscle weakness and abnormal 
sensations, including tingling, numbness and vibrations, which are usually symmetrical and 
evolve over the course of several days, usually beginning 1-3 weeks after the onset of 
diarrhoeal illness. Severity varies between patients; in the most severe cases facial and eye 
movements become abnormal and breathing muscles are weakened, leading to the need for 
pulmonary support. The disease is self-limiting and many patients make a complete recovery, 
although 15-20% of GBS patients are left with severe neurological defects (Nachamkin et al., 
1998). It is estimated that the incidence of GBS is less than one case per 1000 C. jejuni 
infections and that C. jejuni is the trigger for 30% of cases of GBS (Allos,  1997). The 
pathogenesis of post-Campylobacter GBS is believed to involve molecular mimicry, whereby 
patients who suffer from GBS following C. jejuni infection develop antibodies to the bacterial 
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lipooligosaccharides (LOS), specifically to the LOS outer core, and these antibodies cross-
react with peripheral nerve cell surface gangliosides (Young and Mansfield, 2005). This 
would then cause the host immune system to attack the myelin sheath on host neurons. This is 
supported by the observation that the acute stage of the disease usually coincides with the 
highest serum titres of antiganglioside antibodies. This molecular mimicry is thought to 
involve the presence of sialic acid in the LOS; it has been observed that specific combinations 
of genes are required to allow C. jejuni to express ganglioside mimics (Bersudsky et al.; 
2000, Godschalk et al., 2007). 
 
1.4.1.2 Miller Fisher Syndrome (MFS) 
MFS is a variant of GBS which is characterised by ataxia (loss of coordination), 
ophthalmoparesis (paralysis of the eye muscles) and areflexia (loss of tendon reflexes). The 
development of the disease is more gradual than that of GBS and a complete recovery is 
usually made over weeks or months. The cause of MFS is believed to be a molecular mimicry 
similar to that of GBS and in cases of MFS, serum antibodies that recognise the gangliosides 
GQ1b are often identified (Ang et al., 2002). 
 
1.4.1.3 Reactive arthritis (ReA) 
ReA is a non-purulent joint inflammation which can be triggered by infections in the 
gut or urogenital tract. Apart from C. jejuni, other bacteria known to trigger ReA include 
Salmonella, Yersinia enterocolitica and Shigella flexneri (Hannu et al., 2002). The main 
features of ReA are inflamed joints, inflammation of the eyes and inflammations of the 
urogenital or gastrointestinal systems, without apparent local infection. C. jejuni antigens 
have been shown to be present in affected areas, but no viable organisms have been detected 
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(Smith, 1996). The inflammation is believed to result from the response of synovial T-cells to 
any bacterial antigens present. ReA may occur following 0.7- 7% of cases of Campylobacter 
enteritis (Bremell et al., 1991; Hannu et al., 2002).  
 
1.4.2 Treatment of C. jejuni infection 
Generally, Campylobacter enteritis is a self-limiting disease and supportive measures 
such as fluid and electrolyte replacement are the only therapies necessary for the majority of 
patients. Antibiotic therapy is indicated for patients who are acutely ill with enteritis or are 
HIV positive or otherwise immunocompromised (Butzler, 2004). Macrolide antibiotics, such 
as erythromycin, clarithromycin and azithromycin are the drugs most commonly used to treat 
C. jejuni infection, due to their ease of administration, lack of serious toxicity, low cost, high 
efficacy and narrow spectrum of activity (Allos, 2001). Fluoroquinolone antibiotics, such as 
ciprofloxacin, may also be used, with the advantage that other bacterial pathogens capable of 
causing gastroenteritis are also susceptible, removing the need to wait for laboratory test 
results. However, an increasing number of strains worldwide have been found to be 
developing resistance to fluoroquinolone antibiotics, possibly due to the use of substances 
related to these drugs in poultry farming (Snelling et al., 2005). 
Vaccination is a possible option for the control of Campylobacter. Immunity against 
campylobacters has been demonstrated in several groups including: those individuals 
previously infected (Black et al., 1988), in breast-fed infants whose mothers have been 
recently exposed (Nachamkin et al., 1994) and in abattoir workers (Cawthraw et al., 2000). 
Orally administered vaccines have been most frequently evaluated, as the vaccine would need 
to stimulate intestinal immunity to be effective against Campylobacter. Baqar et al. (1995) 
demonstrated that an inactivated whole-cell vaccine produced immunity in primates and Lee 
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et al (1999) used a whole-cell vaccine plus purified flagellin to produce some immunity in a 
mouse model. The C. jejuni capsule has also been investigated for its potential to deliver 
vaccine candidates (Baqar et al., 2007). 
 
1.5 Pathogenesis of C. jejuni 
 Whilst C. jejuni has been recognised as an important human pathogen for more than 
30 years, detailed knowledge of its pathogenicity factors remains elusive. C. jejuni is a food-
borne pathogen and as such enters the host via ingestion in contaminated food or water; 
inocula as low as 800 cells were found by Black et al. (1988) to cause disease in humans. 
Campylobacters enter the host intestine by passing through the stomach acid barrier and 
colonise the mucus layer covering the epithelia of the distal ileum first and then that of the 
colon (Ketley 1997); it is after colonisation of the colon that disease symptoms begin to 
appear (Black et al., 1988). Having successfully colonised the mucus layer, campylobacters 
interfere with the absorptive capacity of the intestine by damaging epithelial cells by invasion 
and toxin production, resulting in inflammation and diarrhoea (Park, 2002). A series of 
processes are necessary for Campylobacter virulence; these include: 1) adhesion, 2) invasion, 
3) toxin production and 4) intracellular survival and intestinal translocation; motility and 
chemotaxis are also necessary for virulence, especially in the early stages of infection. 
 
1.5.1 Adhesion 
 
Adhesion is thought to be fundamental to C. jejuni pathogenesis. Adhesins are 
molecules present on the surface of a bacterial cell that facilitate the attachment of the 
bacterial cell to host cell receptor molecules; this process is thought often to be essential for 
disease to occur. C. jejuni adhesins have been shown to be synthesised constitutively, as 
metabolically inactive (heat-killed and sodium-azide killed) C. jejuni were found to bind to 
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cultured cells at levels comparable with metabolically active organisms (Konkel et al., 1992). 
A variety of outer-membrane proteins have been implicated in adhesion, as have other cell 
surface structures including lipooligosaccharide and the major outer membrane protein. 
 
1.5.1.1 Outer membrane proteins (Peb1, CadF and JlpA). 
Peb1 was first identified by de Melo et al. (1990). It is a 28 kDa protein, homologous 
with membrane proteins involved in amino acid transport from other Gram-negative bacteria 
and has been shown by Pei et al. (1998) to mediate C. jejuni binding to epithelial cells. 
Konkel et al. (1997) characterised another outer membrane protein that facilitates C. jejuni 
binding to the host attachment protein fibronectin, an adhesive protein that provides structural 
support in epithelial cells. This 37 kDa protein was designated CadF and is also believed to 
enhance internalisation of C. jejuni into host cells. JlpA is a 42 kDa lipoprotein originally 
identified by Jin et al. (2001), and is believed to facilitate attachment of C. jejuni to epithelial 
cells but to play no role in internalisation.  
 
1.5.1.2 Lipooligosaccharides (LOS) 
LOS and polysaccharide capsules are major surface antigens of Campylobacter and 
have been shown to have a role in virulence in a variety of pathogenic enteric bacteria, 
including a role in host cell binding and in some cases internalization in E. coli, Salmonella 
typhi and Neisseria gonorrhoeae (Konkel et al., 2001). It has been suggested that structural 
changes in LOS could alter the organisms’ surface charge, so affecting its binding potential; 
McSweegan and Walker, (1986) proposed that the binding of C. jejuni to cultured epithelial 
cells was mediated by LOS.  
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1.5.1.3 Major outer membrane protein (MOMP) 
In 1997 Schröder and Moser proposed that the MOMP of C. jejuni, named PorA, an 
importance surface antigen which functions as a porin to facilitate the transfer of hydrophilic 
molecules across the outer membrane, could also serve as an adhesin, as it was found to bind 
to cultured cell membranes. The specificity and mechanism of MOMP binding to cultured 
cells has not been determined. 
 
1.5.2 Invasion and protein secretion 
  The symptoms of campylobacteriosis, including inflammation, the presence of blood 
and leukocytes in faeces and occasional bacteraemia, strongly suggest that invasion is an 
important pathogenic mechanism in C. jejuni as all of the above are products of the 
mammalian inflammation process; however, little is known about the exact mechanisms used 
to achieve this. Invasion of C. jejuni is strain dependent, with clinical isolates being more 
invasive than environmental strains (Konkel and Joens, 1989); the ability of cells to invade 
can be lost during extensive passage in vitro (Konkel et al., 1990). C. jejuni does not 
constitutively synthesise proteins to induce uptake, as metabolically inactive (sodium-azide 
killed) cells are not internalised.  Also chloramphenicol, a specific inhibitor of bacterial 
protein synthesis, prevents the internalisation of C. jejuni by host cells (Raphael et al., 2005). 
However, blocking host cell protein synthesis with cyclohexamide does not inhibit C. jejuni 
invasion, suggesting that the host cell proteins required for invasion are present during normal 
cell growth (Oelschlaeger et al., 1993).  
 Motility has been demonstrated by several studies as being necessary for invasion, 
although there is no evidence to support a direct role for any of the flagellar apparatus 
proteins in invasion by C. jejuni (Wassenaar et al., 1991; Golden and Acheson, 2002; Carrillo 
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et al., 2004). A range of bacterial proteins have also been linked to invasion as, following co-
cultivation of C. jejuni with INT407 cells, C. jejuni was seen to produce at least 14 additional 
proteins, in comparison to bacteria cultured without cells (Konkel and Cieplak, 1992).  Later 
studies by Konkel et al. (1993) identified nine new proteins relative to media-grown bacteria, 
using rabbit antisera; one of these proteins, CiaB (Campylobacter invasion antigen B), has 
been found to be necessary for the secretion of the other eight (Konkel et al., 1999). CiaB has 
also been shown, by immunofluorescence microscopy, to translocate into infected host cells 
during the infection process. Rivera-Amill et al. (1999) proposed that its translocation 
occurred via a type III-like secretion process, as the Cia proteins conform to the criteria of 
type III secretion proteins. The only type III-like secretion apparatus encoded by C. jejuni 
NCTC 11168 is the flagellar apparatus (Parkhill et al., 2000), Larson et al. (2008) 
demonstrated that CiaB could hypothetically be secreted via the C. jejuni flagellar type III-
like secretion system.  Poly et al. (2007) showed that a minimal flagellar structure was 
necessary for the secretion of the novel virulence factor FspA, which is not thought to be 
involved in adherence or invasion; one version, FspA2, has been shown to be associated with 
host cell monolayers during induced apoptosis. The secretion of proteins via the flagella 
apparatus has also been reported in other bacteria including Yersinia enterocolitica (Young et 
al., 1999) and Bacillus thuringiensis (Ghelardi et al., 2002) and Konkel et al. (2004) found 
that mutations that affected either the export of flagella components or the non-filament 
structural components of C. jejuni 81-176 also resulted in a secretion-negative phenotype.  
 
1.5.3 Toxins 
 Campylobacters reportedly produce a variety of toxic activities, but most current work 
is centred on an exotoxin that is a member of the cytolethal distending toxin (CDT) family 
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and is the only fully defined toxin encoded in the genome sequence of C. jejuni NCTC 11168 
(Parkhill et al., 2000). CDT was first discovered in E. coli and also known to be produced by 
certain Shigella and Salmonella enterica strains and is encoded by many C. jejuni strains 
(Johnson and Lior, 1988; Lara-Tejero and Galan, 2000). It is encoded by three adjacent genes 
cdtA, cdtB and cdtC; the holotoxin consists of one copy of each gene product (Lara-Tejero 
and Galan, 2001; Pickett and Lee, 2005). CDT appears to be toxic to a wide variety of 
cultured mammalian cell lines, apparently by blocking cell division by arresting the cell cycle 
at the G2/M phase, after chromosome duplication but before chromosome separation and cell 
division. Elwell and Dreyfus, (2000) have shown that the CdtB subunit of the toxin has 
homology to certain mammalian DNases and is responsible for bringing about cell cycle 
arrest by degrading the host cell chromosomes, but it is not clear what role the CDT has in 
human infection in vivo. 
 
1.5.4 Intracellular survival and intestinal translocation 
1.5.4.1 Intracellular survival 
 Having colonised the mucus layer of the intestines, campylobacters invade 
intestinal epithelial cells and interfere with the absorptive capacity of the intestine, resulting in 
inflammation and diarrhoea (Park, 2002). There appear to be three key stages in C. jejuni 
interactions with nonphagocytic cells that contribute to this, mediation of uptake into cells, 
avoidance of lysosomes by the modification of vesicular trafficking and stimulation of the 
release of proinflammatory cytokines.  Several studies have investigated the fate of 
campylobacters after entering host cells, in general it has been found that C. jejuni cells lose 
viability over a 24 hour period when within intestinal epithelial cells (Candon et al., 2007; 
Day et al., 2000). However, Watson and Galan (2008a) demonstrated, using LIVE/DEAD 
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staining, that there is no significant decrease in C. jejuni viability after 24 hours within 
epithelial cells, but that these cells could no longer be cultured using standard laboratory 
conditions and additional oxygen limiting conditions were necessary for the successful 
growth of these cultures. C. jejuni cells have been found localized in membrane-bound 
vacuoles, so called C. jejuni containing vacuoles (Kiehlbauch et al., 1985; Russell and Blake, 
1994). It is also apparent that C. jejuni has developed a method of altering normal host 
epithelial cell traffic such that these vacuoles are not delivered to lysosomes (Watson and 
Galan, 2008b). However, these alterations do not function in macrophages as C. jejuni 
containing vacuoles are targeted to lysosomes and hence destroyed in these cells (Kiehlbauch 
et al., 1985; Wassenaar et al., 1997). C. jejuni is susceptible to NO generated both by the 
reaction of dietary nitrate with gastric acid in the stomach and by the nitric oxide synthases of 
macrophages (Iovine et al., 2008). Resistance to NO stress is regulated by NssR, the 
nitrosative stress response regulator and detoxification appears to be carried out largely by 
Cgb, a single domain globin; also regulated by NssR are at least four other genes of unknown 
functions (Elvers et al., 2005). Also produced by host immune cells, particularly neutrophils 
and macrophages are reactive oxygen species, which can include superoxides and hydrogen 
peroxide. C. jejuni is sensitive to reactive oxygen species and encodes several genes to 
enhance its resistance, including katA, which encodes catalase to breakdown hydrogen 
peroxide to H2O and O2 (Grant and Park, 1995). C. jejuni also encodes a single superoxide 
dismutase (SOD) gene, sodB, which catalyses the breakdown of superoxide to H2O2 and O2 
(Cabiscol et al., 2000). 
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1.5.4.2 Intestinal translocation 
The ability of a pathogen to migrate across a cell barrier by invading cells can be an 
important virulence factor, as it allows access to underlying tissues and dissemination through 
a host organism. However, C. jejuni can also translocate across the epithelial cell barrier in an 
alternative invasion mechanism and occasionally may migrate from the intestinal mucosa to a 
variety of extra-intestinal sites, resulting in complications including cholecystitis and 
septicaemia. The mechanism of translocation, which involves the bacteria moving between 
host cells rather than being internalised by them, is unclear, although Bras (1999) reported 
that functional flagella and de novo protein synthesis is required. Grant et al. (1993) also 
reported that mutants in flaA were unable to cross epithelial cell monolayers, indicating that 
FlaA is somehow essential for translocation. Harvey et al. (1999) found no correlation 
between an isolate’s invasive and translocation potential, indicating that the genes encoding 
the products necessary for invasion are different from those that confer translocation ability. 
This may also suggest that C. jejuni may translocate a cell monolayer using a paracellular 
route (between cells) rather than a transcellular route (through cells), as the ability to invade 
would not be necessary for the former type of movement (Raphael et al., 2005).  
 
1.5.5 Chemotaxis and Motility 
Both motility and chemotaxis have been shown to have an important role in host 
colonisation and virulence (Yao et al., 1997). Chemotaxis is necessary for the invasion of host 
tissues and as such campylobacters possess mechanisms to detect chemical gradients, which 
are linked to motility functions, enabling them to move up and down chemical gradients 
(Snelling et al., 2005). The genome sequence of C. jejuni NCTC 11168 revealed the presence 
of orthologues of several genes involved in chemotaxis, the che genes, and aerotaxis, aer 
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genes,  in E. coli and other bacteria; also present are 10 chemoreceptor and two aerotaxis 
receptor orthologues (Parkhill et al., 2000; Korolik and Ketley, 2005). Chemo-attractants of 
C. jejuni include mucin components, including L-fucose and L-serine and particular organic 
acids, such as pyruvate and succinate (Hugdahl et al., 1988). 
Chemotaxis is possible only if the organism is sufficiently motile to move along the 
detected gradient; C. jejuni is highly motile by means of a single, unsheathed flagellum at one 
or both ends of the cell, allowing the organism to travel at up to 75μm.s-1 (Carrillo et al., 
2004). The combination of the flagellum and the spiral cell shape are believed to give 
campylobacters high motility in viscous environments, such as the mucus layer in intestines. 
Whilst it appears that flagella do not have a role in adherence, as non-flagellated C. jejuni 
cells were able to adhere to epithelial cells as effectively as wild-type cells (Grant et al., 1993; 
Nachamkin et al., 1993), it does appear that flagella have a role in the internalisation process. 
Aflagellate mutants were internalised into host cells at a considerably lower level than the 
wild-type (Grant et al., 1993). It has been hypothesised by Yao et al. (1994) that the flagellum 
may also be able to act as a type III-like secretion mechanism, for the secretion of virulence 
proteins; Campylobacter lacks an independent type III system. 
 
1.6 The genome of C. jejuni NCTC 11168 
1.6.1 The genome sequencing project 
The genome sequence of C. jejuni NCTC 11168 was completed in 2000 by Parkhill et 
al and was the first Campylobacter genome to be sequenced. The genome comprises a 
circular chromosome 1,641,481 base pairs in size, with a G+C content of 30.6% which is 
predicted to encode 1,654 proteins and 54 stable RNA species. It is one of the densest 
bacterial genomes sequenced, with about 94.3% of the genome thought to encode proteins. 
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The genome has several remarkable features, one of which was that it was almost devoid of 
phage-associated sequences and contained few repeat sequences, only four within the 
complete genome. Another important feature is the presence of homopolymeric runs of ca. 9-
13 nucleotides, known as hypervariable sequences, which were often seen in genes 
responsible for the biosynthesis and modification of surface structures or in other genes of 
unknown functions closely associated to these genes. These hypervariable sequences would, 
by slipped strand mis-pairing, allow expression of these genes to be phase variable, producing 
a high frequency of on and off changes and which may explain the capacity of C. jejuni to 
produce phase variation in the carbohydrate moieties present in surface structures such as 
flagella. The size of the chromosome means that the number of genes is limited, 
approximately 1,600 in C. jejuni NCTC 11168 as opposed to more than 5,000 in Salmonella, 
which may help to explain why Campylobacter has comparatively fastidious growth 
requirements. When the flagellar genes were compared to those of the E .coli/Salmonella 
model flagellar system, some genes were absent, including several regulatory genes such as 
the flhDC master regulator system, while others were present in addition. All gluconeogenesis 
genes and those of the tricarboxylic acid pathway were present, but at least one of the genes 
of the glycolytic pathway was lacking. About 55.4% of the genes have orthologues in H. 
pylori, many of which have housekeeping functions. 
 Following the sequencing of this first genome by Parkhill et al. (2000) several 
other C. jejuni sequences have been completed including C. jejuni 81-176 (Hofreuter et al., 
2006) and C. jejuni RM1221 (Fouts et al., 2005). Certain non-jejuni Campylobacter have also 
been sequenced including C. coli RM2228, a multidrug-resistant poultry isolate (Miller, 2008) 
and a human clinical isolate of C. lari, RM2100 (Miller, 2008). The availability of multiple 
Campylobacter genome sequences allows the application of comparative genomics 
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approaches to identify virulence determinants and metabolic pathways common to the 
majority of campylobacters, as well as the identification of genes and/or pathways specific to 
particular Campylobacter species, which could potentially be linked to differences host-range, 
colonisation and virulence which are already known. With regards to flagellin glycosylation, 
the availability of multiple genome sequences has allowed the diversity of flagellin 
glycosylation associated genes, both in terms of number and type, to be identified. 
 
1.6.2 The sequenced NCTC 11168 strain differs from the original isolate. 
Following the completion of the genome sequence of C. jejuni, it was observed that 
the genome sequenced C. jejuni NCTC 11168 strain was flagellate but non-motile, and 
defective in its ability to colonise both one-day old chicks (Ahmed et al., 2002) and SCID 
mice (Hodgson et al., 1998). These differences were believed to have arisen due to extended 
subculturing of the 11168-GS WT strain over a period of years (Gaynor et al., 2004). The 
strain was first isolated by Skirrow in 1977 from human diarrhoeic faeces and was 
subsequently added to the National Collection of Type Cultures (NCTC) where the strain was 
subcultured to provide both a freeze-dried stock and for distribution to other laboratories; it 
was from this subcultured background that the genome-sequenced strain was derived, which 
here is designated 11168-GS WT. However, when the 11168-GS WT strain was originally 
isolated, frozen stocks were also kept separately to that accessed to the NCTC. These stocks 
are thought not to have been subcultured so extensively and were presented to the Veterinary 
Laboratories Agency in 1999; it is from this background that the C. jejuni 11168 ‘original’ 
strain is derived, which here is designated 11168-O WT. Gaynor et al. (2004) found that the 
original strain, unlike the genome-sequenced strain, was able to colonise one-day old chicks 
extremely well. In the same study, differences in morphology were also observed; the original 
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strain was spirally shaped as is expected in Campylobacter, whereas the genome-sequenced 
strain had a straight, rod-like morphology. Whilst both isolates retained polar flagella, the 
genome-sequenced strain was deficient in motility in both broth and soft agar, in contrast the 
original strain was highly motile on both substrates and in broth showed the fast, darting 
motility characteristic of Campylobacter.  
Whilst no significant difference in the DNA sequence of the two isolates was found, 
microarray experiments showed that several clusters of genes were differently expressed in 
the genome-sequenced and original strains. Several respiratory and metabolic genes, 
including genes involved in the TCA cycle and in gluconeogenesis, were expressed at higher 
levels in the original strain compared to genome-sequenced, under both microaerobic and 
severely oxygen-limited conditions. A number of flagellar genes were also expressed at 
significantly higher levels in the original strain, particularly under severely oxygen-limited 
conditions; these genes included several putative hook and basal body structures. The major 
flagellins flaA and flaB were expressed at comparable levels in both variants, together with 
other known flagellar genes. Gaynor et al. (2004) hypothesised that these expression 
differences were due to the fact that the original strain was better adapted to the oxygen-
limited conditions that would be encountered in the anaerobic parts of the gut. The genome-
sequenced strain had become, over time, more adapted to the laboratory environment where it 
would be more likely to encounter atmospheric oxygen concentrations than the oxygen 
starvation experienced in the gut, hence it no longer responded to the stimulus of oxygen-
limitation. The 11168-O WT used here may not be identical to that examined by Gaynor and 
co-workers in 2004, but its phenotype appears closely related. 
The difference in motility between the two strains has also been examined by Turner 
and Penn (2005), who compared the whole cell protein profiles of the strains by SDS-PAGE. 
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The flagellin of the 11168-GS strain was seen to have a lower molecular mass than that of the 
11168-O strain; a possible explanation for this is a variation in the post-translational 
modifications of the flagellin protein. Campylobacter flagellin has been shown by Thibault et 
al. (2001) to be one of the most extensively modified prokaryotic proteins known, with 
approximately 10% of the mass of the protein being made up of O-linked carbohydrates; a 
phenomenon which will be discussed in detail later.  
 
1.7 Bacterial flagella 
 The flagellum is a structure which mediates bacterial motility, can act as a protein 
export apparatus and is also an important bacterial virulence factor. Flagellar biosynthesis has 
been most thoroughly studied in Escherichia coli K-12 and Salmonella enterica serovar 
Typhimurium LT2, as historically these bacteria were among the first studied in detail and are 
now used as model systems for the elucidation of processes involved in flagella assembly and 
function.  A general model of bacterial flagellar structure, function, assembly and regulation 
has been derived from these studies. However, it is clear that there are many bacterial species, 
only distantly related to those used to form the model, that are flagellate and whose flagellar 
differ accordingly (Pallen et al., 2005); Campylobacter should be considered one of these 
species. 
 
1.7.1 Flagellar structure 
 Bacterial flagella are long, spiral shaped hair-like structures that protrude from the 
surface of the cell. To produce thrust the flagellum is rotated by a membrane bound molecular 
motor located at its base. A flagellum consists of three structural subunits, a long helical 
filament, a short curved hook structure and the basal body, which is made up of a series of 
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rings surrounding a central rod (See Figure 1.1; also MacNab, 2003). At least 20 separate 
proteins, ranging in copy number from many thousand to a very few, are used to build the 
flagellar structure itself, and approximately another 30 are used to assist in its construction. 
    
 
 
 
 
 
 
 
 
Figure 1.1. A diagrammatic structure of the Escherichia coli/ Salmonella enterica 
flagellar paradigm. The flagellum can be divided into three separate structures, the basal 
body, hook and filament. The basal body consists of the rod (FlgB, FlgC, FlgF, FlgG and 
FliE), the rings: MS ring (FliF), P ring (FlgI) and the L ring (FlgH), the stator MotA and 
MotB), the rotor (FliG), the rotor/ switch apparatus (FliG, FliM and FliN) and the flagellar 
export apparatus (not shown). The hook consists of the FlgE protein separated by the hook/ 
filament junction proteins FlgK and FlgL from the filament, which in E. coli/ Salmonella is a 
single protein, FliC; the filament is capped by FliD, the capping protein. In C. jejuni the 
filament consists of two proteins, FlaA and FlaB. (Adapted from the KEGG database, 
Kanehisa et al. (2004).  
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1.7.1.1 Basal body 
 The basal body is situated at the base of the flagellar structure and spans the 
cytoplasmic membrane, periplasmic space, peptidoglycan layer and outer membrane. It 
produces torque via the flagellar motor and transmits it to the hook and filament and also 
anchors the structure into the cell. The basal body consists of the MS-ring situated in the 
cytoplasmic membrane, a rod that spans the periplasmic space, a periplasmic P-ring and 
finally an outer membrane L-ring. The flagellar motor has two main components, the stator 
and the rotor, the stator is made up of multiple copies of the proteins MotA and MotB and is 
attached non-covalently to the peptidoglycan layer. The rotor, the part which spins, consists of 
multiple copies of FliG and is non-covalently attached to the MS-ring; it extends into the 
cytoplasm to form the C-ring. Together these proteins are responsible for generation of the 
rotary motion of the flagellum by a process which is not entirely understood. In the model 
proposed by Kojima et al. (2001) the MotAB complex harnesses proton movement across the 
cell membrane and couples this proton flow to the generation of rotational torque in the motor 
in a process which involves conformational changes induced by the protonation/ 
deprotonation of the Asp32 residue of MotB. The switch, which consists of proteins FliG, 
FliM and FliN, and allows the motor to switch between clockwise and counter-clockwise 
rotation in response to environmental signals, is located in the cytoplasm around the C-ring. 
 
1.7.1.2 Hook 
 The hook is situated entirely outside of the cell and connects the basal body to the 
filament of the flagellum; it is a cylindrical structure composed of multiple copies of a single 
protein, FlgE. Between the hook and the filament are two short zones of junction proteins, 
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FlgK and FlgL, which may function as adaptors, allowing the differently structured proteins 
of the hook and filament to be joined together.  
 
1.7.1.3 Flagella filament 
 The filament is the largest part of a flagellum. It may be up to 20nm in diameter and 
several microns in length and is composed of tens of thousands of individual flagellin 
proteins. It is helical in shape and so, when rotated, functions as a propeller-like screw; in the 
E. coli/ Salmonella paradigm it is composed of a single type of protein, flagellin, FliC. At the 
distal end of the filament there is a cap made up of FliD, the filament capping-protein which 
plays a critical role in the assembly of a growing flagellar filament (Homma et al., 1984). The 
cap consists of five FliD subunits which form a pentagonal structure with leg-like extended 
domains which insert individually into cavities at the distal end of the forming flagellum. The 
space which forms underneath the pentagonal structure allows the flagellin subunits, which 
have been exported to the distal end of the flagellum, to be added to the structure (Yonekura 
et al., 2000).  
 
1.7.2 Flagellar assembly in Salmonella  
 The assembly of a flagellum is thought to begin with the insertion of the MS-ring into 
the cytoplasmic membrane via the Sec pathway (see Figure 1.2; Aizawa, 1996). The next 
event is likely to be the assembly of the C-ring, containing the switch and the Mot proteins, 
although it has also been hypothesised that the motor and switch proteins are able to insert 
into the membrane at any time during flagellar formation. 
 All flagellar proteins assembled after this point use the flagellar type III-like secretion 
pathway for export, with the exception of the L and P-ring proteins. The remaining proteins of 
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the basal body are assembled next, beginning with FliE and continuing sequentially, ending 
with FlgJ, the rod capping protein. The P-ring protein, FlgI, and the L-ring lipo-protein, FlgH, 
are exported via the Sec pathway. The rod capping protein, FlgJ, is then displaced by FlgD, 
the hook cap.  After this, the addition of hook and filament subunits is only able to take place 
endogenously, via the type III secretion pathway and the axial channel. The hook is made up 
of FlgE and its length is controlled by FliK and FlhB, although the mechanism by which this 
occurs is not entirely understood (MacNab, 2003). Once the hook has reached the correct 
length, the hook cap is displaced by FlgK, the first hook-filament junction protein; FlgL, the 
second junction protein is added next. Once FliD, the filament cap is in place, flagellin 
subunits, FliC, are added underneath it, completing the flagellum.  
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Figure 1.2. Assembly pathway for the flagellum of Salmonella. Brackets indicate 
substructures assembled prior to the utilization of the type III export pathway. Genes or 
proteins necessary at each stage are indicated. CM, cytoplasmic membrane; P, peptidoglycan 
layer; OM outer membrane. Adapted from MacNab (2003)
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1.7.3 Flagellar gene organisation in E. coli/ Salmonella 
 More than 50 genes are required for the assembly and function of the flagellum in the 
E. coli/ Salmonella model; these include structural subunits, regulatory proteins, motor 
proteins and chemosensory mechanisms (Chilcott and Hughes, 2000). The nomenclature of 
the majority of these genes begins with fl and is followed by either g, h or i depending upon 
the location of the gene on the E. coli/ Salmonella chromosome, a final letter, beginning with 
A, is added depending upon the flagellar gene organisation in that region of the chromosome 
(Iino et al., 1988). Whilst this is true for the majority of genes in the E. coli/ Salmonella 
model, some genes were identified after this system had been established and others are 
named for their null phenotype, e.g. motA and motB for motility negative.  
In the E. coli/ Salmonella model, motility and chemotaxis genes are mainly arranged 
in clusters in three chromosomal regions (See Figure 1.3; also Macnab, 1996; Soutourina and 
Bertin, 2003). Cluster I consists of the flg structural genes, cluster II the flh regulator, motor 
and chemotaxis genes and cluster III, the fli structural and export apparatus genes; this region 
consists of two parts, separated by a smaller region of DNA unrelated to the flagellar genes. 
Flagellar gene organisation differs considerably across the various genera that possess 
flagella, with some organisms having quite coherently arranged operons, such as 
Pseudomonas aeruginosa (Dasgupta et al., 2003); others have apparently little organisation, 
such as C. jejuni (Parkhill et al., 2000). 
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Figure. 1.3. Chromosomal locations of the operons that make up the flagellar regulon of 
Salmonella enterica serovar Typhimurium. The operons are labelled E, M, or L for early, 
middle or late expression respectively. Arrows indicate co-expression of a group of genes to 
form an operon. Adapted from Chilcott and Hughes (2000).
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1.7.4 Flagellar gene expression in E. coli/ Salmonella 
 In Gram-negative bacteria flagellar gene expression is hierarchical, with genes 
expressed in the order in which they are required for flagellar assembly and controlled by 
transcriptional regulators, including alternative sigma factors and anti-sigma factors (Macnab, 
2003; Soutourina and Bertin, 2003). Genes are divided into three hierarchical transcription 
classes, early, middle and late (see Figure 1.3). The early genes are regulatory proteins that 
may control the expression of the entire regulon; middle genes generally produce the 
structural components of the basal body, hook and associated type III secretion system. 
Products of late genes include the filament, some components of the motor system and 
chemosensory proteins (Aldridge and Hughes, 2002). As some of the genes or clusters in each 
group are expressed from different promoters, the promoters themselves are organised into 
three classes (Chilcott and Hughes, 2000). Early genes typically have class I promoters, 
middle genes class II and late genes class III.  
 The flhDC master switch operon is at the top of the hierarchy, as FlhD and FlhC are 
required for the expression of all other regulatory genes responsible for flagellar biosynthesis. 
The cyclic AMP catabolite activator protein (cAMP-CAP) is an activator of the flhDC master 
operon and hence the operon is sensitive to environmental and cell state signals. FlhD and 
FlhC form a heterotetrameric complex, which is responsible for the transcription of certain 
middle and late genes from σ70 dependant promoters (Chilcott and Hughes, 2000). Proteins in 
the middle class of expression are mainly structural proteins and those involved in assembly 
of the hook-basal body of the flagellum. Also transcribed are transcriptional regulators FliA, 
an alternative sigma factor, σ28, required for transcription of late flagellar genes and FlgM, an 
anti-sigma factor which negatively regulates late genes (Ohnishi et al., 1992). Before 
formation of the flagellar secretory apparatus FlgM is present in the cytoplasm and is 
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complexed with σ28, inhibiting the association of σ28 with RNA polymerase and hence 
transcription. After hook-basal body synthesis, which includes synthesis of the type III-like 
secretion system, FlgM is secreted, allowing σ28 to bind RNA polymerase and for 
transcription of the late genes to occur (Hughes et al., 1993). Certain genes are transcribed 
from both FlhDC class II and σ28 dependent class III promoters, such as fliD, the filament cap 
gene, and fliK, the hook length control protein; as such they are expressed at both the middle 
and late stages of flagellar biosynthesis (Kutsukake 1994). 
 
1.7.5 Differences between flagella in C. jejuni and the E. coli/ Salmonella paradigm.  
 C. jejuni differs from both E. coli and Salmonella in that it has only a single flagellum 
at one or both ends of the cell. More bacteria are thought to possess these polar flagella than 
the peritrichous flagella of the E .coli/ Salmonella model, although this latter system has been 
studied in more detail. There are several major differences between the two systems; one of 
the most notable is the absence of the flhDC master regulator system in most non-
enterobacteriaceae. There are also observable differences in the quaternary structure of C. 
jejuni and Salmonella flagella; C. jejuni flagella are heavily glycosylated whilst E. coli and 
Salmonella flagella are unglycosylated. Hence it is clear that the E. coli/ Salmonella paradigm 
is not sufficient for the understanding of all flagellar systems and that other models of 
bacterial flagellar systems are required. 
 
1.7.5.1 Flagellar genes in C. jejuni. 
 Approximately 42 genes (Parkhill et al., 2000), are thought to be involved in flagellar 
biosynthesis in C. jejuni, the majority of which are conserved with those of the E. coli/ 
Salmonella paradigm (Jagannathan and Penn, 2005); C. jejuni flagellar genes have been 
Introduction  Chapter I 
  39 
 
named based on their similarities to E. coli/ Salmonella genes. Whilst in many bacteria 
flagella genes are clustered in defined regions, those of C. jejuni are distributed throughout 
the genome at 32 different loci (Guerry et al., 2000; Parkhill et al., 2000). If early C. jejuni 
flagellar genes were regulated and expressed together with genes of other functions, or were 
expressed constitutively, the absence of a master regulator in this species could, at least in 
part, be explained. Genes found in the E. coli/ Salmonella model and missing in C. jejuni 
include the flhDC master regulators, anti-σ28 factor flgM, and several chaperones and rod-
hook associated proteins (Parkhill et al., 2000). Genes encoding additional proteins are also 
present; rpoN encodes σ54, a principle element in flagellar gene expression control. Also an 
NtrC homologue, FlgR, has been shown to act as a transcriptional activator of σ54 dependent 
genes (Jagannathan et al., 2001). Other genes present include a two-component regulator 
system comprising FlgR-FlgS (Hendrixson and DiRita, 2003) and a duplication of flgE, the 
hook structural protein, amongst others (Jagannathan and Penn, 2005). In C. jejuni there are 
also approximately 50 genes involved in flagellar glycosylation which are entirely absent 
from E. coli and Salmonella. The exact function of flagellar glycosylation is unknown but it is 
apparent that it has some role in flagellar biogenesis and function and also probably is 
involved in either bacteriophage or host immune system evasion. 
 
1.7.5.2 Flagellar structure in C. jejuni 
 The structural parameters of Salmonella flagella have been closely measured; 
filaments are usually 15μm long, 220Å wide, are formed of 11 protofilaments and comprise 
of approximately 30,000 FliC subunits (Macnab, 1996). Protofilaments are strands formed of 
stacked flagellin subunits and 11 of these stacks, arrayed helically, are needed in Salmonella 
to form the tubular flagellar filament. Protofilaments can exist in two slightly different 
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conformations, left and right-handed which alter the repeat distance and packing of the 
protofilaments altering the superstructure of the flagellum (O’Brien and Bennett, 1972). 
Different arrangements of protofilaments can produce two straight and 10 types of 
supercoiled flagellar filament (Calladine, 1975). The helical structure of a flagellum is 
necessary to allow the flagellum to generate thrust and propel the cell when rotated; an 
entirely straight flagellum is unable to do so. Given the sequence similarity between the 
flagellar filament genes of C. jejuni (FlaA and FlaB) and Salmonella (FliC) it has been 
generally assumed that C. jejuni and other bacterial flagella are likely to be composed of 11 
protofilaments. However, Galkin et al. (2008) using electron microscopy identified that 
flagella from C. jejuni were in fact narrower than those from Salmonella, approximately 180Å 
rather than 220Å. Given that C. jejuni flagellins have a greater molecular weight (59.5kDa 
alone or approximately 65kDa including glycosylations) than Salmonella FliC (52.2kDa), this 
result was surprising. Further work by this group demonstrated that in fact Campylobacter 
flagella have only seven protofilaments, which are more loosely packed resulting in a lumen 
of a comparable size, Figure 1.4.  
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Figure 1.4. Three dimensional reconstructions of flagellar filaments of Salmonella and C. 
jejuni. Showing the central lumen (coloured red) surrounded by 11 protofilaments in 
Salmonella and seven in C. jejuni. The Scale bar indicates 50 Å. Adapted from Galkin et al. 
(2008). 
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Another major difference between Salmonella and C. jejuni flagella is that C. jejuni flagellin, 
like flagellin from the other epsilon-Proteobacteria, does not activate vertebrate Toll-like 
receptor 5 (TLR5; Andersen-Nissen et al., 2005). Toll-like receptors are an important family 
of innate immune receptors that recognise pathogen associated molecular patterns.  These are 
usually evolutionarily conserved structures, vital for microbial fitness, that are not present in 
the host (Andersen-Nissen et al., 2007). TLR5 is known to recognise bacterial flagellin 
(Hayashi et al., 2001) and the recognition site is located in the highly conserved D1 domain of 
the flagellin protein (Smith et al., 2003), although the D2 and D3 domains also appear to be 
required. No post-translational modifications are thought to be involved. This domain, at least 
in Salmonella, interacts with adjacent flagellin monomers via polar-polar and charged-polar 
interactions to form the flagellar filament (Yonekura et al., 2003); the structure of the 
Salmonella flagellin protein, FliC, is shown in Figure 1.5. In Salmonella, mutants in 
individual residues in the TLR5 recognition site had either severely reduced motility or were 
entirely non-motile (Smith et al., 2003), indicating that the residues recognised by TLR5 are 
also likely to be required for correct flagellin subunit-subunit interactions 
 Work by Andersen-Nissen et al. (2005) showed that C. jejuni flagellin was not 
recognised by TLR5 and identified several specific changes in the TLR5 recognition site 
residues that are responsible for TLR5 evasion. Whilst these changes in structure, if present in 
Salmonella flagellin, would cause a decrease in motility, C. jejuni flagellin possesses as least 
some compensatory mutations that allow for the flagellin subunit interactions necessary for 
motility, but which are not involved in TLR5 recognition. Galkin et al. (2008) suggest that the 
altered protofilament arrangement, and consequent alteration in the packing of D1 domains, 
which they discovered in C. jejuni may be a product of mutations which led to the ability of 
C. jejuni to evade TLR5 recognition.
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Figure 1.5. Structure of the Salmonella flagellin FliC, showing the four domains.  
Domains D0 and D1 are well conserved between different bacterial species and in the 
flagellum are helically stacked to form the filament core. Domains D2 and D3 are highly 
variable in both sequence and length between different bacterial species and are surface 
exposed, protruding from the side of the flagellar filament. Adapted from Samatey et al. 
(2001). 
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1.8 Protein glycosylation in C. jejuni 
Once believed to occur only in eukaryotes, it is now evident that glycoproteins are a 
common feature in all domains of life. Information about the structures of linked glycans and 
the process of glycosylation is limited, although it appears that bacterial glycans are more 
complex than those found in eukaryotes. One of the best studied examples of bacterial protein 
glycosylation is that of C. jejuni where two glycosylation loci have been identified which 
encode both O-linked and N-linked protein glycosylation pathways. 
 
1.8.1 N-linked protein glycosylation 
The N-linked general protein glycosylation system was thought, when the gene cluster 
was first discovered, to be involved in the biosynthesis of lipopolysaccharide (Korolik et al., 
1997). Subsequently it was shown, by Szymanski et al. (1999), to have a role in the 
glycosylation of a multitude of C. jejuni proteins. The N-linked glycosylation locus is 16kb in 
size and genes from this locus are named pgl for protein glycosylation. The structure of the 
glycans, which are heavily modified bacillosamine residues, has been deduced, the glycans 
are linked to proteins through asparagine residues in the motif Asn-Xaa-Ser/Thr, which is the 
same motif used in eukaryotes (Young et al., 2002; Wacker et al., 2002). Glycosylation of 
proteins occurs in the periplasm and more than 30 proteins are believed to be glycosylated by 
this locus (Young et al., 2002), the majority of which appear to be either surface exposed or 
secreted. Unlike the genes involved in C. jejuni flagellin glycosylation, the pgl locus is highly 
conserved between strains of C. jejuni and C. coli and lacks homopolymeric sequences 
(Szymanski et al., 2003). This suggests that the generation of structural and antigenic 
diversity is not the primary role of this system, which remains unclear, although as the 
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majority of proteins modified by this system are surface-exposed or excreted, it is possible the 
protection against extracellular proteases could be an important role for this system. 
 
1.8.2 O-linked flagellin glycosylation 
Initial evidence for the post-translational modification of Campylobacter flagellin 
came from the analysis of C. coli VC167 flagellin by Logan et al. (1989) who identified a 
number of serine residues in the central region of the amino acid sequence that were modified. 
That glycosylation was the post-translational modification involved was originally suggested 
by Doig et al. (1996) who demonstrated that C. jejuni flagellins are sensitive to periodate 
oxidation and could bind sialic-acid-specific lectins. The subsequent sequencing of the C. 
jejuni NCTC 11168 genome by Parkhill et al. (2000) revealed the presence of a flagellar 
glycosylation gene cluster containing almost 50 genes, the majority of which are not shared 
with H. pylori (Jagannathan and Penn, 2005). The genes encoding the flagellin proteins FlaA 
and FlaB are the only flagellar structural genes included in this cluster, which has been 
designated the flagellin glycosylation locus, see Figure 1.8 and Table 1.2. Annotation of the 
glycosylation locus predicted that approximately half of the genes in this region would have a 
role in glycan biosynthesis (Parkhill et al., 2000).  The size of the locus varies considerably 
between strains, from the 20kb locus of C. jejuni 81-176 to the 50kb locus of C. jejuni NCTC 
11168, which is the largest known. It was initially supposed that the sugar biosynthesis genes 
in the flagellin glycosylation locus were involved in sialic acid biosynthesis (Doig et al., 
1996). It was later realised, through the analysis of flagellins in C. jejuni by Thibault et al. 
(2001) and in C. coli by Logan et al. (2002), that the modification on the flagellins was in fact 
pseudaminic acid (Pse), a structural relative of sialic acid. Pse is a nine-carbon sugar member 
of the 5, 7-diamino-3, 5, 7, 9-tetradeoxynon-2-ulosonic acid family; details of all of the 
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flagellar glycans thus far identified in Campylobacter are given in Table 1.1. So far 
investigations have focused on C. coli VC167 and C. jejuni 81-176 (examples include: 
Thibault et al., 2001 and McNally et al., 2007) as these strains have smaller flagellin 
glycosylation loci and it was hypothesised that their post-translational glycosylations would 
be correspondingly simpler.
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Table 1.1 Post-translational modifications of Campylobacter flagellins. Structures adapted from McNally et al. (2007). The major 
modifications present in the various strains are indicated by *. 
Modification Structure 
Neutral Glycan 
mass (Da) 
Glycan residue 
mass (Da)
d
 
Present on flagellins of: 
C. jejuni 
81-176 
C. coli 
VC167 
C. jejuni 
NCTC 
11168 
Pseudaminic acid  
(Pse5Ac7Ac or PseAc) 
 
334 316 
b* a c 
Acetamidino pseudaminic acid 
(Pse5Ac7Am or PseAm) 
- 333 315 
b* 
- 
c 
O-acetyl pseudaminic acid 
(Pse5Ac7Ac8OAc or PseOAc) 
- 376 358 
b 
- - 
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N-acetyl glutamine pseudaminic acid 
derivative (Pse5Ac7Ac8-GlnAc or 
PseGlnAc) 
- 504 486 
b 
- - 
Dihydroxypropionyl pseudaminic 
acid derivative (PsePr) 
- 427 409 
 
b 
- - 
Dimethylglyceric derivative of 
acetamidino pseudaminic acid 
- 405 389 - - 
 
c* 
Dimethylglyceric derivative of 
pseudaminic acid 
- 406 390 - - 
 
c* 
Acetamidino pseudaminic acid- 
deoxypentose 
- 449 431 - 
c 
- 
O-acetyl pseudaminic acid- 
deoxypentose 
- 
 
450 432 - 
c 
- 
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Legionaminic acid derivative 
(Leg5Am7Ac or LegAm) 
 
333 315 - 
a* c 
Legionaminic acid derivative 
(Leg5AmNMe7Ac or MeLegAM). 
 
347 329 - 
a* c 
 
Identified by: 
a
 McNally et al. (2006a); 
b
 Thibault et al. (2001); 
c
 Logan et al. (2009). 
d
 The glycan residue mass gives the mass of the glycan minus the mass of one H2O molecule, which is as it would appear if identified from 
flagellar glycopeptides analysed by mass spectrometry.
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1.8.2.1. Flagellin glycosylation in C. jejuni 81-176.  
Flagellins from C. jejuni 81-176 were examined by Thibault et al. (2001) and found to 
be modified at 19 serine and threonine residues, see Figure 1.6; the modifications together 
contribute approximately 10% (6000Da) to the molecular mass of the flagellin. Pseudaminic 
acid (PseAc) was identified as the major glycosyl component, while other modifications 
structurally related to PseAc are present and include acetamidino pseudaminic acid (PseAm), 
an O-acetyl derivative of PseAc (PseOAc) and a dihydroxypropionyl derivative, (PsePr), see 
Table 1.1. It was shown that only selected serine and threonine residues were glycosylated 
and that the modifications themselves appeared to be restricted to particular residues, 
suggesting that the glycosylation process is specific. However, it was also noted that in a pseA 
mutant that was unable to produce PseAm, the residues which would have been modified with 
PseAm were instead modified with PseAc. Most of the modified residues are located in a 
narrow region of the central flagellin domain, corresponding to domains D2 and D3 in 
Salmonella flagellin, which are believed to be surface exposed (Power et al., 1994; Logan et 
al., 2008); no evidence of the presence of unglycosylated flagellin was found. 
There are 23 flagellin glycosylation associated genes in C. jejuni 81-176, the best 
characterised of which are those of the pse family, which form the pathway by which C. jejuni 
81-176 synthesises and attaches PseAc and PseAm to flagellin (Guerry et al., 2006); the 
means by which PseOAc and PsePr are synthesised are unclear. The full biosynthetic pathway 
for the conversion of UDP-N-acetylglucosamine to pseudaminic acid involves PseB/Cj1293, 
PseC/Cj1294, PseH/Cj1313, PseG/Cj1312, PseI/Cj1317 and PseF/Cj1311. All pse genes thus 
far identified have homologues in C. jejuni NCTC 11168, see Table 1.2.
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Figure 1.6. Locations of glycosyl modifications on C. jejuni 81-176 flagellin (Thibault et al., 2001). Residues shown to be modified with 
pseudaminic acid derived glycosyl groups are shown in red and other serine and threonine residues are shown in yellow.
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1.8.2.2. Flagellin glycosylation in C. coli VC167.  
Flagellin modification in C. coli VC 167 was first examined by Logan et al. (2002), 
who showed that flagellins from this strain were post-translationally modified at more than 16 
amino acid residues. The locations of the modifications are shown in Figure 1.7 and the 
details of the sugars in Table 1.1. Both PseAc and what was initially thought to be a form of 
PseAm slightly different in structure to that found on C. jejuni 81-176 flagellin were 
identified; PseOAc and PsePr were not found. McNally et al. (2007) discovered that the form 
of PseAm was in fact likely to be a legionaminic acid derivative with the same mass. 
Legionaminic acid is a 9-carbon sugar, previously identified as part of the lipopolysaccharide 
of Legionella pneumophila and Pseudomonas aeruginosa (Luneberg et al., 2000; Knirel, 
2003); two legionaminic acid derivatives actually present on C. coli VC167 flagellins are, the 
acetamidino form, LegAm, and an N-methylacetimidoyl form, MeLegAm (McNally et al., 
2007). 
The flagellar glycosylation region of C. coli VC167 contains 14 genes including genes 
homologous to those of the pse family of C. jejuni 81-176, although in this strain pseA, which 
synthesises PseAm directly from PseAc in C. jejuni 81-176, is a pseudogene. C. coli VC167 
also has a separate group of genes, the ptm family (post-translational modification), which are 
involved in the synthesis of the legionaminic acid derivates.
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0 GFRINTNVAA LNAKANSDLN SRALDQSLSR LSSGLRINSA ADDASGMAIA 
51 DSLRSQANTL GQAISNGNDA LGILQTADKA MDEQLKILDT IKTKATQAAQ 
101 DGQSLKTRTM LQADINRLME ELDNIANTTS FNGKQLLSGG FTNQEFQIGS 
151 SSNQTIKASI GATQSSKIGV TRFETGSQSF SSGTVGLTIK NYNGIEDFKF 
201 QNVVISTSVG TGLGALAEEI NRNADKTGIR ATFDVKSVGA YAIKAGNTSQ 
251 DFAINGVVIG KVDYSDGDEN GSLISAINAV KDTTGVQASK DENGKLVLTS 
301 ADGRGIKITG SIGVGAGILH TENYGRLSLV KNDGRDINIS GTGLSAIGMG 
351 ATDMISQSSV SLRESKGQIS AANADAMGFN AYNGGGAKQI IFASSIAGFM 
401 SQAGSGFSAG SGFSVGSGKN YSAILSASIQ IVSSAASISS TYVVSTGSGF 
451 SAGSGNSQFA ALRISTVSAH DETAGVTTLK GAMAVMDIAE TAITNLDQIR 
501 ADIGSVQNQI TSTINNITVT QVNVKSAESQ IRDVDFASES ANYSKANILA 
551 QSGSYAMAQA NSSQQNVLRL LQ 
 
Figure 1.7. Locations of glycosyl modifications on C. coli VC167 flagellin (Logan et al., 2002). Peptides examined for modified residues are 
underlined and residues known to be definitely modified are shown red, while other serine and threonine residues are shown in yellow
Introduction  Chapter I 
  54 
 
1.8.2.3. Flagellin glycosylation in C. jejuni NCTC 11168.  
Whilst homologues of genes from both the pse and ptm pathways are present in the 
flagellin glycosylation region of C. jejuni NCTC 11168, many other genes in this region 
remain hypothetical; the genes of this region are detailed in Table 1.2. The types of 
modifications present on C. jejuni 11168 flagellin have been examined by Logan et al. 
(2009), but none have been located to specific residues. As the genes of the flagellin 
glycosylation region of C. jejuni 11168 have homologues in the glycosylation regions of 
C. jejuni 81-176 and C. coli VC167 it is unsurprising that C. jejuni 11168 flagellin 
should be glycosylated with some of the carbohydrates found on flagellins from these 
strains including PseAc, PseAm and legionaminic acid derivatives (Logan et al., 2009). 
But the increased complexity of the glycosylation locus in this strain also suggests that a 
wider variety of modifications, resulting from several different pathways could also be 
present. As such, Logan et al. (2009) also identified di-O-methylglyceric derivatives of 
both PseAc and PseAm which had not been identified previously in Campylobacter and 
were the most abundant modifications present. 
Whole genome comparisons have identified the flagellar locus as one of seven 
hypervariable plasticity regions in the Campylobacter genome (Pearson et al., 2003). 
The genes of the C. jejuni NCTC 11168 flagellar glycosylation region are detailed in 
Table 1.2, together with their proposed functions and details of homologous genes in C. 
jejuni 81-176 and C. coli VC167. Some of these genes are members of the 1318 motility 
accessory factor (1318/maf) family of flagellin-associated proteins. The maf family has 
seven members, Cj1318, pseD (Cj1333), Cj1334, Cj1335/6, pseE (Cj1337), Cj1340 and 
Cj1341, several of which are involved in motility variation by slipped-strand mispairing 
of homopolymeric tracts (Karlyshev et al., 2002). maf2 (Cj1333) has recently been re-
annotated as pseD and has been shown to have some involvement in the attachment of 
Introduction  Chapter I 
  55 
 
PseAm to flagellin in C. jejuni 81-176 (Guerry et al., 2006). maf5 (Cj1337) has likewise 
been re-annotated as pseE (McNally et al., 2006a); the functions of the other members 
of the maf family are unknown, although as both pseD and pseE have been implicated 
in the attachment or transfer of sugar groups to flagellin it is possible that all genes in 
this family have roles in the later stages of flagellin glycosylation if all are not involved 
in attachment. The proteomic map produced by Parrish et al. (2007) indicated that PseE 
interacts directly with FlaA and FlaB, further supporting its assignment as a gene 
involved in sugar transfer or attachment.  
A comparative phylogenomic study by Champion et al. (2005) identified a 
cluster of genes (Cj1321 to Cj1326) as being characteristic of a livestock clade. 
Recently Howard et al. (2009) confirmed that the genes of this locus, especially Cj1324, 
have a significant part in promoting the ability of C. jejuni to colonise chickens. 
Mutants in Cj1324 (ptmG), which were motile and retained full-length flagella, were 
also less hydrophobic and less able to autoagglutinate and form biofilms than the wild-
type. Analysis of Cj1324 mutant flagellin also showed that certain legionaminic acid 
derivatives were absent from flagellins, subsequently, these particular glycans were 
shown to be prevalent in Campylobacter strains isolated from chickens, providing 
strong evidence for the involvement of flagellin glycosylation in colonisation and 
explaining why certain Campylobacter isolated are more likely to colonise chickens 
than others (Howard et al., 2009). 
maf1 and maf4 are direct repeats, each containing a homopolymeric sequence; 
another homopolymeric tract is located in maf7 (Cj1342c). Altogether the flagellin 
glycosylation locus includes 10 homopolymeric sequences, nine of which are located 
within the coding region of a gene (Turner and Penn, 2005). In Campylobacter these 
tracts have been seen to vary in length at a frequency higher than that found in other 
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organisms; some regions of the C. jejuni genome show two or three sequence variants 
present simultaneously in similar amounts, which is not often seen in other organisms 
(Parkhill et al., 2000). 
 
1.8.2.4 Flagellin glycosylation in Helicobacter pylori 
 Helicobacter pylori, a mucosal pathogen and closely related species to 
Campylobacter also produces flagellins that are glycosylated with PseAc. In this 
bacterium it appears that both the FlaA and FlaB proteins are glycosylated, with seven 
and ten residues respectively (Schirm et al., 2003); in Campylobacter it has never been 
possible to determine whether both flagellins are glycosylated due to their high 
sequence similarity. Only the single glycan, PseAc, has been observed decorating H. 
pylori flagellin, this is reflective of the limited number of flagellin glycosylation related 
genes present in H. pylori in  comparison to Campylobacter (Josenhans et al., 2002; 
Parkhill et al., 2000). Glycosylation appears, as in Campylobacter, to be necessary for 
flagellar assembly in Helicobacter (Schirm et al., 2003). The presence of a sheath 
covering the flagellar filament may reduce the need for a great diversity in the types of 
flagellar glycans on H. pylori flagellin, particularly if the glycans are involved in host 
immune system or bacteriophage evasion.  
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Table 1.2. The flagellin glycosylation locus of C. jejuni NCTC 11168. Genes shown in bold are part of the flagellar modification region 
(FMR). c indicates that the coding sequence of the gene in located on the complementary strand. 
Gene 
Homolog in Motility of 
mutant in C. 
jejuni 81-176 
maf family 
genes 
Homopolymeric 
tract
c
 
Function 
C. jejuni 81-
176 
C. coli VC167 
pseB (Cj1293) 
 - Mot- - - 
The first stage in PseAc synthesis, 
the mutant accumulates 
unglycosylated flagellin 
monomers intracellularly
1 
pseC (Cj1294) 
 - Mot- - - 
PseAc biosynthesis
2 
Cj1295 
 - Mot+ - G(9) 
Unknown 
Cj1296 - - - -  G(9) Unknown 
Cj1297 - - - -  Unknown 
Cj1298 
 - Mot+ - - 
Unknown 
Cj1299 - - Mot+ - - Unknown 
Cj1300 
 - Mot+ - - 
Unknown 
-on c strand 
Cj1301 - - - - - Unknown 
Cj1302 
 - Mot+ - - 
Unknown 
fabH2 (Cj1303) 
 - Mot+ - - 
Putative acyl-carrier-protein 
synthase 
accP (Cj1304) 
 - Mot+ - - 
Putative acyl-carrier-protein 
Cj1305c 
 - Mot+ - C(9) 
Unknown 
Cj1306c - - - - C(9) Unknown 
Cj1307 - - - - - Unknown 
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Cj1308 - - - - - Unknown 
Cj1309c - - - - - Unknown 
Cj1310c - - - - C(9) Unknown 
pseF (Cj1311) 
 - Mot- - - 
PseAc biosynthesis
2 
pseG (Cj1312) 
 - Mot- - - 
PseAc biosynthesis
3 
pseH (Cj1313) 
 - Mot- - - 
PseAc biosynthesis
3
 
HisH (Cj1314c) 
  Mot+ - - 
Histidine biosynthesis
2 
HisF (Cj1315c) 
  Mot+ - - 
Histidine biosynthesis
2 
pseA (Cj1316c) 
 
 
Mot+ - - 
Synthesis of PseAm directly from 
PseAc, a mutant in C. jejuni 81-
176 was motile but had all PseAm 
modifications replaced with 
PseAc
4
. Is a pseudogene in C. coli 
VC167 
-pseudogene
b 
pseI (Cj1317) 
  Mot- - - 
Final stage of PseAc synthesis in 
C. jejuni 81-178
5 
Cj1318 - - - maf1 G(11) Unknown 
Cj1319 -  - - - Unknown 
Cj1320 -  - - Integenic 
G(10-11) 
Unknown 
Cj1321 - - - - Unknown 
Cj1322 - - - - - Unknown 
Cj1323 - - - - - Unknown 
ptmG (Cj1324) -  - - - Legionaminic acid biosynthesis 
6
 
ptmH (Cj1325/6)
d
 -  - - G(10) Legionaminic acid biosynthesis 
6
 
ptmC (Cj1327) -  - - - 
Legionaminic acid biosynthesis 
7
 
ptmD (Cj1328) -  - - - 
Legionaminic acid biosynthesis 
6
 
ptmE (Cj1329) -  - - - 
Legionaminic acid biosynthesis 
6
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ptmF (Cj1330) -  - - - 
Legionaminic acid biosynthesis 
6
 
ptmB (Cj1331) -  - - - Legionaminic acid biosynthesis 
7 
ptmA (Cj1332) -  - - - 
Legionaminic acid biosynthesis 
6
 
pseD (Cj1333) 
 - Mot+ maf2 - 
Involved in attachment of 
PseAm to flagellin
2,3 
Cj1334 
 - Mot+ maf3 - 
Unknown 
Cj1335/6
d
 
- - - maf4 G(9) 
Unknown; in C. jejuni 108 a 
functional maf4 gene caused novel 
flagellin glycoforms and increased 
autoagglutination
8 
pseE (Cj1337) 
 - Mot- maf5 - 
Involved in assembly and transfer 
of glycosyl groups to flagellin
3,9 
flaB (Cj1338c) 
  - - - 
Minor flagellin protein 
flaA (Cj1339c) 
  - - - 
Major flagellin protein 
Cj1340c - - - - - Unknown 
Cj1341c 
 - Mot+ maf6 - 
Unknown 
Cj1342c 
 - Mot+ maf7 C(9) 
Unknown 
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a
 - In C. jejuni 81-176 the Cj1300 coding sequence is on the complementary strand. 
 
b
 - In C. coli VC167 pseA (Cj1316c) is present but as a pseudogene. 
 
c
 - All homopolymeric sequences are located within a gene unless stated. The figure in brackets indicates the consensus number of residues in 
that tract in the C. jejuni NCTC 11168 genome sequence (Parkhill et al., 2000). 
 
d
 - Presence of a non-consensus number of residues in the homopolymeric tracts between these coding sequences would allow them to be 
expressed as a single gene, as in Gundogdu et al. (2007) 
 
 
1
 - Goon et al. (2003)       
2
 - Guerry et al. (2006)     
3
 - McNally et al. (2006a)     
4
 - Thibault et al. (2001)
 
     
5
 - Chou et al. (2005) 
6
 - Logan et al. (2002) 
7
 - McNally et al. (2007) 
8
 - van Alphen et al. (2008)
  
9
 - Schirm et al. (2003)
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1.8.3 Mechanism of flagellin glycosylation 
 Whereas the N-linked glycosylation system of Campylobacter glycosylates a 
relatively wide range of proteins with a motif, Asn-Xaa-Ser/Thr, linked to the transfer 
of glycans, the O-linked system appears to be more specific as only the flagellin 
structural proteins are known to be glycosylated and there is no apparent motif linked to 
glycosylation. Other prokaryotic glycosylation systems have been associated with the 
cell membrane in the periplasm (Aas et al., 2007, Chaban et al., 2006 and Smedley et 
al., 2005); this can not be true for flagellin glycosylation as flagellin monomers are 
secreted through the flagellar apparatus to the tip of the growing filament and never 
enter the periplasm. It is possible that glycosylation takes place in the cytoplasm, 
possibly in association with the flagellar basal body, although there is no evidence to 
support this; alternatively it may be at the level of transit across the cytoplasmic 
membrane. As there is no motif linked to glycosylation, as there is with the N-linked 
system, it is not easy to identify the mechanism that determines which serine and 
threonine residues are to be glycosylated. It is possible that, as the glycosylations are 
localised to the central domains of the flagellin, folding of the protein plays a part, 
although it is also possible that glycosylation in the central domain is determined by 
function only. 
  
1.8.4 Biological role of O-linked glycosylation in Campylobacter 
The Campylobacter flagellin glycosylation locus is, as previously mentioned, 
highly variable, containing many genes which encode enzymes involved in the 
biosynthesis of a variety of complex carbohydrates and have the potential to be phase 
variable by means of slipped-strand mispairing of homopolymeric runs of single 
nucleotides. The potential for generating so wide a diversity of flagellin glycoproteins 
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suggests a mechanism for immune system or bacteriophage evasion by antigenic 
diversity; this is supported by the fact that the flagellin is both surface exposed and an 
immunodominant protein. However, it has been shown by Schirm et al., (2003) that the 
membrane sheathed (hence not exposed) flagella of H. pylori are also glycosylated with 
pseudaminic acid, which could suggest a role other than immune system evasion for 
flagellin glycosylation. This role may be in flagellar assembly and/or function.  An 
increasing body of evidence suggests that glycosylation is required for the assembly 
and/or function of Campylobacter flagella. Upon mutagenesis several genes located in 
the flagellin modification locus give a non-motile phenotype (see Table 1.2). A mutant 
in pseB, which encodes the first stage of the PseAc synthesis pathway, in C. jejuni 81-
176 is unable to synthesis PseAc, lacks flagella and accumulates unglycosylated 
flagellin intracellularly (Goon et al., 2003). It is also possible that flagellar glycans 
contribute to flagellin subunit-subunit interactions in compensation for those mutations 
which allow for evasion of TLR5 by Campylobacter flagellin but also affect flagellin 
subunit interactions in flagellar biogenesis.  
It is not currently evident how flagellin glycosylation is involved in flagellar 
assembly; it is quite possible that the effects on flagellar assembly may be incidental, 
and glycosylation may have a different and as yet unclear primary role.  It is likely to be 
of some importance, as a relatively large part of the compact genome of C. jejuni 
appears to be devoted to these processes. Likewise almost nothing is understood about 
the regulation of flagellin glycosylation in Campylobacter and how it is integrated with 
other regulatory circuits. 
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1.8.5 Regulation of flagellin glycosylation genes by NssR 
The response to nitric oxide (NO) related stress in C. jejuni is regulated by NssR 
(Cj0466), a member of the FNR-CRP family of transcriptional regulators (Elvers et al., 
2005); more details are given in Section 1.3.6. NssR controls the expression of a 
regulon of at least four genes in response to nitrosative stress in both the C. jejuni 
NCTC 11168 sequence strain and its ‘original’ motile variant, detailed in section 1.6.2 
and here designated 11168-O WT and 11168-GS WT respectively, representing original 
and genome sequenced.  
It has been observed (Sue Turner, unpublished data) that in the ‘original’ strain 
background, 11168-O, a deletion mutant in nssR, designated 11168-O 0466
-
, exhibited 
lower levels of expression of several genes in the flagellin glycosylation region than 
was observed the wild-type, under normal, NO-free, conditions. Microarray analysis 
was carried out for both the wild-type and NssR mutant (11168-O WT 0466
-
 ) without 
nitrosative stress, and 17 genes located in the flagellin glycosylation region were found 
to be down-regulated in the 11168-O 0466
-
 mutant in comparison to the wild-type. 
These genes are located between the direct repeats Cj1318 and Ci1336 and have been 
designated the flagellin modification region (FMR) in this study. This NO-independent 
difference in gene expression suggests that NssR is involved, either directly or 
indirectly, in the regulation of this cluster of genes. Examination of motility in the 
11168-O 0466
-
 mutant indicated that although it is still motile, it is less motile than the 
parent strain. Differences in mass of the flagellin protein were also observed by SDS-
PAGE. An NssR mutant was also constructed in the 11168-GS strain background and 
microarray analysis conducted, without NO stress, for the 11168-GS wild-type and 
mutant. The 17 genes were found not to be down-regulated in the 11168-GS strain 
(Lynne Lawrence, unpublished data), suggesting that expression differences in this 
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region may contribute to the differences observed between the 11168-O WT and 11168-
GS WT strains.  
Amongst the cluster of 17 genes down regulated in the ‘original’ background 
nssR mutant, there are several that are known to be involved in the post-translational 
glycosylation of flagellin in other Campylobacter strains, such as ptmA-G and pseD. 
How NssR is involved in the regulation of these genes is unknown, as are the effects of 
the down-regulation of these genes themselves.  
 
1.9 Aims 
Whilst the nature of the glycosyl groups present on Campylobacter flagellins, 
the genes responsible and even, to some degree, the functions of flagellin glycosylation 
are being discovered, no information is available on the regulation of flagellin 
glycosylation in Campylobacter. As a relatively large number of genes, given the small 
size of the Campylobacter genome, are involved in flagellin glycosylation, regulation of 
this process would appear to be important. The first aim of this project is to investigate 
the detailed response and potentially the mechanism by which NssR regulates the genes 
of the FMR, to attempt to establish whether NssR acts directly on the genes themselves 
or indirectly, via another regulator.  
Motility is vital for Campylobacter virulence; several genes involved in flagellar 
glycosylation, when mutated, cause a loss or alteration of motility. The NssR mutant 
created in the original background appears significantly less motile than its parent 
strain, although it retains a certain level of motility; the 11168-GS background strains 
are non-motile. The motility of the Campylobacter strains used in this study will be 
examined and recorded using rigorous and potentially quantitative methods. 
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The glycosyl groups present on the flagellins of two Campylobacter strains (C. 
jejuni 81-176 and C. coli VC167) have been deduced and located to specific serine and 
threonine residues. Whilst the glycosyl modifications present on C. jejuni 11168 
flagellin have been identified, the particular residues upon which they reside have not. 
The final aim of this project is to identify and locate, using mass spectrometry, the 
glycosyl residues present on the flagellin of the Campylobacter strains used here. 
Taken together, data gained using these approaches will significantly enhance 
knowledge and understanding of the mechanisms and role of flagellin glycosylation in 
C. jejuni NCTC 11168.  
General materials and methods  Chapter II 
  66 
 
Chapter II: General Materials  
and Methods 
 
2.1 Bacterial culture media 
All culture media were obtained from Oxoid (Basingstoke, UK), prepared using 
distilled water and sterilised by autoclaving at 121°C at 15 p.s.i for 15 minutes. 
Supplements were added to the media after it had cooled to 52°C; all media were stored 
at 4°C. 
 
Muller Hinton Broth (CM0405) 
Dehydrated Beef Infusion   From 300 g 
Casein hydrolysate    17.5 g 
Starch      1.5 g 
Made up to 1 litre with distilled water 
For 1 litre Muller Hinton agar add 17 g agar 
 
Luria Bertani Broth 
Tryptone     10 g 
Yeast extract     5 g 
NaCl      10 g 
Made up to 1 litre with distilled water 
For 1 litre Luria Bertani agar add 17 g agar 
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2.2 Antibiotics and other additives 
All antibiotics and additives used in this study are listed in Tables 2.1 and 2.2 
respectively. All antibiotics and additives dissolved in water were filter-sterilised with 
0.22 µm syringe filters (Pall Corporation, Portsmouth, UK) before use and stored in 
aliquots at 
-
20°C. 
 
Table 2.1 List of antibiotics 
Antibiotic Stock solution 
(mg.ml
-1
) 
Concentration used 
(µg.ml
-1
) 
 
Ampicillin 
(Sigma, Gillingham, UK) 
100 in H2O 100 
Chloramphenicol 
(Sigma, Gillingham, UK) 
50 in H2O 50 
Kanamycin 
(Sigma, Gillingham, UK) 
20 in absolute ethanol 20 
 
 
Table 2.2 List of additives 
Additive Stock solution Concentration used 
Isopropyl-β-D-
thiogalactopyranoside 
(IPTG, Bioline, London, 
UK) 
0.1 M in H2O 0.1 mM 
5-Bromo-4-chloro-3-
indolyl-β-D-galactoside 
(X-gal, Bioline, London, 
UK) 
40 mg.ml
-1
 in dimethyl 
formamide (Fluka, 
Gillingham, UK) 
40 µg.ml
-1 
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2.3 Bacterial strains and plasmids 
The bacterial strains and plasmids used in this study are detailed in Table 2.3 
Table 2.3. Bacterial strains and plasmids used in this study. 
Bacterial strains and 
plasmids 
Characteristics Source or reference 
C. jejuni NCTC 11168 The genome sequenced strain, here 
designated 11168-GS. 
National collection 
of type cultures 
(HPA Culture 
Collections, 
Salisbury, UK) 
C. jejuni 11168-GS 0466
-
 11168-GS nssR::Kan
r
, a Kan
r
 cassette is 
inserted into the remains of the nssR 
gene, which has been deleted. 
Strain made by Sue 
Turner at the 
University of 
Birmingham 
according to the 
method of Elvers et 
al. (2005) 
C. jejuni 11168-GS 0466C 11168-GS 0466
-
 with the  mutation 
complemented by insertion of nssR::Cm
r
 
into Cj0752 
Strain made by Sue 
Turner at the 
University of 
Birmingham 
according to the 
method of Elvers et 
al. (2005) 
C. jejuni 11168-O A version of the original clinical isolate, 
here designated 11168-O. 
Gaynor et al. (2004) 
C. jejuni 11168-O 0466
-
 11168-O nssR::Kan
r
, the same mutation 
as in 11168-GS but in the original stain 
background. 
Elvers et al. (2005) 
 
C. jejuni 11168-O 0466C 11168-O 0466
-
 with the mutation 
complemented by insertion of nssR::Cm
r
 
into Cj0752 
Elvers et al. (2005) 
 
E. coli DH5α F- Φ80dLacZ ΔM15. A standard strain 
used for cloning. 
Invitrogen (Paisley,  
UK) 
E. coli BL21 (DE3) F
-
ompT hsdSB(rB
-
mB
-
) gal dcm (DE3). A 
standard strain for protein expression. 
Bioline (London, 
UK) 
pET 22b Expression vector, amp
r
, with C-terminal 
6xHis•Tag periplasmic export sequence 
to aid recovery of recombinant proteins 
Novagen 
(Darmstadt, 
Germany) 
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pDEX_Fcc Contains 3x FLAG sequence, kan
r
, 
contains two multiple cloning sites 
allowing insertion of sequences for 
homologous recombination onto the 
Campylobacter genome 
For sequence see 
appendix 1. 
pGEM-T Easy High copy number cloning vector, amp
r
, 
allows blue/white screening by 
insertional inactivation of β-galactosidase 
α-peptide 
Promega (Madison, 
USA) 
 
 
2.4 Culture conditions for E. coli and C. jejuni 
Campylobacter jejuni strains were routinely grown from frozen on Muller 
Hinton (MH) agar (Oxoid, Basingstoke, UK)  at 37°C in a microaerobic atmosphere 
containing 5% (v/v) O2, 10% (v/v) CO2 and 85% (v/v) N2, generated by a MACS 500 
variable atmosphere incubator (Don Whitley Scientific Ltd, Shipley, UK) Liquid 
cultures were grown in MH broth in vented cap tissue culture flasks (Becton Dickinson, 
Oxford, UK) at 37°C under the same microaerobic conditions, with shaking at ≈220 
rpm.  
Escherichia coli strains were grown on Luria Bertani (LB) agar medium at 37°C 
under aerobic conditions, liquid cultures in LB broth were incubated aerobically with 
shaking at ≈100rpm.  
 
2.5 Storage of E. coli and C. jejuni 
Strains were stored at -80°C in either MH broth (C. jejuni) or LB broth (E. coli) 
containing 15% (v/v) glycerol (Fisher Scientific, Loughborough, UK) and 2% (v/v) 
foetal bovine serum. Strains were routinely recovered from stocks. 
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2.6 Isolation of genomic DNA 
Cells were grown overnight in broth culture using the strain specific culture 
conditions given above.  To produce a pellet, 40 ml of E. coli culture or 60 ml of C. 
jejuni culture was centrifuged for 10 min at 5,000 x g and the supernatant discarded. 
Genomic DNA was then isolated using the Qiagen genomic DNA extraction kit 
(Qiagen, Crawley, UK), with a 500/G tip, according to the manufacturers instructions.  
The bacterial pellet was re-suspended in 11 ml buffer B1, with 22 l RNase  
(100 mg.ml
-1
), by vortexing to form a homogeneous suspension. To lyse cells 300 l 
lysozyme (100 mg.ml
-1
) in TE buffer and 500 l of Qiagen proteinase K (Qiagen, 
Crawley, UK) were added to the solution, which was then incubated at 37C for 90 
minutes. Following incubation, 4 ml buffer B2 was added to the sample, mixed by 
inverting the tube several times and incubated at 50C for 60 minutes. DNA was 
purified using the Qiagen genomic tip 500/G (Qiagen, Crawley, UK). The genomic tip 
was equilibrated with 10 ml buffer QBT, the sample was then applied to the genomic tip 
and allowed to empty by gravity flow. The tip was washed twice with 15 ml buffer QC 
and DNA eluted into a clean collection tube with 15 ml buffer QF which had been 
warmed to 50C to increase DNA yield. DNA was precipitated with 0.7 volumes of 
room temperature isopropanol and spooled using a glass rod. The DNA was then 
transferred to an Eppendorf tube containing 1 ml TE buffer and allowed to dissolve on 
an orbital shaker at 4C overnight. To determine DNA yield and quality 5 l of DNA in 
the following dilutions: neat, 1:10, 1:20, 1:50, 1:100, together with molecular size 
marker (Hyperladder I, Bioline, London, UK) was examined by agarose gel 
electrophoresis. DNA concentration and quality was also examined using a Nanodrop 
spectrophotometer. 
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2.7 Isolation of plasmid DNA 
2.7.1 Qiagen Midi Kit 
Plasmid DNA was extracted using the Qiagen Midi Kit (Qiagen, Crawley, UK), 
according to the manufacturers’ instructions, when a high yield of concentrated plasmid 
DNA was required, for example for electroporation. A 10 ml liquid culture of E. coli 
was grown to an OD600nm of 0.6; 2 ml of this culture was used to inoculate 25 ml of 
fresh media, which was then grown overnight. Bacteria were then harvested by 
centrifugation at 6,000 x g for 10 minutes at 4°C. The pellet was resuspended in 4 ml 
buffer P1 containing RNase A at a final concentration of 100 µg.ml
-1
 and vortexed to 
ensure a homogenous suspension. Buffer P2 (4 ml) was added, mixed by inversion and 
incubated for 5 minutes at room temperature. Chilled buffer P3 (4 ml) was added, 
mixed by inversion and incubated for 15 minutes on ice. The sample was then 
centrifuged at 15,000 x g for 30 minutes at 4°C, the supernatant was removed promptly 
after centrifugation was complete, retained and centrifuged again at 15,000 x g for 15 
minutes at 4°C.  
A QIAGEN-tip 100 was equilibrated with 4 ml Buffer QBT and allowed to 
empty by gravity flow. The supernatant from the previous step was applied to the 
column and allowed to enter the resin by gravity flow. The column was washed with 2 x 
10 ml aliquots of buffer QC; the DNA was then eluted in 5 ml buffer QF. DNA was 
precipitated by adding 3.5 ml (0.7 volumes) of room-temperature isopropanol, mixing 
and centrifuging immediately at 15,500 x g for 30 minutes at 4°C. The supernatant was 
decanted and the DNA pellet washed twice with 2 ml room-temperature 70% ethanol 
with centrifugation at 15,500 x g. After removal of the supernatant, the pellet was air-
dried for 10 minutes at room-temperate and redissolved in 1 ml TE buffer (pH 8.0). 
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Yield was determined a Nanodrop spectrophotometer and purity examined by agarose 
gel electrophoresis as required. 
  
2.7.2 QIAprep Miniprep 
The QIAprep Miniprep (Qiagen, Crawley, UK) was used according to the 
manufacturers’ instructions as a method of preparing relatively small amounts of 
plasmid DNA, usually for PCR screens or DNA sequencing. Cultures of E. coli were 
grown overnight in 5 ml LB broth, supplemented with the appropriate antibiotic, which 
was inoculated with a single colony from an LB agar plate. Bacterial cells were 
harvested with centrifugation at 8,000 x g for 10 minutes at 4°C. The pelleted cells were 
resuspended in 250 µl buffer P1, transferred to a 1.5 ml Eppendorf tube, where 250 µl 
buffer P2 was added, and the tube inverted to mix. Buffer N3 (350 µl) was added, 
immediately mixed and centrifuged at 13,000 x g for 10 minutes. The supernatant was 
applied to a QIAprep spin column which was then centrifuged for 60s at 13,000 x g and 
the flow-through discarded. The column was washed with 0.5 ml buffer PB and 0.75 ml 
buffer PE, the flow-through was discarded and the column centrifuged for an additional 
1 minute to remove all traces of the wash buffers. The column was transferred to a clean 
1.5 ml Eppendorf tube and plasmid DNA eluted with 50 µl buffer EB. DNA yield and 
purity was assessed using a Nanodrop spectrophotometer or agarose gel electrophoresis 
as necessary. 
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2.8 Agarose gel electrophoresis 
DNA was examined and purified on a 0.7% w/v agarose (Bioline, London, UK) 
gel in 0.5% Tris-borate EDTA (TBE) buffer. To visualise DNA, 0.5μg.ml-1 ethidium 
bromide (Fisher, Loughborough, UK) was mixed into the gel whilst still molten. Prior 
to loading the sample was mixed with 5x loading buffer (Bioline, London, UK), 5-20 μl 
of sample was run as required. Hyperladder I (Bioline, London, UK; 200bp- 10kb) or 
Hyperladder IV (Bioline, London, UK; 100bp- 1kb) was used as a molecular weight 
marker. The gel was usually run at 80V for 1.5h in 1 x TBE buffer. 
 
 
5 x TBE  buffer 
Tris-HCl (Fisher, Loughborough, UK)   54 g 
Boric acid (Fisher, Loughborough, UK)   27.5 g 
0.5 M EDTA (Fisher, Loughborough, UK)   20 ml 
Sterile distilled H2O      to 1L 
 
2.9 Polymerase chain reaction (PCR) 
2.9.1 Primer design 
Primers for PCR were designed based on the following criteria: a melting 
temperature (Tm, °C) calculated as 4°C x (G + C) + 2°C x (A +T) of as close as possible 
to 60C, with each primer pair within 5C of each other where possible.  A primer 
length of 20-30 nucleotides, with as near as possible to a 50 % GC content was 
preferred, although this was not always achievable as Campylobacter has a very AT-
rich genome. Where possible several G or C residues were included at the 3' end of the 
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primers (3’ clamp), to provide a stronger annealing region from which replication can 
be initiated, again this was not always possible. Primer pairs were chosen to avoid cross 
complementarity and inverted repeat sequences which could lead to secondary structure 
formation.  CampyDB pattern search (http://campy.bham.ac.uk) was used to ensure that 
each primer sequence was unique to one location within the genome.  Primers to be 
used for cloning were designed with the necessary restriction sites at their 5` ends. 
Primers were obtained as lyophilized DNA from Eurofins MWG Operon (Ebersberg, 
Germany) and resuspended Milli-Q purified water (Millipore, Billerica, USA) pure 
water to a final concentration of 100μM. 
 
2.9.2 PCR 
For PCR reactions where the amplicon was less than 3 kb in length, either 
BioMix Red (Bioline, London, UK) or GoTaq Flexi DNA Polymerase (Promega, 
Madison, USA) was used; GoTaq was used exclusively in place of BioMix Red after 
problems with the efficiency of the later were encountered. For PCR reactions greater 
than 3 kb in length, or for those reactions where high fidelity was required, for example 
for DNA to be used in cloning reactions, BIO-X-ACT (Bioline, London, UK) was used 
as, it possesses higher fidelity than Taq due to an improved 3`-5` exonuclease proof 
reading activity. Reactions were carried out in 0.2 ml PCR tubes (Star Lab, Milton 
Keynes, UK), with 50μl of reaction solution. To PCR screen clones, the supernatant of 
colony material, taken from cells added to 100 μl of sterile distilled water and boiled for 
10 minutes and centrifuged, was used as a template; for cloning purposes genomic DNA 
was always used as a template.  
 
 
General materials and methods  Chapter II 
  75 
 
The following components were used for reactions with BioMix Red: 
2 x BioMix Red     25.0 μl 
Forward primer (100 μM)    2.0 μl 
Reverse Primer (100 μM)   2.0 μl 
Template (genomic DNA)   2.0 μl 
Sterile distilled water to   50.0 μl 
 
For reactions using either GoTaq or BIO-X-ACT long the following components were 
used: 
5 x Reaction buffer     10.0 μl 
dNTP mix (25 mM each)    0.5 μl 
MgCl2 (100 mM)     4.0 μl 
Forward primer (100 μM)    1.0 μl 
Reverse primer (100 μM)    1.0 μl 
DNA polymerase - BIO-X-ACT (100U.μl) 1.0 μl 
   - GoTaq (200U.μl)  0.25 μl   
Sterile distilled water     to 50 μl 
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The following protocol was used, unless otherwise stated: 
1. Heating at 94°C for 2 minutes 
2. 15 x cycles 
1. Denaturisation at 94°C for 30s 
2. Annealing at Tm of the annealing part of primers only for 30s 
3. Extension at 72°C for estimated time (≈1 minute per kb) 
3. 15 x cycles 
1. Denaturisation at 94°C for 30s 
2. Annealing at Tm of whole primers (including restriction sites) for 30s 
3. Extension at 72°C for estimated time (≈1 minute per kb) 
4. Final extension at 72°C for 10 minutes 
 
After PCR, DNA was purified using either a QIAquick PCR purification kit (Qiagen, 
Crawley, UK) or a QIAquick gel extraction kit (Qiagen, Crawley, UK) if the desired 
DNA was contaminated with other DNA products. See section 2.10 
 
2.10 DNA purification 
 DNA purification was carried out as required, using either a QIAquick PCR 
Purification Kit or, if the required piece of DNA was contaminated with other DNA, by 
subjecting the sample to agarose gel electrophoresis, excising the required band and 
purifying it using a QIAquick Gel Extraction Kit (Qiagen, Crawley, UK). 
 
2.10.1 DNA purification by QIAquick Purification Kit 
 A QIAquick PCR Purification Kit (Qiagen, Crawley, UK) was used according to 
the manufacturers’ instructions to clean DNA. Buffer PB (5 volumes) was added to 1 
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volume of PCR product, mixed by pipetting and added to a QIAquick spin column in a 
2 ml collection tube. The spin column was centrifuged for 1 minute at 8,000 x g, the 
flow-through discarded and the column washed with 750μl buffer PE. The column was 
then centrifuged for an additional 1 minute, to remove all traces of wash buffer, and 
placed into a clean 1.5 ml Eppendorf tube. Buffer EB (50 μl) was added to the spin 
column membrane and the sample eluted. DNA yield and quality was checked using a 
Nanodrop spectrophotometer or agarose gel electrophoresis as required. 
 
2.10.2 DNA purification by QIAquick Gel Extraction Kit. 
 The DNA fragment to be purified was run out on a 0.7% agarose gel until 
clearly separated from any contaminating DNA, the required band was then excised 
from the gel using a sharp, clean scalpel blade, taking care to remove as much 
unnecessary agarose as possible. The mass of the slice was determined and 3 volumes 
of buffer QG added. The slice was then incubated at 50°C with vortexing every 2 
minutes until completely dissolved. Once dissolved, 1 volume of isopropanol was 
added, mixed by pipetting and the sample added to a QIAquick spin column in a 2 ml 
collection tube. The spin column was centrifuged at 13,000 x g for 1 minute, the flow-
through discarded and the column washed with 500μl buffer QC and 750μl buffer PE. 
The column was then centrifuged for an additional minute to remove any traces of wash 
buffer remaining, placed in a clean 1.5 ml Eppendorf tube and the DNA eluted with 50 
μl buffer EB. DNA yield and quality was checked using a Nanodrop spectrophotometer 
or by agarose gel electrophoresis as required. 
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2.11 Restriction digestion 
DNA was digested as needed with the required restriction enzyme, obtained 
from New England Biolabs (NEB, Hitchen, UK). The digestion was usually carried out 
in a 50 µl final volume containing 5 µl of the appropriate 10 x NEBuffer, DNA and 1 µl 
of enzyme per μg of DNA, to a maximum of 3 μl per reaction. The digestion was 
incubated for 1h usually at a temperature of 37°C, unless a specific temperature was 
required by the enzyme. Where digestion with two restriction enzymes was required, the 
buffer with the best suitability for both was used, in cases where this was impossible, 
DNA was digested with the first enzyme and the DNA cleaned prior to digestion with 
the second enzyme. DNA was cleaned with either a QIAquick PCR purification kit or a 
QIAquick gel extraction kit as required.  
 
2.12 Dephosphorylation of vector DNA 
Plasmid cloning vectors were dephosphorylated after digestion with a single 
restriction enzyme to decrease the chance of self-ligation occurring. Calf intestinal 
alkaline phosphatase (CIP), obtained from NEB (Hitchen, UK), was added directly to 
the restriction digestion reaction in the ratio of 0.5 units of CIP per µg of vector and 
incubated at 37°C for 1h. DNA was then cleaned with a QIAquick gel extraction kit 
(Qiagen, Crawley, UK). 
 
2.13 Ligation 
To clone a piece of DNA, both insert and vector were digested with the same 
restriction enzymes then ligated together. T4 DNA ligase (NEB, Hitchen, UK) was used 
in a 20 µl reaction volume containing 2 µl 10 x ligase buffer, vector DNA, insert DNA, 
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1 µl T4 DNA ligase and sterile distilled water. The reaction was incubated at room-
temperature for 20 minutes. A control reaction, where the insert DNA was substituted 
for an equal volume of sterile distilled water, was used to assess the amount of re-
ligation of vector occurring. Insert and vector DNA was added in the ratio 3:1, the 
following equation was used to calculate the amount of insert DNA required: 
 
Vector DNA (ng) x Size of insert (kb) X molar ratio of Insert = Insert 
DNA (ng) Size of vector (kb) Vector 
 
 
2.14 Preparation of chemically competent E. coli cells 
Chemically competent E. coli were produced using the calcium chloride method. 
A 50 μl aliquot of an overnight culture of E. coli was inoculated into 5 ml LB broth and 
grown at 37ºC until the OD600nm reached 0.3. The cells were then centrifuged at 10,000 
x g for 3 minutes, the supernatant removed, the pellet resuspended in 1 ml 0.1M CaCl2 
and left on ice for 30 minutes. The cells were then washed twice in 0.1M CaCl2 and left 
on ice for 1h after the final wash. Finally the cell suspension was dispensed into 100 μl 
aliquots, flash frozen in liquid nitrogen and stored at -80°C until required. 
 
2.15 Transformation 
As required 100 µl aliquots of chemically prepared competent E. coli were taken 
from storage at -80°C, kept on ice for approximately 20 minutes until thawed and then 
mixed by flicking the tube. DNA from a ligation reaction, in a total volume of no 
greater than 10 µl, was added to the cells and mixed by flicking. The cells were then 
incubated on ice for 10 minutes and heat shocked at exactly 42°C for 50s, before being 
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placed back onto ice for 2 minutes. Ice-cold SOC medium (900 µl) was added to the 
cells, which were then incubated aerobically at 37°C for 1h without shaking. Cells were 
then spread onto LB agar plates containing the necessary antibiotics and supplements.  
A positive control consisting of the high copy number plasmid pUC19 was used to 
assess the competency of the cells. A ‘cells only’ control, consisting of competent cells 
put through the transformation procedure without the addition of DNA, was used to 
assess the antibiotic sensitivity of the cells if spread onto supplemented plates and to 
assess the viability of the cells following the procedure, when spread onto plain LB 
agar. The ligation control detailed in section 2.13 was also transformed to assess the 
amount of circular vector DNA present due to re-ligation of the vector occurring in the 
reaction or failure to achieve complete digestion.  
 
SOC medium 
Tryptone   2.0 g   MgCl2 (1M)   0.5 ml 
Yeast extract   0.5 g   MgSO4 (1M)   0.5 ml 
NaCl (1M)   1.0 ml   Glucose (2M)   1.0 ml  
KCl (1M)   0.25 ml  Sterile distilled water  to 100 ml  
 
2.16 Preparation of electrocompetent C. jejuni cells 
 To prepare electrocompetent C. jejuni, cells were grown on a MH agar plate as a 
lawn and harvested in 2 ml MH broth with a sterile loop. After centrifugation at 10,000 
x g for 20 minutes at 4°C the cells were gently resuspended in 1 ml ice-cold wash 
buffer. Centrifugation and washing were repeated three times, the cells were then 
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resuspended in 1 ml wash buffer, dispensed into 100 µl aliquots, snap frozen in liquid 
nitrogen and stored at -80°C until required. 
  
Wash buffer 
 Sucrose    9.31 g 
 Glycerol    1.5 ml 
 Sterile distilled water   to 100 ml  
 
2.17 Electroporation 
 When required, 100 µl aliquots of electrocompetent C. jejuni were taken from 
storage at -80°C and kept on ice for approximately 20 minutes until thawed. Between 1-
3 µg DNA, in volume no greater than 2 µl, was added to pre-cooled cuvettes and kept 
on ice. Competent cells (100 µl) were added to each cuvette, mixed and electroporated 
at 2.5kV, 200 Ω and 25 µF using a BioRad (Hemel Hempstead, UK) gene-pulser with a 
time constant between 4-6 ms. Cuvettes were flushed with 100 µl SOC buffer (section 
2.15), the cells spread onto non-selective MH plates and incubated overnight to allow 
time for the expression of antibiotic resistance genes to occur. After overnight 
incubation (preferably lasting no longer than 20h) cells were harvested with 1 ml MH 
broth and spread onto MH agar plates containing a reduced concentration (40%) of the 
appropriate antibiotic(s). These plates were incubated for up to five days and any 
resulting colonies purified on MH agar plates containing the full concentration of 
antibiotic(s).  
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2.18 DNA sequencing 
DNA was sequenced on an automated ABI 3700 sequencer using the ‘ABI 
PRISM BigDye Terminator Cycle Ready Kit’ (Applied Biosystems, Foster City, USA), 
at the Genomics Laboratory of the School of Biosciences, University of Birmingham. 
The primers used were either the primers used for PCR or specifically designed for 
sequencing, depending upon the type of sequencing to be carried out; in all cases a final 
primer concentration of  3.2 pM was used. The amount of DNA added to the reaction 
was dependant upon the size of the DNA fragment to be sequenced, Table 2.4 details 
the amount of DNA required; the total reaction volume was 10 μl, sterile distilled water 
was added to the reaction if necessary. 
 
Table 2.4. Amounts of DNA required for sequencing 
DNA Amount 
PCR product, size: 100 - 200 bp 1 - 3 ng 
 200 - 500 bp 3 – 10 ng 
 500 - 1000 bp 5 - 20 ng 
 1000 - 2000 bp 10 - 40 ng 
 >2000 bp 40 ng 
Double stranded DNA 200 - 500 ng 
Genomic DNA 2 - 3 μg 
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2.19 Transmission Electron Microscopy (EM)  
 The sample to be examined was suspended in a 1% (v/v) ammonium molybdate 
solution containing 70 µg.ml
-1
 bacitracin; for samples containing bacteria, a slightly 
turbid suspension was desirable. A 10 µl drop of the sample suspension was placed into 
a sterile Petri dish and a Formvar
TM
 carbon coated grid inverted and applied to the 
sample for 2 minutes. Grids were blotted dry, taking care not to dislodge the sample, 
and viewed on a JEOL JEM 1200 EX transmission electron microscope. 
 
2.20 Sodium Dodecyl Sulphate- Polyacrylamide Gel 
Electrophoresis (SDS-PAGE) 
SDS-PAGE was performed by the method of Laemmli (1970), using a 
MiniProtean-3 mini-slab gel apparatus (BioRad Laboratories, Hemel Hempstead, UK) 
according to the manufacturers instructions, the buffers and solutions used here are 
detailed in Appendix 2. Glass plates, spacers and combs were washed in water and 
polished with ethanol prior to assembly. 12.5% acrylamide resolving gels and 4% 
acrylamide stacking gels were used. Samples to be analysed were added to sample 
buffer in the ratio 2:1 and heated to 100ºC for 10 minutes. Electrophoresis was carried 
out for 2h at 100V in 1 x electrode buffer; both Pre-stained broad range Protein Markers 
(NEB, Hitchen, UK) and unstained Perfect Protein Markers (Novagen, Darmstadt, 
Germany) were run with the protein sample. Gels were stained on a shaker using 
Coomassie blue staining solution for 1h and de-stained using destain solution, which 
was changed every 30 minutes for 3h. Gels were recorded by scanning with a BioRad 
(Hemel Hempstead, UK) GS-710 Densitometer.  
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Chapter III: Transcriptional analysis of 
the flagellin modification region of  
C. jejuni 11168 
3.1 Introduction 
Flagellin glycosylation has been studied most extensively in two particular 
Campylobacter strains, C. jejuni 81-176 and C. coli VC167. Studies such as those 
carried out by McNally et al. (2007) and Thibault et al. (2001) have led to the 
characterisation of the flagellar glycans present in both species. Other work has focused 
on the assignment of functions to many flagellar glycosylation genes and to elucidation 
of the biochemical pathways by which flagellar glycans are synthesised (Guerry et al., 
2006; McNally et al., 2006a; Obhi and Creuzenet, 2005). Some work has been carried 
out in C. jejuni 11168, particularly by Logan et al. (2009), who identified the presence 
of several flagellar glycans including pseudaminic acid itself and the derivative PseAm, 
as well as the two legionaminic acid derivatives previously identified on C. coli VC167 
flagellin. Given the homology between many flagellin glycosylation genes found in C. 
jejuni 11168, C. jejuni 81-176 and C. coli VC167 it is perhaps not surprising that many 
similar glycans should also be present on the flagellin of these strains. However, the 
flagellin glycosylation locus in C. jejuni 11168 is larger than any yet identified in 
Campylobacter, so it could also be expected that there would be other novel glycans 
present on the flagellin of C. jejuni 11168 (Guerry et al., 2006; Parkhill et al., 2000). 
The study by Logan et al. (2009) also identified two previously unknown pseudaminic 
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acid related glycans, both dimethylglyceric derivatives of both pseudaminic acid and 
acetamidino pseudaminic acid; these two new glycans were together the most prevalent 
modifications found on C. jejuni 11168 flagellin.  
There is relatively little known about the regulation of flagellin glycosylation. 
Goon et al. (2003) identified that pseB (Cj1293), which forms the initial step in 
pseudaminic acid synthesis, was expressed from both σ54 and σ70 promoters in C. jejuni 
81-176. pseB was found to be transcribed alone by σ54, which is involved in control of 
the mid-stage flagellar regulon, and co-transcribed with the preceding gene Cj1292 
under the control of σ70. pseB is a dehydratase and mediates the first stage in the 
biosynthesis of the major flagellar glycan, pseudaminic acid.  Thus, if flagellin 
glycosylation has a role in flagellar biogenesis, it would be necessary for those genes 
involved in glycan biosynthesis and transfer to be regulated temporally with the late-
stage flagellar structural genes, such as the late basal body proteins and the flagellin and 
hook proteins, so that the flagellin glycosylation machinery was already in place when 
the flagellin, which is consistent with σ54 activity (Carrillo et al., 2004; Wosten et al., 
2004). Co-regulation by σ70 may ensure that there is a certain level of pseB present in 
the cell at all times in case of a sudden need to synthesise flagellar glycans, as 
Campylobacter flagella are subject to phase variation. There is also a certain level of 
cross-talk between the O-linked and N-linked pathways via PseB, which has homology 
to the N-linked dehydratase PglF (McNally et al., 2006b; Schoenhofen et al., 2006) and 
it is possible that the σ70 controlled expression of pseB is linked somehow to a function 
within the N-linked pathway, although this remains unclear. Carrillo et al. (2004) also 
identified several genes involved in flagellin glycosylation that were located 
downstream of putative σ28 promoters, including the legionaminic biosynthesis genes 
ptmA and ptmB and pseudaminic acid biosynthesis genes pseA, pseG and pseH. The 
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potential co-regulation of flagellin glycosylation genes by the two major flagellar 
regulators, σ28 and σ54,  helps to support the idea of flagellin glycosylation having an 
integral role in flagellar function; some evidence for which has already been provided in 
the form of mutants studies by Karlyshev et al. (2002) and Goon et al. (2003). 
Although, as detailed above, there is some evidence of the mechanism(s) of regulation 
of certain genes, for the majority of flagellin glycosylation genes it is entirely unclear; 
there is no evidence of regulation of any flagellin glycosylation associated genes by 
anything other than the flagellar associated sigma-factors σ54 and σ28. 
The overall aim of this study is to attempt to determine the effects that NssR, the 
nitrosative stress response regulator in Campylobacter, has on a small subset of the 
flagellin glycosylation genes. An initial observation during the work carried out on 
NssR and its associated regulon by Elvers et al. (2005) indicated that an nssR deletion 
mutant in the ‘original’ strain background, 11168-O, exhibited lower levels of 
expression of a small number of genes in the flagellin glycosylation region than the 
wild-type, under normal, NO-free, conditions (Sue Turner, unpublished data). 
Subsequently, microarray analysis of the wild-type and nssR mutant (11168-O WT 
0466
-
 ), without nitrosative stress, positively identified 17 genes located in the flagellin 
glycosylation region, which were down-regulated in the 11168-O 0466
-
 mutant in 
comparison to the wild-type. These genes are located between the direct repeats Cj1318 
and Cj1336 and have been designated the flagellin modification region (FMR) in this 
study. When an nssR mutant was constructed in the genome sequenced background 
(11168-GS) no differences in gene expression in this region were identified (Lynne 
Lawrence, unpublished data). The NO-independent difference in gene expression 
between the wild-type and ΔnssR mutant in the original strain background suggests that 
NssR is involved, either directly or indirectly, in the regulation of this cluster of genes. 
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The fact that no gene expression differences were identified in the genome sequenced 
background suggests that overall expression differences in this region may contribute to 
the differences observed between the 11168-O WT and 11168-GS WT strains, 
including differences in motility and flagellin mass. 
Examination of motility in the 11168-O 0466
-
 mutant indicates that, although 
the strain is still motile, it is less motile than the parent strain; differences in mass of the 
flagellin protein were also observed by SDS-PAGE. Amongst the cluster of 17 genes 
down regulated in the ‘original’ background nssR mutant, several are known to be 
involved in the post-translational glycosylation of flagellin in other Campylobacter 
strains, such as ptmA-G, which are involved in legionaminic acid biosynthesis in C. coli 
VC167 and pseD, which is implicated in the attachment of acetamidino pseudaminic 
acid to flagellin monomers in C. jejuni 81-176 (Guerry et al., 2006).  
The promoter regions of those genes regulated by Crp-Fnr superfamily members 
contain distinctive recognition motifs, such as the inverted repeat sequence TTGAT-N4-
ATCAA recognised by FNR proteins (Eiglmeier et al., 1989). Elvers et al. (2005) 
discovered a consensus sequence, TTAAC-N4-GTTAA, upstream of all of the NssR-
dependent genes that they identified, which is therefore predicted to be the NssR-
binding motif, at least under conditions of nitrosative stress. How NssR is involved in 
the regulation of these genes is unknown, as are the effects of the down-regulation of 
these genes themselves, other than that a ΔnssR mutant in defective in motility and has a 
lower flagellin mass than the wild-type. 
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Aims 
This part of the study aims to examine gene expression in the 17 gene region 
down-regulated in the 11168-O background nssR mutant. Using transcript mapping by 
conventional qualitative RT-PCR and assays of gene expression by real-time 
quantitative PCR (qPCR), transcriptional organisation of the locus will be assessed in 
detail. The upstream regions of Cj1318 (containing a homopolymeric sequence), 
Cj1319 and Cj0466 will also be examined for the presence of sequence changes in these 
areas that could explain the phenotypic differences seen between the strains; inversion 
of the DNA between the direct repeats Cj1318 and Cj1336 will also be tested for. 
Chromatin immunoprecipitation coupled with high density microarrays, also 
known as ChIP-chip, will be attempted to try to identify locations at which NssR binds 
across the 11168-O WT genome. This will allow identification of any other genes 
regulated by NssR under normal growth conditions and should show whether NssR 
regulates these genes directly or indirectly, by modulating the expression of other 
regulator(s); this approach could also aid the identification of transcriptional start points 
associated with NssR regulation. The ChIP will be carried out in two different ways; 
firstly a polyclonal antibody will be raised to His•tagged NssR protein expressed and 
purified from E. coli and used to immunoprecipitate NssR cross-linked to DNA in 
chromatin prepared from 11168-O WT. Secondly, a FLAG•tagged version of the nssR 
gene from 11168-O WT will be inserted onto the 11168-O WT chromosome in the 
original location, replacing the wild-type gene. Having ensured that expression of the 
nssR gene in this strain is not disrupted and that there are no evident phenotypic effects, 
a commercially available monoclonal antibody to the FLAG•tag will be used to 
immunoprecipitate DNA cross-linked to the NssR protein from 11168-O WT 
chromatin. Although these two approaches increase the workload required to perform 
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this analysis, it should allow certain technical difficulties to be avoided, such as lack of 
specificity of the polyclonal antibody and, if both approaches are successful, will allow 
the results obtained to be verified. An electrophoretic mobility shift assay will also be 
used to examine the ability of NssR to bind to a fragment of DNA containing the NssR 
binding sequence, in the absence of exogenously applied nitrosative stress.
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3.2 Methods 
3.2.1 Isolation of total RNA 
Total RNA for analysis by qualitative reverse- transcription PCR (RT-PCR) or 
quantitative Real-Time PCR (qPCR) was isolated from 11168-O WT cells using a 
Qiagen RNeasy Plus Mini Kit (Qiagen, Crawley, UK) according to the manufacturers’ 
instructions. Overnight liquid cultures of the strain to be examined were diluted 1:1 with 
MH broth and grown microaerobically with shaking for 3h; these cultures were then 
used to inoculate fresh broth to an OD600nm of 0.08. Cultures were then grown to an 
OD600nm of 0.30-0.40 before 5 ml of culture was removed and mixed with 5 ml 
RNAprotect bacterial reagent (Qiagen, Crawley, UK), vortexed for 5 s and incubated at 
room temperature for 5 minutes to stabilise the RNA prior to isolation. After 
centrifugation at 6,000x g for 15 minutes at 4°C the pellet was resuspended in 200 µl 
TE buffer containing 1 mg.ml
-1
 lysozyme, incubated for 10 minutes at room 
temperature and mixed by vortexing every 2 minutes. RLT buffer (700 μl) was added 
and mixed by vortexing, 500 µl absolute ethanol was then added and the sample 
transferred to an RNeasy Mini spin column, in 700 µl aliquots, and centrifuged at 
10,000 rpm for 15 s. Buffer RW1 (350 µl) was added to the column and centrifuged at 
10,000 rpm for 15 s. A 70 µl aliquot of buffer RDD (RNA-free DNaseI set; Qiagen, 
Crawley, UK) was mixed with 10 µl of DNaseI, added to the column and incubated at 
room temperature for 15 minutes. After incubation 350 μl buffer RW1 was added and 
the column centrifuged at 10,000 rpm for 15 s; this was repeated using the same column 
to attempt to ensure removal of all contaminating DNA. The RNeasy column was then 
transferred to a fresh collection tube, 500 µl of buffer RPE added and the column 
centrifuged at 10,000 rpm for 2 minutes. The column was then transferred to a fresh 
tube and centrifuged at 13,000 rpm for 1 minute. Finally, the RNeasy column was 
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transferred to a 1.5 ml Eppendorf tube, 50 µl RNase- free water added to the RNeasy 
membrane and centrifuged at 10,000 rpm for 1 minute. The concentration of RNA was 
determined on a NanoDrop 100A spectrophotometer and the purity examined by 
agarose electrophoresis; RNA was aliquoted as required and stored at -70°C. 
Contamination of the RNA with genomic DNA was tested for using PCR. 
 
3.2.2 Reverse Transcription 
Total RNA was converted to cDNA using random hexanucleotide primers 
(Promega, Madison, USA) and Superscript II Reverse Transcriptase (Invitrogen, 
Paisley, UK) according to the manufacturers’ instructions. Total RNA (500 ng) was 
transcribed using 300 ng of random hexanucleotide primers and 1 μl 500µM dNTP’s 
(Bioline, London, UK; 125µM per dNTP) in a 20 µl reaction volume. The reaction was 
heated to 65°C for 5 minutes then cooled on ice before 4 µl First-strand buffer 
(Invitrogen, Paisley, UK), 2 µl DTT (Invitrogen, Paisley, UK) and 40 units  Rnasin 
Ribonuclease Inhibitor (Promega, Madison, USA) were added. The reaction was 
incubated at 25°C for 2 minutes after which Superscript II (200 units) was added to RT+ 
reactions and RNase-free water added to RT- reactions; the reaction was then incubated 
at  25°C for 10 minutes, 42°C for 50 minutes and 70°C for 15 minutes. The resulting 
cDNA was aliquoted and stored at -20°C prior to use. The reaction volume was 
increased proportionally depending upon the amount of RNA required. 
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3.2.3 Transcriptional mapping of the FMR cluster using qualitative reverse-
transcription PCR 
An analysis of transcription within the flagellin modification cluster of C. jejuni 
11168-O WT was carried out using qualitative reverse-transcription PCR. Transcription 
was tested in three separate log-phase total RNA samples isolated from 11168-O WT 
and converted to cDNA using the method given above. The oligonucleotide primers 
used for real-time PCR were used to test for the presence of each gene of the FMR 
within the cDNA pool created from each RNA sample. The primer combinations used 
are given in Table 3.1 and primer sequences in Table 3.2. The transcript continuity of 
each gene in the FMR was also tested. Combinations of primers for every gene less than 
4kb downstream of the gene being examined were tested; the primers used are also 
given in Table 3.1. BioMix Red (Bioline, London, UK) was used for all PCR reactions 
less than 2kb in length and Bio-X-act long (Bioline, London, UK) for all PCR reactions 
greater than 2kb. The following PCR protocols were used. Expected product size less 
than 1kb: 95°C 2 minutes, 30 cycles of 95°C 30s, 55°C 30s, 68°C 1 minute followed by 
a 5 minute final extension at 68°C. Expected product size 1-2kb: 95°C 2 minutes, 30 
cycles of 95°C 30s, 55°C 30s, 68°C 2 minutes and a 5 minute final extension at 68°C. 
Expected product size greater than 2kb 95°C for 2 minutes, 30 cycles of 92°C 30s, 55°C 
30s, 68°C 3 minutes with a +10s/cycle extension gradient added to the final 15 cycles, 
followed by a final extension of 7 minutes at 68°C. Amplicons representing the 
transcripts present in the sample were visualised using 1.0% agarose gels and stained 
with 0.5 µg.ml
-1
 ethidium bromide. Negative controls for all reactions were carried out 
(data not shown) using RNA as a PCR template, while positive controls were carried 
using 11168-O WT genomic DNA. 
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Table 3.1.  Primer combinations used for transcript analysis. The primers used are 
identical to those used for qPCR; the numbering system used here is the same as that of 
Table 3.2, where the primer sequences are given.  
 
Gene(s) tested for 
transcript continuity 
Primers used (sequences 
listed in Table 3.2) 
Distance between 
primers (bp) 
Cj1317 1-2   (1317F - 1317R) 178 
Cj1317- Cj1318 1-4   (1317F -  1318/36R) 1923 
Cj1317- Cj1319 1-6   (1317F - 1319R) 3323 
Cj1318
1
 3-4   (1318/36F-1318/36R) 145 
Cj1318- Cj1319 3-6   (1318/36F - 1319R) 1545 
Cj1318- Cj1320 3-8   (1318/36F - 1320R) 2346 
Cj1318- Cj1321 3-10  (1318/36F
 
- 1321R) 3853 
Cj1319 5-6  (1319F - 1319R) 180 
Cj1319- Cj1320 5-8  (1319F - 1320R) 981 
Cj1319- Cj1321 5-10  (1319F - 1321R) 2488 
Cj1319- Cj1322 5-12  (1319F - 1322R) 2710 
Cj1320 7-8  (1320F - 1320R) 191 
Cj1320- Cj1321 7-10  (1320F - 1321R) 1698 
Cj1320- Cj1322 7-12  (1320F - 1322R) 1920 
Cj1320- Cj1323 7-14  (1320F - 1323R) 2487 
Cj1321 9-10  (1321F - 1321R) 193 
Cj1321- Cj1322 9-12  (1321F - 1322R) 415 
Cj1321- Cj1323 9-14  (1321F - 1323R) 982 
Cj1321- Cj1324 9-16  (1321F - 1324R) 2031 
Cj1322 11-12  (1322F - 1322R) 81 
Cj1322- Cj1323 11-14  (1322F - 1323R) 648 
Cj1322- Cj1324 11-16  (1322F - 1324R) 1697 
Cj1322- Cj1325 11-18 (1322F - 1325R) 2079 
Cj1323 13-14  (1323F - 1323R) 232 
Cj1323- Cj1324 13-16  (1323F - 1324R) 1281 
Cj1323- Cj1325 13-18  (1323F - 1325R) 1663 
Cj1323- Cj1326 13-20  (1323F - 1326R) 2148 
Cj1324 15-16  (1324F - 1324R) 134 
Cj1324- Cj1325 15-18  (1324F - 1325R) 516 
Cj1324- Cj1326 15-20  (1324F - 1326R) 1001 
Cj1324- Cj1327 15-22  (1324F - 1327R) 1973 
Cj1325 17-18  (1325F - 1325R) 89 
Cj1325- Cj1326 17-20  (1325F - 1326R) 574 
Cj1325- Cj1327 17-22  (1325F - 1327R) 1546 
Cj1325- Cj1328 17-24  (1325F - 1328R) 1948 
Cj1326 19-20  (1326 F - 1326R) 229 
Cj1326- Cj1327 19-22  (1326 F - 1327R) 1201 
Cj1326- Cj1328 19-24  (1326 F - 1328R) 1603 
Cj1326- Cj1329 19-26  (1326 F - 1329R) 3067 
Cj1327 21-22  (1327 F - 1327R) 188 
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Cj1327- Cj1328 21-24  (1327 F - 1328R) 590 
Cj1327- Cj1329 21-26  (1327 F - 1329R) 2054 
Cj1327- Cj1330 21-28  (1327 F - 1330R 3063 
Cj1328 23-24  (1328 F - 1328R) 198 
Cj1328- Cj1329 23-26  (1328 F - 1329R) 1662 
Cj1328- Cj1330 23-28  (1328 F - 1330R 2671 
Cj1328- Cj1331 23-30  (1328F - 1331R 3379 
Cj1329 25-26 (1329F - 1329R) 237 
Cj1329- Cj1330 25-28  (1329F - 1330R) 1246 
Cj1329- Cj1331 25-30  (1329F - 1331R) 1954 
Cj1329- Cj1332 25-32  (1329F - 1332R) 2469 
Cj1330 27-28  (1330F - 1330R) 117 
Cj1330- Cj1331 27-30  (1330F - 1331R) 825 
Cj1330- Cj1332 27-32  (1330F - 1332R) 1340 
Cj1330- Cj1333 27-34  (1330F - 1333R) 3263 
Cj1331 29-30  (1331F - 1331R) 163 
Cj1331- Cj1332 29-32  (1331F - 1332R) 678 
Cj1331- Cj1333 29-34  (1331F - 1333R) 2601 
Cj1332 31-32  (1332F - 1332R) 181 
Cj1332- Cj1333 31-34  (1332F - 1333R) 2104 
Cj1333 33-34  (1333F - 1333R) 123 
Cj1333- Cj1334 33-36  (1333F - 1334R) 2026 
Cj1333- Cj1335 33-38  (1333F - 1335R) 2678 
Cj1333- Cj1336 33-4 (1333F - 1318/36R) 3018 
Cj1334 35-36  (1334F - 1334R) 196 
Cj1334- Cj1335 35-38 (1334F - 1335R) 848 
Cj1334- Cj1336 35 - 4 (1334F - 1318/36R) 1714 
Cj1334- Cj1337 35-40  (1334F - 1337R) 3838 
Cj1335 37-38  (1335F - 1335R) 87 
Cj1335- Cj1336 37-44  (1335F - 1318/36R) 953 
Cj1336
1
 3-4  (1318/36F -1318/36R) 145 
Cj1336- Cj1337 3-40  (1318/36F  - 1337R) 2269 
Cj1337 39-40  (1337F - 1337R) 121 
 
1
Cj1318 and Cj1336 are directly repeated genes; hence it is not possible to distinguish 
between expression of these genes. 
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3.2.4 Relative quantification of gene expression using SYBR Green real-time PCR 
(qPCR). 
Specific primers for quantitative real-time PCR (qPCR) were designed using the 
Primer 3 software (CampyDB; http://campy.bham.ac.uk). Primers were checked for 
dimer formation and suitability for real-time PCR according to the method of Livak and 
Schmittgen (2001); checked primer sequences are given in Table 3.2. The delta-delta CT 
(ΔΔCT) method used here is an approximate calculation which makes a critical 
assumption, in that the efficiencies of amplification of target and reference genes are 
assumed to be approximately equal (Livak and Schmittgen, 2001). To ensure the 
validity of carrying out relative quantification using the ΔΔCT method, a validation 
experiment must be carried out, which is described as follows. Genomic DNA was 
extracted from 11168-O WT and serially diluted three times with water; the three 
dilutions (200, 20 and 2ng.μl-1) were then used as templates for qPCR for all genes. The 
average crossing threshold (CT) and ΔCT (the difference in crossing threshold between 
the target and reference genes) was determined for each DNA dilution of each gene, 
including the control gene gyrA. CT is also sometimes described as the cycle threshold, 
although the meaning of these two terms is identical. The DNA gyrase gene, gyrA, has 
previously been used as a control to quantify transcript levels by qPCR (Wosten et al., 
2004; Elvers et al., 2005). The log10 of template dilution was plotted against ΔCT, 
according to the manufacturers’ recommendations, if the slope is less than 0.1, then the 
assumption (that the target and reference genes have equal amplification efficiencies) is 
true and the ΔΔCT method can be used for the relative quantification of target 
transcripts. A gradient of close to zero was obtained for the majority of genes indicating 
that the ΔΔCT calculation was valid for these genes (data not shown). For those genes 
Transcriptional analysis of the FMR of C. jejuni 11168  Chapter III 
  96 
 
where the gradient obtained was not close to zero, primers were redesigned and retested 
until the desired result was obtained.  
cDNA was used as the template for qPCR. The positive control used was the 
supernatant of 11168-O WT boiled for 10 minutes and centrifuged at 10,000 rpm for 5 
minutes to remove all cell debris. Per reaction 12.5 µl 2 x Rainbow SYBR Green Master 
Mix (Quantace), 50nM of gene-specific primers in 2 µl total volume, 3 µl cDNA and 
7.5 µl HPLC quality water (Fisher Loughborough, UK) were used, giving a 25 µl total 
volume. Reactions were loaded into an optical 96-well microtitre plate with optical plate 
seal (Applied Biosystems, Foster City, USA). An ABI prism 7000 Sequence Detector 
(Applied Biosystems, Foster City, USA) was programmed with the following cycle: an 
initial denaturation step of 10 minutes at 95°C followed by 40 cycles of 15 s at 95°C 
and 1 minute at 60°C. Melting curve analysis following the PCR reactions was used to 
monitor PCR specificity and detect any mispriming and primer dimerisation.  
 The qPCR data generated by the ABI Prism 7700 sequence detection software is 
presented as plots showing fluorescence from SYBR green binding to dsDNA against 
the cycle number. Following adjustment of a base line of fluorescence, an arbitrary 
threshold was set at the beginning of the linear part of the curve, when viewed as a log 
plot. This gives the cycle number (CT) at which the fluorescence crosses the threshold, 
which represents the point at which the amplification of PCR products becomes 
exponential, allowing quantification and comparison of the amount of cDNA in 
different samples. Three replicates for each gene were carried out for each of the four 
biological replicates and exported to Excel 2007 (Microsoft) where the mean CT value 
was used for statistical analysis by the method described by Livak and Schmittgen 
(2001). The ΔCT was calculated by subtracting the mean CT value of the target gene 
from the mean CT value of the endogenous control gene (gyrA). Next the relative fold 
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changes of the mRNA expression levels of each test gene were obtained using the 2
-ΔΔCT
 
formula:  
ΔΔCT = (CTtarget - CTgyrA) A - (CTtarget - CTgyrA) B 
 
where A and B correspond to the different test samples, 11168-O WT and 11168-O 
0466
-
 respectively, when examining expression in the mutant, and both A and B 
tov11168-O WT, when examining expression in that strain only. The data were 
expressed as fold changes ± SD (standard deviation) for the four separate RNA samples 
and combined to represent the data graphically. 
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Table 3.2. Gene-specific primers for qPCR 
Number Primer Name Sequence (5’-3’) 
1 1317F CGCAGGAAGTCTTGAAATGG 
2 1317R CCATTCATAAGGGGTTTTTGC 
3 1318/36F
1
 TTGTGCGGATTCTTCTTATCC 
4 1318/36R
1
 GCCTTTGGATGAACAACACC 
5 1319F GGCGCTTTAATCGCTATCC 
6 1319R GGGCTTTGAGGTTGTAAAGG 
7 1320F CATGAGCCTTGCTTTATAGGC 
8 1320R TGACTTCGCAGTTTTCATCG 
9 1321F GACAAGGGGTTATAGTGTGTCC 
10 1321R GACAAGGGGTTATAGTGTGTCC 
11 1322F AGACTTTGGTTTAATGGGTAAGC 
12 1322R TGTTTTTCAAATTCGTATATATTGAGC 
13 1323F CATTTGCAGTAAAGGCAATCG 
14 1323R GGCCTTTTTAAAGATTTTTGG 
15 1324F CTGATCTAGAAGGCGAATGG 
16 1324R AGTCCATAACGCACGAAACG 
17 1325F TTTCCAGATGGTCATGTAGTACG 
18 1325R CGCTGAATGTACACCATTGC 
19 1326 F CACAGGTGGAATACTTTTTGC 
20 1326 R AAATATAATGGTGTGCCGATCC 
21 1327 F GGCCTGATCATAAAGCAAGC 
22 1327 R GGCGTTTGGTAGTAAGATTTCC 
23 1328 F CCTTCAAATCATCGCTACAGG 
24 1328 R AACGATCGCCTAAAATCACC 
25 1329 F ATCATGGCTGGAGGCTTAGG 
26 1329 R CTTAAAGCCCCTGCTGTACC 
27 1330 F AGGTGGTGGGGTTTTACTCG 
28 1330 R CCAAAAAGGCAAAATCATCG 
29 1331F GATCGGACTGCAAAACTTCC 
30 1331 R AACTGCGGTGATGAGATTGG 
31 1332 F TTTGTAGCAGGAGCTTGTGG 
32 1332 R TGAAGGGCGGTTTGTAAGC 
33 1333 F TCAAGCTTACGGAGACAATGG 
34 1333 R CTATCCTTGCTCCACCTTCG 
35 1334  F TTAGCTTATGGCGAGGATGG 
36 1334  R ACCTTCGGTGCAGTTGTAGG 
37 1335 F CTTCACCCCTACCCAAAAAG 
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38 1335 R ACCTAAGATAAGTTCAAATTTACTAGAC 
39 1337 F TTGGGGCTAGACGATTATGG 
40 1337 R ATGTGTTTGCCCATCTTTGG 
41 gyrAF ATGCTCTTTGCAGTAACCAAAAAA 
42 gyrAR GGCCGATTTCACGCACTTTA 
 
1
 Primers for Cj1318 and Cj1336 are identical as these genes are direct repeats of one 
another, therefore it is impossible to distinguish between levels of expression of these 
genes by qPCR and any result obtained is an average expression level. 
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3.2.5 5’Rapid Amplification of cDNA Ends (RACE) to identify 
transcriptional start points in the FMR. 
5’RACE is a technique used for the amplification of nucleic acid sequences 
from an mRNA template between a defined internal sequence and the unknown 
sequence at the 5’ end of the mRNA, allowing the identification of the transcriptional 
start point of the mRNA. The first step in 5’RACE is the synthesis of cDNA using a 
gene-specific antisense oligonucleotide primer (GSPI). The cDNA is then purified to 
remove primers and any unincorporated dNTPs. Terminal deoxynucleotide transferase 
(TdT) is used to add a homopolymeric tail to the 3’ end of the cDNA, allowing 
amplification of the cDNA using a nested gene-specific primer (GSPII) which binds 3’ 
to GSPI and an anchor primer which anneals to the homopolymeric tail. This 
amplification can be repeated if necessary using a third gene-specific primer (GSPIII), 
located 3’ of the GSP II. The PCR product can then be sequenced directly or after 
cloning into a vector, allowing the transcriptional start point to be identified from 
sequence analysis. In this study 5’RACE was used to attempt to identify any 
transcriptional start points associated with potential NssR binding sites in the FMR. A 
5’RACE kit (version 2.0, Invitrogen, Paisley, UK) was used together with total RNA 
extracted from 11168-O WT; the primers used are listed in Table 3.3. 
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Table 3.3. Primers used in 5' RACE.  
Gene Primer Name Primer Sequence (5’-3’) Position1 
1318 Cj1318RACE1 
(GspI) 
GCAACTCTTTAATGGGATCT Cj1318  
+ 222 
Cj1318RACE2 
(GspII) 
GATATCTAGATTATCTTTACCTAA Cj1318  
+ 137 
Cj1318RACE3 
(GspIII) 
ATATTGTTTAAAGCCTCAA Cj1318  
+ 61 
1319 Cj1319Race1 
(GspI) 
ACTAAATTTGAACCGATAATC Cj1319 
+ 324 
Cj1319Race1 
(GspII) 
CCTCTGCGTACTCAATTTGAAC Cj1319 
+ 168 
Cj1319Race1 
(GspIII) 
None - no suitable sequence available, GSPII used in 
place. 
ptmG 
(Cj1324) 
Cj1324  
(GspI) 
TGAAGCATCTAAGTCTAT ptmG  
+ 355 
Cj1324  
(GspII) 
CGACTTGCCAATGATCGGACTGA ptmG  
+ 240 
Cj1324 
(GspIII) 
CGATGATGAAATCGCAAGTGTAGG
C 
ptmG 
 + 195 
ptmH 
(Cj1325/6) 
Cj1325Race1 
(GspI) 
TGTTCTATCCCATTCGCCTT ptmH  
+ 358 
Cj1325Race1 
(GspII) 
GAAATACCCTAAATTTGGTCATGC ptmH  
+ 279 
Cj1325Race1 
(GspIII) 
GTAGAAAAACATTACAATATGG ptmH  
+ 94 
ptmB 
(Cj1331) 
Cj1331  
(GspI) 
AGCTAATGATATGACAAC Cj1331 
 + 312 
Cj1331 
 (GspII) 
CGAGTGCATATCATGAAAGAAAAA
CTTGG 
Cj1331  
+ 219 
Cj1331 
(GspIII) 
CGATGATTGTGCTATTGCCGTAAG
TGG 
Cj1331  
+ 162 
1
 Position relative to the predicted translational start of gene (CampyDB) 
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3.2.5.1 First strand cDNA synthesis 
First strand cDNA synthesis was carried out by adding 1 μl gene specific primer 
I (GSPI; 2.5μM), 5 μg total RNA and RNase-free water to a volume of 15.5 μl to an 
RNase-free Eppendorf tube and incubating at 70ºC for 10 minutes to denature RNA. 
The reaction mixture was then chilled on ice and 2.5 μl 10x PCR buffer, 2.5 μl MgCl2 
(25mM), 1 μl dNTP mix (10mM) and 2.5 μl  DTT (0.1M) added and incubated at 42ºC 
for 1 minute. SuperScript II reverse transcriptase (1 μl; 50 units) was added and the 
reaction incubated at 42ºC for 1h; the reaction was then incubated at 70ºC for 15 
minutes to terminate cDNA synthesis. Following incubation 1μl of RNase mix was 
added and the reaction incubated at 37ºC for 30 minutes to remove the template RNA. 
The first strand cDNA was purified using a QIAquick PCR Purification Kit (Qiagen, 
Crawley, UK) and stored at -20ºC prior to TdT tailing. 
 
3.2.5.2 TdT tailing of cDNA 
An oligo-dC tail was added to the cDNA using TdT. Purified cDNA (10 μl) was 
added to 6.5 μl DNase-free water, 5 μl 5x tailing buffer and 2.5 μl dCTP (2mM) and 
incubated at 94ºC for 3 minutes, the reaction was then chilled on ice for 1 minute. TdT 
(1 μl) was added and the reaction incubated at 37 ºC for 10 minutes, heat inactivated at 
65 ºC for 10 minutes and stored at 
-
20 ºC, if necessary, prior to PCR. 
 
3.2.5.3 PCR of dC-tailed cDNA 
Tailed cDNA was amplified directly by PCR. A thermal cycler (Eppendorf, 
Mastercycler Gradient) was equilibrated to 94 ºC and the following components added 
to a thin-walled PCR tube kept on ice: 31.5 μl sterile distilled water, 5 μl 10x PCR 
buffer, 3 μl MgCl2 (25mM), 1 μl dNTP mix (10mM), 2 μl GSP II (10μM), 2 μl abridged 
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anchor primer (10μM) and 5 μl dC-tailed cDNA. Taq polymerase (0.5 μl; 5U. μl-1) was 
added immediately before mixing and the tube placed into the thermal cycler; the PCR 
protocol detailed below was used. 
1. Heating at 94°C for 2 minutes 
2. 35 cycles 
1. Denaturation at 94°C for 1 minute 
2. Annealing  55ºC for 1 minute 
3. Extension at 72°C for 3 minutes 
4. Final extension at 72°C for 10 minutes 
 
Following PCR, 10 μl of product was analysed using agarose gel electrophoresis and the 
remainder of the reaction stored at -20 ºC prior to nested amplification. 
 
3.2.5.4 Nested amplification 
Re-amplification using a dilution of the original PCR and a nested gene specific 
primer was used to generate sufficient product to be visible by agarose gel 
electrophoresis, as a single PCR of 35 cycles was not always sufficient. A 5 μl aliquot 
of the original PCR was diluted with 495 μl of TE buffer (pH 8.0). A thermal cycler 
(Techne) was equilibrated to 94°C and the following components added to a thin walled 
PCR tube kept on ice: 33.5 μl sterile distilled water, 5 μl 10x PCR buffer, 3 μl MgCl2 
(25mM), 1 μl dNTP mix (10mM), 1 μl nested GSP III (10μM), 2 μl abridged anchor 
primer (10μM) and 5 μl dilution of primary PCR product. Taq DNA polymerase (0.5 μl; 
5U.μl-1) was added, the tube placed in the thermal cycler and 35 cycles of PCR carried 
out. Following PCR, 10 μl of product was analysed using agarose gel electrophoresis 
and the product stored at -20 ºC. Any suitable sharp band(s) produced were purified 
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from the agarose gel using a Qiagen Gel Extraction Kit (Qiagen, Crawley, UK) and 
sequenced. If no bands were visible or a heterologous smear was present, a further 
round of nested PCR was carried out, using the same primers and protocol detailed 
above. Positive and negative controls for the various stages were carried out according 
to the manufacturers’ instructions (data not shown). 
 
3.2.6 Sequencing of upstream regions of nssR (Cj0466), Cj1318 and Cj1319. 
The regions of DNA upstream of Cj0466 (nssR), Cj1318 and Cj1319 were 
amplified from both C. jejuni 11168-O WT and 11168-GS WT genomic DNA by PCR, 
using the oligonucleotide primers detailed in Table 3.4. PCR products were sequenced 
in both directions and compared to the relevant parts of the genome sequence obtained 
from CampyDB (http://campy.bham.ac.uk) to identify any changes in sequence, 
particularly in the homopolymeric tract upstream of Cj1318. PCR products were tested 
for and quantified by agarose gel electrophoresis and purified prior to sequencing using 
a QIAquick PCR Purification Kit (Qiagen, Crawley, UK).  
 
3.2.7 Testing for inversion between Cj1318 and Cj1336 
Possible inversion between the directly repeated genes Cj1318 and Cj1336 was 
tested for using oligonucleotide primers 1-4, detailed in Table 3.4 and Figure 3.1, in 
both the 11168-O WT and 11168-GS WT strains. Primers 1 and 2 are located 5’ to and 
3’ to Cj1318 respectively, primers 3 and 4 are located 5’ to and 3’ to Cj1336 
respectively. Primers 1 & 2 and 3 & 4 were used as pairs to test for the presence of the 
region in the orientation shown in the genome sequence. Primers 1 & 3 and 2 & 4 were 
used in pairs to test for presence of the region in the opposite orientation. Locations of 
the primers are shown in Figure 3.1.  
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Table 3.4 Primers used in amplification, sequencing and inversion testing. 
Oligonucleotide sequence written 5’ to 3’.  1 Position relative to predicted start codon 
unless stated. 
 
Primer Sequence Position
1
 
Cj1318fseq GCGATGCTTTAAAACAAGGAG Cj1318 -749 
Cj1318rseq TGCAACACTAAGTCCTACAGCA Cj1318 + 838 
Cj1319fseq CCAAAAGATGCTCTTCAAGGC Cj1319+624 
Cj1319rseq TCTCCACTTATAACTTCCATGTC Cj1319 +172 
Cj0466fseq ATCACCTTCGCCTAAAAGCA Cj0466 -218 
Cj0466rseq TCAAAAACAGCATTAGCAGGA Cj0466 stop+285 
Cj1318invf (1) ATGAAAAGGTGCTTAAAAACCG Cj1318 -205 
Cj1318invr (2) ACCTATAAAACCATCAGCACC Cj1318 stop +38 
Cj1336invf (3) ATTGGTTTATCCAAGGTTTAGG Cj1336 –276 
Cj1336invr (4) AAGTTGTTATACTCAAAACCGC Cj1336 stop +61 
 
  
 
 
Figure 3.1. Relative locations of inversion primers. Primer 1, Cj1318invF; 2, 
Cj1318invR; 3, Cj1336invF and 4, Cj1336invR (adapted from CampyDB; 
http://campy.bham.ac.uk). 
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3.2.8 Purification of the NssR protein. 
The nssR gene was to be cloned from C. jejuni 11168-O WT, His•tagged and 
expressed in E. coli, allowing a polyclonal antibody to NssR for use in chromatin 
immunoprecipitation to be raised.  
 
3.2.8.1 Construction of NssR-His6 expression plasmid 
The nssR (Cj0466) gene was amplified from C. jejuni 11168-O WT genomic 
DNA using the oligonucleotide primers given in Table 3.5.  
 
Table 3.5 Primers used for the cloning of nssR. Bold letter indicates the base changed 
to remove the stop codon following nssR. 
Name Sequence (5`-3`) Restriction 
enzyme 
Tm (°C) 
0466F-
NcoI 
GCGCCCATGGTAATGAAAGA 
TTATTTAGAAC 
NcoI 60.0 
0466R-
HindIII 
GCGCAAGCTTTGCCCAAAGT 
TCTTTCATGA 
HindIII 66.9 
 
The resulting 598bp fragment was digested with the appropriate restriction 
enzymes and cloned into the expression vector pET22b (+) (Novagen, Darmstadt, 
Germany), between the NcoI and HindIII sites and transformed into E. coli DH5α. The 
gene was cloned in frame with the C-terminal 6x His•Tag, allowing protein purification 
by Ni
2+
 affinity chromatography. The stop codon following the nssR coding sequence 
was mutated into a serine residue by altering the A residue in the gene sequence to a C 
residue in the primers, such that the C-terminal His•Tag was expressed fused with the 
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NssR protein. Clones were selected by screening on ampicillin plates and checked by 
restriction digestion and sequencing. 
 
3.2.8.2 Production of NssR-His6 fusion protein 
The plasmid generated in the previous step, designated pETNssR, was 
transformed into the general purpose expression host E. coli BL21 (DE3). A starter 
culture of the transformed strain was prepared by inoculating 6 ml LB broth 
supplemented with 50 µg.ml
-1
 ampicillin with a single colony from a plate or 20 µl of 
glycerol stock. This starter culture was then incubated at 37°C with shaking at 200 rpm 
until an OD600nm of approximately 0.5 was reached. The entire 6 ml starter culture was 
then added to 200 ml of LB broth, supplemented with ampicillin, and incubated as 
above. Once an OD600nm of 1.5 was achieved, the culture was centrifuged at 10 000 x g 
for 10 minutes and the pellet resuspended in an equal volume of fresh LB broth 
supplemented with ampicillin and IPTG to a final concentration of 1mM. This 
expression culture was incubated at 20°C overnight with shaking at 200 rpm. After 
incubation induced cells were harvested by centrifugation at 10,000 x g for 15 minutes 
at 4°C and stored as a pellet at -20°C.  
 
3.2.8.3 Purification of the NssR-His6 fusion protein by Ni
2+
 Chromatography 
 The NssR-His6 fusion protein was purified from E. coli BL21 (DE3) using 
His•Bind 900 cartridges (Novagen, Darmstadt, Germany). The cartridges are large 
diameter cellulose matrix cartridges pre-charged with Ni
2+
 which allow a higher flow 
rate than resin based columns. The cartridges are capable of binding 2.0 mg of 
His•tagged protein, which is estimated from SDS-PAGE analysis to be the amount of 
protein produced in approximately 100 ml cells after induction using the method above 
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which was not trapped in inclusion bodies. The purification method used was adapted 
from the manufacturers’ instructions and the buffers used are detailed in Appendix 2. 
The harvested cell pellets were resuspended in 17.5 ml sterile distilled water, 100 µl of 
15 mg.ml
-1
 lysozyme added and incubated at 30°C for 15 minutes. After incubation 2.5 
ml 8 x binding buffer was added and the suspension sonicated at 20% amplitude 
(Soniprep 150 sonicator (MSE)) for 2 x 30s on ice, to break up any un-lysed cells. The 
lysate was centrifuged at 15,000 x g for 20 minutes to remove cell debris; at this point 
samples were taken from both the pellet and supernatant for analysis by SDS-PAGE. 
The supernatant was passed through a 0.45 µm syringe filter (Millipore) to remove any 
remaining debris and prevent clogging of the column, a sample of the filtered 
supernatant was then collected for SDS-PAGE analysis. The column was prepared by 
equilibration with 6 ml 1 x binding buffer, which was pushed through the column at a 
rate of two drops per second using a luer-fitting syringe. The filtered cell extract was 
then loaded onto the column, as detailed above, washed with 4 x 5 ml, 1 x binding 
buffer, 2 x 5 ml wash buffer and finally eluted in 2 x 2 ml elute buffer; samples were 
taken after each stage for analysis by SDS-PAGE. The calculated mass of the protein 
with the 6 x His•Tag was 23.2 kDa. 
 
3.2.8.4 Preparation of NssR protein for polyclonal antibody production 
 The NssR protein was purified and concentrated prior to preparation of a 
polyclonal antibody to be used in ChIP-chip. The eluted protein was placed into dialysis 
tubing with a molecular weight cut off of 12-14 kDa. To concentrate the protein, solid 
PEG-15,000 was sprinkled onto the dialysis tubing and left for 1h. After this, a sample 
of the protein was removed for SDS-PAGE analysis and the protein dialysed into 
200mM NaCl 20mM Tris-HCl (pH 7.9) overnight at 4°C. Overall, four rounds of 
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concentration and dialysis were required to produce protein of the required 
concentration for polyclonal antibody production. 
 
3.2.9 Polyclonal antibody production. 
 Polyclonal antibodies to the NssR protein were produced in two rabbits by 
Covalab ltd. (Villeurbanne, France). A total of 3 ml of NssR protein antigen, at a 
concentration of 200 µg.ml
-1
, was provided. Per injection, 50 µg of antigen was required 
in a volume of less than 500 µl, as there were four injections per animal and two 
animals a total of 400 µg of antigen was required. The immunisation protocol for both 
animals is given in Table 3.6. The antibodies produced were checked by Western 
blotting for effectiveness and cross-reactivity. 
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Table 3.6. The immunisation protocol for production of polyclonal antibodies to 
NssR 
Day Action 
0 Pre-immune bleed (4 - 5 ml per rabbit) 
0 
Injection 1 (0.5 ml antigen + 0.5 ml complete Freund’s adjuvant 
per animal) 
21 
Injection 2 (0.5 ml antigen + 0.5 ml incomplete Freund’s adjuvant 
per animal) 
42 
Injection 3 (0.5 ml antigen + 0.5 ml incomplete Freund’s adjuvant 
per animal) 
53 Test bleed (4 - 5 ml per rabbit) 
63 
Injection 4 (0.5 ml antigen + 0.5 ml incomplete Freund’s adjuvant 
per animal) 
74 Test bleed (12 - 15 ml per rabbit) 
88 Final bleed 
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3.2.9.1 Antibody purification 
 
The polyclonal antibody to NssR was purified and concentrated using a 5 ml 
gravity flow column (Pierce, #29925) packed with 2 ml 50% UltraLink immobilised 
protein A/G beads (Pierce) in 1 x TBS. The column was equilibrated with 5 ml IP buffer 
(all buffers are detailed in section 3.2.12.1, ChIP), 10 ml antibody serum was added to 
10 ml IP buffer, centrifuged for 20 minutes at 10 000 x g and the supernatant added and 
the column and allowed to drain through. The column was washed with 15 ml IP buffer, 
15 ml IP salt buffer and eluted with 2 ml elution buffer (0.1M Glycine pH 3.0). The 
eluted antibody was dialysed into 0.05M Tris buffer (pH 8.0) with 0.02% sodium azide 
and 1% BSA and stored at 4°C. 
 
3.2.10 Western Blotting 
 Western blots were used to assess the purity and specificity of polyclonal 
antibodies raised to the NssR protein; the buffers used are detailed in Appendix 2. 
Proteins were separated by SDS-PAGE on a 12.5% polyacrylamide gel, including a pre-
stained molecular weight marker, and transferred to a nitrocellulose membrane 
(Amersham Biosciences, Little Chalfont, UK) by transverse electrophoresis in 1 x 
Western blot buffer at 300 mA for 3 h or at 100 mA overnight, as required. The 
membrane was washed with 1 x TBST for 5 minutes with gentle agitation then 
incubated for 1h in blocking solution with gentle agitation at 4°C. The membrane was 
then washed in TBST for 30s and incubated in a 1:500 dilution of the primary anti-NssR 
antibody in blocking solution for 2h at room-temperature with gentle agitation. The 
membrane was then washed in 1 x TBST for 5 minutes then incubated in a 1:10,000 
dilution of the secondary antibody in blocking buffer for 1 hour with gentle shaking. 
The membrane was washed three times in 1 x TBST for 5 minutes each time and 
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incubated in 5-Bromo-4-chloro-3-indolyl phosphate/ nitro blue tetrazolium (BCIP/NBT) 
solution prepared from Sigma Fast BCIP/NBT tablets (Sigma, Gillingham, UK) until 
the colour had developed to the desired level. A wash with 1% acetic acid was used to 
stop the reaction. The membrane was scanned using a BioRad GS-710 Densitometer. 
 
Primary antibody 
Polyclonal antibody raised in Rabbit against purified NssR protein (Section 
3.2.9.1). 
 
Secondary antibody 
Anti-Rabbit IgG (whole molecule)- Alkaline phosphatase conjugate antibody 
produced in goat (Sigma, Gillingham, UK;  product number: A3687). 
 
 
3.2.11 Flag tagging NssR for ChIP 
As an alternative to the previous approach which involved raising a polyclonal 
antibody to purified His-tagged NssR and as a method to provide confirmation of any 
results generated, a copy of the nssR gene was fused to a sequence encoding the FLAG 
protein tag and transferred to the 11168-O WT chromosome, to replace the wild-type 
gene. This allowed chromatin immunoprecipitation to be carried out using a 
monoclonal, commercially produced, anti-FLAG antibody, which should be more 
efficient and specific than a polyclonal antibody. 
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3.2.11.1 Preparation of the nssR-FLAG construct. 
The plasmid pDEX_Fcc was used to produce the nssR-FLAG fusion sequence 
which was transferred to the 11168-O WT chromosome in the original position of the 
nssR gene (for the sequence of pDEX_Fcc see Appendix one). The locations of the 
multiple cloning sites in relation to the FLAG-tag sequence and antibiotic resistance 
gene are detailed in Figure 3.2. 
 
Figure 3.2. pDEX_Fcc. Location of multiple cloning sites (MCS), 3 x FLAG-tag 
sequence and chloramphenicol resistance gene (cat).  
 
 
The nssR sequence was cloned into the kpnI site in MCS1, in-frame with the 
FLAG sequence and with the stop codon following the nssR gene, which was mutated 
to a serine residue by altering a base in the reverse primer, creating a translational fusion 
of the NssR protein with the C-terminal FLAG-tag. The Cj0467 sequence was cloned 
into the sacI restriction site in MCS2 to provide the second, downstream, sequence 
allowing homologous recombination to occur. This allows the transfer of the NssR-
FLAG fusion sequence and the cat gene, conferring resistance to chloramphenicol, to 
the chromosome in the original position of the nssR gene, replacing the wild-type 
sequence. 
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Table 3.7. Primers used for amplification of cloned regions 
Name Sequence (5’ → 3’) 
nssR_kpnI_F GCGCGGTACCATGAAAGATTATTTAGAACT 
nssR_kpnI_R GCGCGGTACCTTCCCAAAGTTCTTTCATG 
Cj0467_sacI_F GCGCGAGCTCAATTTAAGGTAGAGAATGG 
Cj0467_sacI_R GCGCGAGCTCGTTCAAGCATGAAGCAACC 
 
 
Table 3.8 Primers used to check the plasmid construct by PCR and sequencing. 
Primer locations shown in Figure 3.3. 
Name Sequence (5’→ 3’) 
pDEX_Fcc_1F_vector GGGTAATCGATGAATTCAAGC 
pDEX_Fcc_2F_FLAG CGACTACAAAGATGACGACG 
pDEX_Fcc_3F_cat GGATGAATTACAAGACTTGC 
pDEX_Fcc_4F_0467 CCTATAAGAACAGATGAGCTA 
pDEX_Fcc_1R_nssR CACTCGAGATAAAGATTGCG 
pDEX_Fcc_2R_cat TACCGTCATACTATATGTGC 
pDEX_Fcc_3R_0467 TTATCGTAAGCCAAGCAGCC 
pDEX_Fcc_4R_vector CGTTGTAAAACGACGGCCAG 
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Figure 3.3. The final construct, pDEX_Fcc_nssR_Cj0467. Showing location of 
inserts and sequencing primers. 
 
The nssR and Cj0467 sequences were amplified from 11168-O WT genomic 
DNA using BIO-X-ACT long (Bioline, London, UK) and the primers detailed in Table 
3.7. PCR reactions were checked by agarose gel electrophoresis to ensure that a single, 
homogeneous, fragment was produced. The nssR fragment was digested with kpnI 
(NEB, Hitchen, UK) and the Cj0467 fragment with sacI (NEB, Hitchen, UK); both 
fragments were purified using a Qiagen PCR purification kit (Qiagen, Crawley, UK). 
Next, the pDEX_Fcc plasmid was digested with kpnI, treated with calf intestinal 
alkaline phosphatase (CIP), the nssR fragment ligated into the plasmid and the ligation 
transformed into E. coli DH5α to create the pDEX_Fcc-nssR plasmid. A total of twenty 
two chloramphenicol resistant clones were recovered and analysed by colony PCR, 
using primers 1F_vector and 2R_cat (Table 3.8). Colonies showing the correct PCR 
product size (860bp) were grown in LB broth and the plasmids isolated using a Plasmid 
Midi kit (Qiagen, Crawley, UK). The sequence of the pDEX_Fcc_nssR plasmid was 
confirmed by DNA sequencing using primers 1F_vector, 2F_FLAG, 1R_nssR and 
2R_cat.  
The pDEX_Fcc_nssR plasmid was digested with sacI and treated with CIP prior 
to ligation of the Cj0467 fragment and transformation into E. coli DH5α to create the 
pDEX_Fcc_nssR_Cj0467 plasmid.  Chloramphenicol resistant clones were isolated and 
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checked by colony PCR, using primers 4R_vector and 3F_cat. A correct clone was 
selected, the pDEX_Fcc_nssR_Cj0467 plasmid isolated using a Plasmid Midi kit 
(Qiagen, Crawley, UK) and confirmed by sequencing using primers 3F_cat, 3R_0467, 
4F_0467 and 4R_vector. 
 
3.2.11.2 Homologous recombination of NssR-FLAG into 11168-O WT 
Electrocompetent C. jejuni 11168-O WT cells were prepared, as described in 
Section 2.16, and electroporated with pDEX_Fcc_nssR_Cj0467. Ten chloramphenicol 
resistant colonies were selected at random and examined by colony PCR, using primer 
pairs detailed below and in Table 3.8:  
 
1) nssR_FLAG_F and 2R_cat 
2) nssR_FLAG_F and 3R_0467 
3) 3R_cat and Cj0467_sacI_R  
4) Cj0467_sacI_F and 4R_vector 
 
A colony producing PCR product of the correct size for all reactions, excluding reaction 
4, where no product is expected if the sequence has recombined correctly, was selected 
and grown in MH broth. Genomic DNA was isolated and sequenced using primers 
1R_nssR and 4F_Cj0467 to check that the DNA sequence outside of the regions used 
for homologous recombination was correct. Glycerol stocks of the correct clone were 
produced and the strain was designated 11168-O nssR-FLAG. 
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3.2.11.3 Confirmation of nssR activity in 11168-O nssR-FLAG by light microscopy 
To confirm that replacement of the wild-type nssR gene with an nssR-FLAG 
fusion did not alter the expression or activity of the NssR protein, the 11168-O nssR-
FLAG strain was examined by phase-contract light microscopy to compare its motility 
to that of the parent strain; 11168-O WT motility was adversely affected when the nssR 
gene was deleted, creating the 11168-O 0466
- 
strain. 
 
3.2.11.4 Confirmation of nssR activity in 11168-O nssR-FLAG by qPCR 
 The expression levels of the genes of the FMR together with nssR itself and 
Cj0467, a gene whose expression is regulated by NssR, were examined by qPCR to 
attempt to identify whether the addition of a FLAG-tag to NssR had any affect on its 
function. These expression levels were compared to those seen in the parent strain. The 
methods used for the qPCR analysis of the 11168-O WT, detailed in section 3.2.4, were 
used here. Primer sequences used to analyse nssR (Cj0466) and Cj0467 expression in 
both 11168-O WT and 11168-O nssR-FLAG are given in Table 3.9 and Table 3.2, 
section 3.2.4. 
 
Table 3.9 Primer sequences used for real-time qPCR 
Name Sequence (5’ → 3’) 
0466_F_qPCR TGCTGTTTTTGAAGAGGATGG 
0466_R_qPCR CGAGATAAAGATTGCGCTCTAAC 
0467_F_qPCR TTAAGAGCGGGATTTGAAGC 
0467_R_qPCR ATTCACCAAATCTGGCAAGG 
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3.2.12 Chromatin immunoprecipitation (ChIP). 
The buffers and solutions used here are detailed in Appendix 2. 
 
3.2.12.1 Preparation of chromatin from C. jejuni 
MH Broth (10 ml) was inoculated with 11168-O WT and grown overnight. This 
culture was used to inoculate 20 ml of fresh MH broth to an OD600nm of 0.05, which was 
then grown until an OD600nm of approximately 0.3 was reached. To prepare chromatin, 
15 ml of the 11168-O WT culture was transferred to a fresh falcon tube, 405 μl of 37% 
formaldehyde (Sigma, Gillingham, UK) was added (to a final concentration of 1% 
formaldehyde) and incubated at room-temperature for 20 minutes. 3M glycine (1.5 ml) 
was added and the reaction incubated for 5 minutes at room-temperature, to quench any 
un-reacted formaldehyde. The reaction was then centrifuged at 15,000 x g to pellet the 
cells which were then washed three times in 1 x TBS. Finally the cells were 
resuspended in 0.5 ml lysis buffer, with lysozyme, transferred to a 1.5 ml Eppendorf 
tube and incubated at 37°C for 30 minutes with gentle shaking. After incubation, the 
lysis was stopped by adding 4 ml IP buffer, then 260 μl 0.1M PMSF (to a final 
concentration of 1mg.ml
-1
) and incubating at 37°C for 10 minutes. The sample was then 
sonicated on ice for 2 x 30s at an amplitude of 20% using a Soniprep 150 sonicator 
(MSE) with a microtip probe. The chromatin was then centrifuged at 13,400 x g for 15 
minutes to remove cell debris and dispensed into 800 μl aliquots. It was not found to be 
suitable to store chromatin either at 4°C or at -20°C as this decreased the amount of 
chromatin isolated, so all steps were carried out concurrently. 
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3.2.12.2 Chromatin Immunoprecipitation (ChIP). 
Protein A/G beads (Pierce) were washed three times in 1 x TBS prior to use and 
stored as a 50% suspension in 1 x TBS. Experimental antibody
+
 reactions were prepared 
containing 800 μl chromatin, 20 μl 50% Protein A/G bead suspension and 100 μl NssR 
polyclonal antibody (final bleed) or 5 μl monoclonal FLAG antibody (Sigma,  
Gillingham, UK; F7425) as appropriate. Antibody
-
 control reactions containing 800 μl 
chromatin and 20 μl 50% Protein A/G beads were also set up. All reactions were 
incubated on a rotating wheel at room-temperature for 90 minutes, and then centrifuged 
at 3,000 rpm for 1 minute. The beads were transferred to a spin-x-column (Costar) and 
washed by resuspending them in 500 μl IP buffer, incubating on a rotating wheel for 3 
minutes and centrifuging at 3,000 rpm for 1 minute. The beads were then washed with a 
further 500 μl IP buffer, IP salt buffer, wash buffer and finally TE buffer (pH 8.0), by 
resuspending, incubating for 3 minutes and centrifuging. Next the columns was 
transferred to a fresh 1.5 ml Eppendorf  tube and the protein-DNA complexes heat 
eluted by adding 100 μl elution buffer to the beads and incubating for 15 min at 65°C 
with gentle shaking. The column was centrifuged at 3,000 rpm for 1 minute and the 
flow though retained. The elution was repeated with another 100 μl elution buffer and 
the eluate combined and the samples were transferred to 0.2 ml PCR tubes. 
 
3.2.12.3 De-crosslinking 
A total sample, comprising 70 μl chromatin, 10 μl 20% SDS, 20 μl 1M NaHCO3 
and 100 μl water, was set up and 8 μl 5M NaCl added to AB+, AB- and total samples 
which were then incubated overnight to reverse the formaldehyde induced DNA-protein 
crosslink. Next, 1 μl RNaseA (Qiagen, Crawley, UK) was added and the sample 
incubated at 37°C for 30 minutes. To all samples 4 μl 0.5M EDTA, 8 μl 1M Tris HCl 
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(pH 7.5) and 10 μl Pronase (40mg.ml-1; Roche) were added and the samples incubated 
at 42°C for 2h. Finally, samples were cleaned using a QIAquick PCR Purification Kit 
(Qiagen, Crawley, UK), checking first to ensure that all samples were at pH ≤ 7.5 and 
10 μl 3M sodium acetate (pH 5) added where necessary to decrease the pH. The PCR 
Purification Kit protocol was carried out according to the manufacturers’ instructions 
and DNA was resuspended in 50 μl elution buffer. De-crosslinked total sample (5 μl) 
was analysed by agarose gel electrophoresis, to check that the sizes of the sonicated 
DNA fragments were between 500 and 1000 bp, as required by the micro-array. 
 
3.2.12.4 Direct labelling of immunoprecipitated DNA 
DNA isolated by chromatin immunoprecipitation was fluorescently labelled 
with either Cy3 or Cy5 Cy-dyes using the BioPrime Array CGH Genomic Labelling 
System (Invitrogen, Paisley, UK) and Cy3-dCTP (#PA53021) and Cy5-dCTP 
(#PA55021; Amersham Biosciences, Little Chalfont, UK). DNA isolated from 11168-O 
WT and 11168-O nssR-FLAG was labelled using the same method and ‘reference’ 
samples, containing total chromatin, were labelled with Cy3 and ‘test’ samples which 
had been immunoprecipitated using an antibody, were labelled with Cy5. To label 400 
ng DNA in a total volume of 21 μl, 20μl 2.5x random primers were added and the 
samples incubated at 95°C for 5 minutes. Next, 5 μl 10x dCTP mix, 1 μl Exo-Klenow 
fragment and 3 μl of the appropriate CyDye-dCTP nucleotide was added and the 
samples incubated at 37°C for 3 hours; finally 5 μl stop buffer was added. Labelled 
probes were purified using a QIAquick PCR Purification Kit (Qiagen, Crawley, UK) 
and the extent of labelling was determined using the Microarray function on a 
NanoDrop 1000A Spectrophotometer. Control reactions using 11168-O WT genomic 
DNA were carried out as necessary. 
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3.2.12.5 PCR checking of ChIP isolated DNA. 
The DNA isolated by chromatin immunoprecipitation using both methods was 
examined by PCR. GoTaq (Promega, Madison, USA) was used, with 2.0 μl of the DNA 
isolated by ChIP (AB+, AB
-
 or total sample DNA) and the products analysed by agarose 
gel electrophoresis. Positive controls were carried out for all primer pairs using 0.5μl of 
11168-O WT DNA and negative controls using sterile distilled water. The primers used 
are detailed in Table 3.2 (section 3.2.4), Table 3.9 (section 3.2.11.4) and below: 
 
fla_L 5’-TTCAGTTGGAACAGGACTTGG -3’ 
fla_R 5’-AAGGCTCCATTAGCATCACC -3’ 
cgb_L 5’- GCTTTAGCAATGGCGATTTT -3’ 
cgb_R 5’- CCATAAGCAACTTCCCAAGC -3’ 
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3.2.13 Electrophoretic mobility shift assay of NssR and cgb promoter fragment 
DNA. 
 An electrophoretic mobility shift assay was carried out using purified, 
His•tagged NssR protein and P32 –labelled DNA fragments amplified from the promoter 
region of the cgb gene, which contains the consensus NssR binding site under 
nitrosative stress conditions, TTAAC-N4-GTTAA. 
 
3.2.13.1 Preparation of the cgb promoter fragment 
 The cgb promoter fragment from 133bp 5’ of the transcriptional start point of 
the gene to 64bp 3’ of the transcriptional start point was amplified by PCR from 11168-
O WT DNA using the following primers: 
 
cgb_apaI_F 5’-GCGCGGGCCCGCCATAGTCCCTCTTTTTAA-3’ 
cgb_apaI_R 5’-GCGCGGGCCCGGCACACAATCTTTG-3’ 
 
GoTaq DNA polymerase (Promega, Madison, USA) in a reaction volume of 200 
μl was used to generate sufficient DNA for labelling. Following PCR, the product was 
checked by agarose gel electrophoresis to ensure that a single, homogeneous band was 
produced. 
 The PCR reaction was cleaned using a Qiagen PCR clean-up kit (Qiagen, Crawley, 
UK), digested using the apaI restriction enzyme (NEB, Hitchen, UK) and treated with 
calf intestinal alkaline phosphatase (NEB, Hitchen, UK) to remove the 5’ phosphates, 
leaving the ends of the DNA free to be labelled. The fragment was purified on a 0.7% 
agarose gel, excised and extracted using a Qiagen gel extraction kit (Qiagen, Crawley, 
UK). 
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3.2.13.2 End-labelling DNA fragments with [γ32-P] ATP. 
Taking appropriate precautions for the use of radioactive compounds, a labelling 
mix containing 16 μl of the cgb DNA fragment prepared in the previous step, 2 μl 10x 
kinase buffer (NEB, Hitchen, UK), 1 μl [γ32-P] ATP (Amersham Biosciences, Little 
Chalfont, UK) and 1 μl T4 polynucleotide kinase, was prepared and incubated at 37°C 
for 30 minutes. 
 
3.2.13.3 Removal of unincorporated nucleotides. 
 Unincorporated radio-nucleotides were removed by passing the labelling 
reaction through a Sephadex G-50 column. A 50% suspension of Sephadex G-50 in TE 
buffer was prepared by autoclaving 5g of dried Sephadex G-50 in 150 ml TE buffer and 
washing the resulting suspension three times in 150 ml sterile TE buffer; finally the 
Sephadex was resuspended in 50 ml TE buffer giving a 50% stock. 
 Two 2 ml Spin-X columns (Costar) were prepared and 400 µl 50% Sephadex G-
50 suspension added to each, the columns were then centrifuged at 3,400 rpm for 3 
minutes to pack the Sephadex. The entire labelling reaction was then added to the first 
column and centrifuged at 3,400 rpm for 3 minutes; the flow-through was applied to the 
second column and centrifuged. The flow-through, containing the P
32
-end-labelled cgb 
DNA fragments, was aliquoted and stored at -20°C until required. The Sephadex 
columns, containing the unincorporated radio-nucleotides, were placed into lead pig and 
allowed to decay for several half lives prior to disposal.  
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3.2.13.4 Electrophoretic mobility shift assay 
Purified NssR protein was added to the radio-labelled cgb DNA fragments, in a 
buffer designed to allow binding, then applied to an acrylamide gel to observe any 
retardation in the movement of the radio-labelled DNA through the gel which could be 
caused by the NssR protein binding the DNA. Purified NssR protein, with a final 
concentration of 3.2µM was used in the assay. Binding reactions containing a range of 
concentrations of NssR were used to assess the ability of NssR to bind DNA. The 
buffers and solutions are detailed in Appendix II. 
 
The binding reactions contained: 
γ32P-labelled cgb fragment (approximate concentration 50nM)  20 µl 
10x binding buffer        1 µl 
50% glycerol         1 µl 
Bovine serum albumin (10mg.ml
-1
)      0.5 µl 
Herring sperm DNA (500µg.ml
1
; Promega, Madison, USA)  1.0 µl 
Sterile distilled water        5.3 µl 
 
Together with 1 μl of NssR at one of the following concentrations: 0.32µM, 0.16µM, 
0.08µM, 0.04µM, 0.02µM or 1 μl of sterile distilled water as a control.  
As necessary reactions also contained varying concentrations of the unlabelled 
oligonucleotide 
5’-GGGGGGTTAACTATAGTTAAGGGGGG-3’ 
which contains the NssR binding site which is underlined. The concentrations used were 
1μM, 2.5μM, 5μM, 10μM, 100μM, for these experiments the concentration of NssR 
remained at 0.32μM. 
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These reactions were then incubated for 10 minutes at 37°C prior to loading onto a 
continuous 6% acrylamide gel. The gel was pre-run for 5 minutes at 166V (12V.cm
-1
) in 
0.25 x TBE buffer, 10µl 2x loading buffer was added to one of the wells and allowed to 
run into the gel for a further 5 minutes. Before loading the samples the current was 
turned off and the wells washed thoroughly with 0.25 x TBE buffer; the current was 
then reapplied and all samples loaded quickly. The gel was then run for 2h at 166V. 
After electrophoresis the gel was vacuum dried for 1h, placed into a phosphor-imaging 
cassette (Kodak) and exposed for 2h; to obtain the image the phosphor-screen was 
scanned using a Molecular Imager FX (BioRad, Hemel Hempstead, UK). 
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3.3 Results 
3.3.1 Transcript mapping of the flagella modification region by qualitative RT-
PCR. 
Transcript analysis by conventional qualitative reverse-transcription PCR was 
carried out for the FMR (Cj1318-Cj1336) and the neighbouring genes pseI (Cj1317) 
and pseE (Cj1337) to attempt to locate transcripts within this region in the 11168-O WT 
and nssR mutant. Analysis was carried out on three preparations of RNA from separate 
cultures and results were consistent for all samples. Table 3.10 details the transcripts 
identified in this region and Figure 3.4 shows a map of transcription within the FMR 
produced from this data, Figure 3.5 shows agarose gels representative of the results 
generated. Cj1319 and Cj1320 were apparently transcribed together, as were ptmH and 
ptmC, ptmD and ptmE, and ptmB, ptmA and pseD. pseI and pseE are outside of the 
FMR and appeared to be transcribed separately to it. Within the FMR Cj1318/Cj1336, 
Cj1321, ptmG, Cj1334 and were transcribed alone; no evidence for the transcription of 
Cj1322, Cj1323 or ptmF was seen using this method. 
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Figure 3.10 Transcription of the FMR of C. jejuni 11168-O assessed by qualitative 
RT-PCR. ‘+’ indicates the presence of a transcript, ‘-’ indicates the absence of a 
transcript between the genes tested. 
Gene(s) tested for 
transcript continuity 
Presence of transcript 
Cj1317 + 
Cj1317- Cj1318 - 
Cj1317- Cj1319 - 
Cj1318
1
 + 
Cj1318- Cj1319 - 
Cj1318- Cj1320 - 
Cj1318- Cj1321 - 
Cj1319 + 
Cj1319- Cj1320 + 
Cj1319- Cj1321 - 
Cj1319- Cj1322 - 
Cj1320 + 
Cj1320- Cj1321 - 
Cj1320- Cj1322 - 
Cj1320- Cj1323 - 
Cj1321 + 
Cj1321- Cj1322 - 
Cj1321- Cj1323 - 
Cj1321- Cj1324 - 
Cj1322 - 
Cj1322- Cj1323 - 
Cj1322- Cj1324 - 
Cj1322- Cj1325 - 
Cj1323 - 
Cj1323- Cj1324 - 
Cj1323- Cj1325 - 
Cj1323- Cj1326 - 
Cj1324 + 
Cj1324- Cj1325 - 
Cj1324- Cj1326 - 
Cj1324- Cj1327 - 
Cj1325 + 
Cj1325- Cj1326 + 
Cj1325- Cj1327 + 
Cj1325- Cj1328 - 
Cj1326 + 
Cj1326- Cj1327 + 
Cj1326- Cj1328 - 
Cj1326- Cj1329 - 
Cj1327 + 
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Cj1327- Cj1328 - 
Cj1327- Cj1329 - 
Cj1327- Cj1330 - 
Cj1328 + 
Cj1328- Cj1329 + 
Cj1328- Cj1330 - 
Cj1328- Cj1331 - 
Cj1329 + 
Cj1329- Cj1330 - 
Cj1329- Cj1331 - 
Cj1329- Cj1332 - 
Cj1330 - 
Cj1330- Cj1331 - 
Cj1330- Cj1332 - 
Cj1330- Cj1333 - 
Cj1331 + 
Cj1331- Cj1332 + 
Cj1331- Cj1333 + 
Cj1332 + 
Cj1332- Cj1333 + 
Cj1333 + 
Cj1333- Cj1334 - 
Cj1333- Cj1335 - 
Cj1333- Cj1336 - 
Cj1334 + 
Cj1334- Cj1335 - 
Cj1334- Cj1336 - 
Cj1334- Cj1337 - 
Cj1335 + 
Cj1335- Cj1336 + 
Cj1336
1
 + 
Cj1336- Cj1337 - 
Cj1337 + 
 
1
Cj1318 and Cj1336 are directly repeated genes; hence it is not possible to distinguish 
between these genes. 
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Figure 3.4 Transcript map of the flagella modification region and surrounding genes. Arrows indicate the presence and extent of mRNA 
transcripts identified, for those genes lacking arrows, no evidence of transcription was found. Data is collated from all three repeats. 
Transcription of Cj1318 and Cj1335/6 could not be individually assessed as these genes are direct repeats and therefore identical in sequence, 
hence it is possible that only one of these genes is in fact expressed, rather than both, as is shown above.   
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Figure 3.5 Qualitative RT-PCR analysis of Cj1325 transcription. 1.0% agarose gel stained 
with ethidium bromide and showing amplicons generated using gDNA (Lanes 1-4) and cDNA 
(Lanes 5-8) as template. Different primer combinations were used to test for the expression of 
multiple genes on the same transcript. Lanes 1 & 5: primers 5 & 6 used to test for transcription 
of Cj1319; Lanes 2 & 6: primers 5 & 8 used to test for transcription from Cj1319 to Cj1320. 
Lanes 3 & 7: primers 5 & 10 used to test for transcription from Cj1319 to Cj1321. Lanes 4 & 8: 
primers 5 & 12 used to test for transcription from Cj1319 to Cj1322. M: molecular weight 
markers, sizes given.
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3.3.2 Transcriptional analysis of the flagella modification region in the 11168-O 
0466
-
 mutant by quantitative real-time PCR. 
Previous work carried out by Elvers et al. (2005) had indicated that there were 
differences in gene expression in the flagella modification region between the 11168-O 
WT and nssR mutant, 11168-O 0466
-
, that were unrelated to exposure to nitrosative 
stress. Quantitative real-time PCR was carried out to examine the extent of these 
differences in gene expression. The DNA gyrase gene gyrA was used as an internal 
control (Wosten et al., 2004; Elvers et al., 2005). Growth experiments confirmed that 
although 11168-O WT has a slower rate of growth than 11168-O 0466
- 
(data shown in 
appendix III), the cells from which RNA was extracted were in the same growth phase, 
hence differences observed in the real-time PCR results would be unlikely to be due to 
growth phase-related effects.  
These experiments compared expression of the flagella modification region and 
outlying genes pseI (Cj1317) - pseE (Cj1337) in 11168-O WT to expression in 11168-O 
0466
-
 The expression level of the genes between Cj1318 and Cj1336 in the 11168-O 
0466
-
 strain could not be quantified as the signals from all of these genes were below 
the limits of detection of the instrument used; this was true for each of the three 
biological replicates. pseI and pseE were expressed in 11168-O 0466
-
 at levels 
comparable with those of the wild-type, indicating that only the flagella modification 
region itself (Cj1318-Cj1336) is subject to down regulation in the 11168-O 0466
-
 strain. 
The selective down regulation of the FMR indicated that genes at the beginning of the 
region, such as Cj1318 and Cj1319, were very likely to be transcribed independently of 
genes just upstream of the region, such as pseI (Cj1317) and therefore may contain 
promoter sequences. 
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3.3.3 Transcriptional analysis of the flagella modification region in the 11168-O 
WT by quantitative real-time PCR. 
These qPCR experiments examined the expression of the FMR itself within 
11168-O WT by comparing gene expression in the FMR, and outlying genes pseI and 
pseE, in 11168-O WT to the expression of the control gene gyrA, allowing the level of 
gene expression in this region to be quantified relative to gyrA using the 2
-ΔΔCT 
method. 
A signal was detected for all genes except Cj1322 and Cj1323; it is possible that either 
these genes are not transcribed and so do not produce any signal, or that that signal was 
below the limits of detection of the instrument used, such the expression level of these 
genes could not be quantified. The levels of expression detected from the other FMR 
genes and calculated relative to gyrA are shown in Figure 3.6. Cj1318 and Cj1335/6 
expression is shown together as these genes are directly repeated and hence are 100% 
identical in sequence, therefore it was impossible to design separate primers and only a 
mean level of expression could be obtained.  
The difference in expression levels across the region indicates this region is 
unlikely to be transcribed from a single promoter. There are several hypothetical 
locations for promoters in this region, the major criterion being that they are located at 
the beginning of a region of increased expression relative to the upstream genes. 
Possible promoter locations could include ptmG (Cj1324), ptmH (Cj1325/6), ptmD 
(Cj1328), ptmB (Cj1331) and Cj1334 as these genes are located at the beginning of 
regions of increased expression, relative to the genes just upstream of each. There is 
also a possibility that the differences in mRNA levels seen here may not reflect the 
actual promoter activity in this region and may in fact be due to mRNA stability and 
degradation. Possible mechanisms could include post-transcriptional cleavage of 
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mRNAs seen in rRNA transcription or protection against degradation which can 
sometimes be conferred by the secondary structure of the mRNA.
 
   
   
 
 
 
Figure 3.6 Quantitative real-time PCR assays of FMR gene expression in 11168-O WT. The 
relative level of gene expression compared with the reference gene (gyrA) is shown, calculated 
using the 2
-ΔΔCT
 method; where no bar is present no expression of the gene was observed. The 
error bars represent the range determined using the 2
-ΔΔCT
 calculation, with ΔΔCT+S and ΔΔCT-S 
where S= the standard deviation of the value for ΔΔCT. These results represent one data set; the 
results were reproducible using separate RNA extracts from four independent cultures. 
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As the qPCR results demonstrated the possibility of there being transcriptional 
start points located upstream of Cj1318, Cj1319, ptmG (Cj1324), ptmH (Cj1325/6), 
ptmD (Cj1328), ptmB (Cj1331) and Cj1334, 5’RACE was used to attempt to map the 5’ 
ends of any mRNA transcripts starting from these genes. ptmD and Cj1334 were 
excluded from this analysis as the qPCR results indicated that these genes were 
expressed at a lower level than the other candidates and 5’RACE has a greater chance of 
being successful when used to examine genes with a relatively high level of expression. 
Unfortunately, despite multiple attempts, no PCR products could be produced from the 
dt-tailed mRNA for any of the genes tested. 
A search for the nitrosative stress dependant NssR binding sequence (consensus 
TTAAC-N4-GTTAA) was also carried out using the Pattern Search function of 
CampyDB (http://xbase.bham.ac.uk/campydb/, accessed July 2007) . No perfect 
matches were found outside of the regulon regulated by NssR in response to nitrosative 
stress. No sites with a single mismatch were located in the FMR; however, multiple 
sites with two and three mismatches were located throughout the FMR, even when the 
search was restricted to only those potential binding sites located less than 200bp 
upstream of a predicted translation start point there were still too many potential sites 
for any to be used to aid in the identification of possible promoter regions.  
 
3.3.4 Sequencing of the upstream regions of Cj0466, Cj1318 and Cj1319. 
 Verification of the DNA sequences of the upstream and 5’ regions of Cj0466 
(nssR), Cj1318 and Cj1319 was undertaken in strains 11168-O WT and 11168-GS WT. 
The aim of this work was to discover any DNA sequence differences in areas of DNA 
likely to contain promoter sequences linked to these genes and so begin to elucidate the 
causes of the observed differences in flagellin glycosylation between these strains.  
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The 5’ end of Cj1318 contains a homopolymeric tract (consensus = G11) located 
at the putative start codon +168bp. The sequence of this region was checked in both 
strains by PCR amplification and DNA sequencing; six biological repeats were carried 
out for both wild-type strains. Every sequence generated from the 11168-GS WT 
contained the consensus number of residues, as did five of the six sequences generated 
from the 11168-O WT. The DNA sequence following these sequences was ‘clean’ and 
easily legible, suggesting that the DNA template and hence the bacterial population 
from which these sequences were generated was homogeneous; an example of a ‘clean’ 
chromatograph is given in Figure 3.7. The sixth 11168-O WT sequence contained only 
ten G-residues and the following sequence was ‘noisy’, suggesting that the template 
DNA was displaced by the varying number of bases in the homopolymeric tract. As, in 
a non-clonal population of bacteria, there could be heterogeneity in the number of bases 
in a homopolymeric tract due to slipped-strand mispairing, so the DNA downstream of 
a tract where variation was present would appear to be staggered by one or more bases 
when sequenced, giving ‘noisy’ indistinguishable sequence which reflects the variation 
in the bacterial population; an example of a ‘noisy’ chromatograph is given in Figure 
3.7. This suggests that these homopolymeric tracts are capable of variation, at least in 
Cj1318 in the 11168-O WT. The DNA sequences of the upstream regions of Cj1319 
and nssR from both wild-type strains agreed in all respects with each other and the 
published genome sequence.  
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Figure 3.7. ‘Clean’ and ‘noisy’ chromatograms generated from the sequencing of 
the homopolymeric tract of Cj1318. The upper chromatogram demonstrates the 
‘clean’ sequence generated from a DNA template where the homopolymeric tract does 
not vary and contains 11 residues. The lower chromatogram demonstrates the type of 
‘noisy’ sequence generated from a population in which the homopolymeric tract 
contains a mixture of ten and eleven residues, with about half the population in each 
category, evidenced by the mixed G and T signals seen at the tenth position. 
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3.3.5 Testing for an inversion between Cj1318 and Cj1336 
To test whether an inversion between the directly repeated genes Cj1318 and 
Cj1336 had taken place in either 11168-GS WT or 11168-O WT and could explain any 
of the differences in flagellin glycosylation seen between these strains, primer pairs 
Cj1318inv and Cj1336inv, located in unique sequences outside of the two genes, were 
used. When the presence of the FMR in the orientation given in the genome sequence 
was tested for, a band of the expected size of 1.2kb was produced, indicating that no 
inversion had taken place in at least in part of the population. When an inversion 
between Cj1318 and Cj1336 was tested for, no amplicon was produced, suggesting that 
inversion between these genes had not taken place in any of the bacterial population 
examined. Figure 3.8 shows the results of inversion testing in strains 11168-O WT and 
11168-GS WT using primer pairs 1 & 2 and 1 & 3; the data for primer pairs 3 & 4 and 2 
& 4 corroborates this but is not shown. 
Transcriptional analysis of the FMR of C. jejuni 11168  Chapter III 
 
  139 
 
 
 
 
 
 
 
 
Figure 3.8. No inversion between the direct repeats Cj1318 and Cj1336 occurs in 
wild-types of both backgrounds. 0.7% agarose gels stained with ethidium bromide and 
showing products of inversion testing. Lane 1: product of primers 1 & 2 using template 
DNA from 11168-O WT. Lane 2: product of primers 1 & 2 using template DNA from 
11168-GS WT. Lane 3: product of primers 1 & 3 using template DNA from 11168-O 
WT. Lane 4: product of primers 1 &3 using template DNA from 11168-GS WT. 
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3.3.6. Analysis of genome-wide NssR binding by chromatin immunoprecipitation 
(ChIP). 
3.3.6.1 Purification of the NssR protein 
The His6-NssR protein (23.2kDa) is visible in the total protein extract from induced 
cells (Figure 3.9, lane 2). Insufficient protein was present in the culture supernatant to 
allow it to be purified so protein was obtained directly from the E. coli cells. Lane 5 
shows that even after lysozyme treatment and sonication to lyse the cells some protein 
remains in the cell debris, probably in the form of inclusion bodies. Enough protein is 
present in the supernatant of lysed cells (lane 4) to allow purification from this fraction, 
rather than attempting inclusion body purification and protein re-folding. The protein 
was not removed by filtration with a 0.45µm syringe filter which was used to remove 
debris to avoid clogging of the purification cartridge. NssR was purified using Novagen 
His-Bind 900 cartridges (Novagen, Darmstadt, Germany) and when visualised using a 
Coomassie stained SDS-PAGE gel (Figure 3.10 lane 8) appeared to be homogeneous. 
Protein concentration was measured using the Nanodrop spectrophotometer. Following 
four rounds of concentration and dialysis in Tris-NaCl buffer the protein reached a 
concentration of 200 µg.ml
-1
 and was at a suitable concentration for polyclonal antibody 
production. 
 
3.3.6.2 Preparation of a polyclonal antibody to NssR 
Purified, concentrated NssR protein produced in E. coli BL21 was used to produce 
polyclonal antibodies in rabbits. The antibody was then successfully purified and 
concentrated from the serum and its specificity tested by western blotting (Figure 3.11).  
 
 
Transcriptional analysis of the FMR of C. jejuni 11168  Chapter III 
 
  141 
 
 
 
 
 
 
Figure 3.9. Extraction of NssR from E. coli BL21(DE3) pETNssR. Lane 1 - Culture 
prior to induction with IPTG. Lane 2 - Culture after induction with 1mM IPTG and 
incubation O/N at 20°C. Lane 3 - Culture supernatant post centrifugation. Lane 4 - 
Supernatant after lysozyme treatment, sonication and centrifugation to remove cell 
debris. Lane 5 - Cell pellet after lysozyme treatment, sonication and centrifugation to 
remove cell debris. Lane 6 - Supernatant prior to 0.45µm filtration. Lane 7 - Supernatant 
post 0.45µm filtration.  
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Figure 3.10. Purification of NssR Lane 1 - Flow through from cartridge after addition 
of supernatant. Lane 2 - Binding buffer wash 1. Lane 3 - Binding buffer wash 2. Lane 4 
- Binding buffer washes 3 & 4. Lane 5 - Wash buffer wash 1. Lane 6 - Wash buffer 
wash 2. Lane 7 - Elute buffer wash 1. Lane 8 - Elute buffer wash 2. 
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Figure 3.11. Specificity of the polyclonal NssR antibody examined by western 
blotting. Lane 1: 5 μl boiled cell lysate from a broth culture of 11168-O WT with an 
OD600nm of 0.2. The western blot was performed using the purified, concentrated NssR 
antibody as the primary antibody and demonstrates that the antibody has a high 
specificity for the 23.2kDa his-tagged NssR protein. The sizes of the marker proteins 
are shown. 
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3.3.6.3 Confirming gene expression in 11168-O nssR-FLAG 
The sequence of the nssR region of the 11168-O nssR-FLAG strain was 
successfully confirmed by DNA sequencing (data not shown). The motility of the strain 
was examined by light microscopy and found to be indistinguishable from that of the 
parent strain 11168-O WT. As the nssR mutant strain 11168-O 0466
-
 has a significant 
motility defect it can be concluded that nssR is being expressed in the FLAG-tagged 
strain and that the FLAG-tag is not impairing protein function sufficiently to cause 
phenotypic effects. Real-time quantitative PCR was used to compare the expression of 
the FMR and outlying gene. Expression levels identical to those of the parent strain, 
given the limits of the instrument, were found in the 11168-O nssR-FLAG strain for the 
genes between pseI (Cj1317) and pseE (Cj1337) inclusive (data not shown). As the 
expression of Cj0466 (nssR) and the immediate downstream gene Cj0467 had not been 
previously analysed in the wild-type the expression of these genes was examined in 
11168-O WT and 11168-O nssR-FLAG. Figure 3.12 shows representative expression 
levels of Cj0466 and Cj0467 in both strains, compared to the internal control gene gyrA. 
This indicates that nssR and Cj0467 are expressed at the same level and suggests that 
the replacement of the wild-type nssR gene with the nssR-FLAG construct has not 
adversely affected expression of this gene. This suggests that the ChIP-chip work can be 
carried out using this strain with reasonable confidence that any results generated are 
not artefactual. 
 
Transcriptional analysis of the FMR of C. jejuni 11168  Chapter III 
 
  145 
 
 
 
 
Figure 3.12. Quantitative real-time PCR assays of Cj0446 and Cj0467 gene 
expression in 11168-O WT and 11168-O nssR-FLAG. The relative change in gene 
expression compared to the reference gene (gyrA) is shown, calculated using the 2
-ΔΔCT
 
method. The error bars represent the range determined using the 2
-ΔΔCT
 calculation, with 
ΔΔCT+S and ΔΔCT-S where S= the standard deviation of the value for ΔΔCT. These 
results represent a data set from one culture; the results were reproducible using 
separate RNA extracts from independent cultures.    
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3.3.6.4 Development of the chromatin immunoprecipitation method 
 As chromatin immunoprecipitation from Campylobacter has not been previously 
reported, the method used here and detailed in section 3.2.12 was adapted from that 
used by Grainger et al. (2005). Alterations to increase the amount of quality of DNA 
isolated were made, including an increase in the number and stringency of the washing 
steps during immunoprecipitation to take into account the fact that a greater volume of 
more concentrated chromatin was needed for a sufficient amount of DNA to be isolated. 
To increase the stringency of the final wash buffer NaCl was added; LiCl was also 
tested but was found to produce conditions which were too stringent, as no DNA was 
isolated. An elution buffer containing NaHCO3 was also substituted for 
Tris/EDTA/SDS buffer as it increased the amount of DNA eluted (Cho et al., 2008). 
The conditions used to reverse the DNA-protein crosslink induced by formaldehyde 
were also increased to an overnight incubation at 65°C to decrease the amount of 
protein remaining on the DNA prior to the protease digestion. Proteinase K was 
substituted for the Pronase used by Grainger et al. (2005) as preliminary PCR 
experiments showed that it removed more protein from the immunoprecipitated DNA. 
 
3.3.6.5 Failure of direct labelling 
 In order to identify the genes present in the DNA isolated by ChIP and so 
identify the location of NssR binding, it was necessary to first label the DNA with the 
appropriate CyDye. A BioPrime Array CGH Genomic Labelling System was used to 
attempt to label the DNA; this system has previously been used to successfully label 
ChIP DNA for use on microarrays (C. Constantinidou, personal communication). The 
system incorporates the fluorescently labelled nucleotides into the DNA during a 
polymerisation reaction catalysed by the exo-Klenow enzyme and using random 
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octamers, which should result in an approximately 10-fold amplification of DNA; the 
resulting DNA is then purified from the reaction prior to use in microarray 
hybridisation.  
 Unfortunately, all attempts at the direct labelling of ChIP DNA isolated during 
this work failed, despite repeated attempts at troubleshooting which included varying 
the amounts of ChIP DNA added to the reactions and the amount of exo-Klenow DNA 
polymerase used. Extended incubations of protease with the ChIP DNA were also used 
in an attempt to remove any protein remaining on the DNA from the initial DNA-
protein cross-linking with formaldehyde. If any protein had resisted the protease 
digestion and heating used to reverse the cross-links during the ChIP protocol, it could 
interfere with the progress of the exo-Klenow DNA polymerase along the DNA strand, 
causing premature termination of polymerisation and resulting in failure of the reaction. 
Unfortunately these attempts also ended in failure and it was not possible to generate 
fluorescently labelled DNA suitable for microarray hybridisation before the end of the 
project.  
 
3.3.6.6 Analysis of immunoprecipitated DNA by PCR 
Due to the failure of the direct labelling procedure it proved impossible to use 
high-density microarrays to obtain a genome-wide picture of NssR binding as was 
originally planned. However, the process of troubleshooting the direct labelling reaction 
also identified an alternative, albeit more limited, method for the analysis of the DNA 
isolated by chromatin immunoprecipitation. It was found that PCR with a Taq DNA 
polymerase, as opposed to the exo-klenow enzyme used for the direct labelling reaction, 
was successful. Hence the ChIP DNA was instead analysed by PCR and examined for 
the presence of a defined set of genes, including those of the FMR and surrounding 
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genes together with nssR itself and cgb, a single domain globin known to be regulated 
by NssR under nitrosative stress conditions. The flagellin genes were also tested for but 
due to the high sequence similarity exhibited by these genes it was only possible to test 
for both flaA and flaB together, in Table 3.10 below these are listed as ‘fla’; as Cj1318 
and Cj1335/6 are direct repeats it was only possible to test for these genes in 
combination. The AB
+
 (ChIP carried in the presence of the appropriate antibody), AB
- 
(ChIP carried out with the antibody substituted by water) and total chromatin fractions 
were tested from both the 11168-O WT DNA immunoprecipitated using the polyclonal 
NssR antibody and the 11168-O nssR-FLAG DNA immunoprecipitated using the 
monoclonal FLAG antibody. The results are given in Table 3.11, each set of 
immunoprecipitations were carried four times and all samples were tested by PCR, the 
results were consistent for all comparative samples.  
The results were consistent between both immunoprecipitation methods used, 
indicating that adding the FLAG-tag to the coding sequence of the nssR gene in the 
11168-O nssR-FLAG strain had no observable effect on the action of the NssR protein. 
The fact that the results were consistent across all samples indicates that the 
immunoprecipitation method developed here is capable of consistently isolating DNA. 
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Table 3.11. PCR testing of chromatin immunoprecipitated DNA. ‘+’ indicates that 
the PCR generated an amplicon of the correct size for that sample, ‘-’ indicates that no 
PCR amplicon was produced. ‘AB+’: ChIP carried in the presence of the appropriate 
antibody;  ‘AB- ’: ChIP carried out where the appropriate antibody was substituted for 
water and ‘Total’: chromatin which has not been used for immunoprecipitation and was 
isolated from the appropriate C. jejuni culture. 
 
Gene 
11168-O WT 11168-O nssR-FLAG 
AB
+
 AB
-
 Total AB
+
 AB
-
 Total 
pseI (Cj1317) - - + - - + 
Cj1318/36 + - + + - + 
Cj1319 + - + + - + 
Cj1320 - - + - - + 
Cj1321 - - + - - + 
Cj1322 - - + - - + 
Cj1323 - - + - - + 
ptmG (Cj1324) + - + + - + 
ptmH (Cj1325/6) - - + - - + 
ptmC (Cj1327) - - + - - + 
ptmD (Cj1328) - - + - - + 
ptmE (Cj1329) - - + - - + 
ptmF (Cj1330) - - + - - + 
ptmB (Cj1331) + - + + - + 
ptmA (Cj1332) - - + - - + 
pseD (Cj1333) - - + - - + 
Cj1334 + - + + - + 
pseE (Cj1337) - - + - - + 
fla (incorporating flaA 
& flaB) 
- - + - - + 
nssR + - + + - + 
cgb + - + + - + 
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3.3.7 NssR binds DNA in vitro 
An electrophoretic mobility shift assay was carried out using purified, 
His•tagged NssR protein and P32 –labelled DNA fragments amplified from the promoter 
region of the cgb gene, which contains the consensus NssR binding site under 
nitrosative stress conditions, TTAAC-N4-GTTAA. The retardation of the movement of 
radio-labelled cgb DNA in the presence of NssR, compared to the unimpeded 
movement of the radio-labelled cgb DNA alone, indicates that NssR is able to bind in 
vitro to this DNA; a representative gel image is shown in Figure 3.13. When an 
increasing concentration of unlabelled oligonucleotides carrying the NssR binding site 
sequence (TTAAC-N4-GTTAA) was added to reactions containing 3.2μM NssR and 
the same radio-labelled DNA as used above, the DNA-NssR band disappeared as 
greater concentrations of the unlabelled oligonucleotide were added, Figure 3.14. This 
result also suggests that the NssR protein is binding to DNA containing the NssR 
consensus binding sequence.  This sequence was deduced by examining the promoter 
regions of genes induced by NssR under conditions where nitrosative stress was present. 
Non-specific binding of NssR to DNA would not have been detected by this method as 
unlabelled herring sperm DNA was present in all reactions in a large excess. These 
results together suggest that NssR is able to bind, in vitro and in the absence of 
externally applied nitrosative stress, to the consensus binding sequence known to be 
used under conditions where nitrosative stress has been applied; whether this binding 
also occurs in vivo is unknown.
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Figure 3.13 NssR binds DNA containing the NssR binding motif in the absence of 
externally applied NO stress. Electrophoretic mobility shift assay showing binding of 
purified NssR protein to radio-labelled DNA fragments from the cgb promoter region 
and the resulting retardation of movement of the DNA, in comparison to unbound, free 
DNA.  The DNA fragments were incubated with 0.32, 0.16, 0.08, 0.04, 0.02 or 0μM 
(control) NssR as indicated.
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Figure 3.14 Loss of NssR binding upon addition of an oligonucleotide containing 
the NssR binding motif. An electrophoretic mobility shift assay showing loss of 
binding of purified NssR protein to radio-labelled DNA fragments from the cgb 
promoter region when an oligonucleotide containing the NssR binding sequence 
TTAAC-N4-GTTAA was added in increasing concentrations. The DNA fragments were 
incubated with 0.32μM NssR and the concentrations of the oligonucleotide added were 
0μM (control), 0.10μM, 0.25μM, 0.50μM, 1.0μM, 10.0μM respectively.  
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3.4 Discussion 
The overall aim of this part of the study was to determine the effects that NssR 
has on the small subset of flagellin glycosylation genes that constitute that FMR. A 
mutant in nssR constructed in the 11168-O strain background of C. jejuni 11168 did not 
express the genes of the FMR. However, a similar mutant constructed in the 11168-GS 
background showed no loss of expression of the FMR, indicating that NssR is not 
involved in the regulation of these genes in this strain. Hence, the work here was 
focused on the activity of NssR in strains of the 11168-O background. 
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Table 3.12 Analysis of expression of the FMR of C.jejuni, by quantitative RT-PCR, 
qualitative qPCR and chromatin immunoprecipitation. 
 
Gene Transcript 
continuity tested 
by RT-PCR
a 
 
Expression 
tested by 
qPCR
b 
 
Tested by 
5’RACE as 
potential 
transcript start 
site 
NssR 
assessed by 
ChIP
c
  
pseI (Cj1317) + + - - 
Cj1318
1
 + + + + 
Cj1319 Cj1320 + + + 
Cj1320 + + - - 
Cj1321 + + - - 
Cj1322 - - - - 
Cj1323 - - - - 
ptmG 
(Cj1324) 
+ + + + 
ptmH 
(Cj1325/6) 
ptmC + + - 
ptmC (Cj1327) + + - - 
ptmD 
(Cj1328) 
ptmE + - - 
ptmE (Cj1329) + + - - 
ptmF (Cj1330) - - - - 
ptmB (Cj1331) pseD + + + 
ptmA (Cj1332) pseD + - - 
pseD (Cj1333) + + - - 
Cj1334 + + - + 
Cj1335/6
d
 + + - + 
pseE (Cj1337) + + - - 
 
a: transcript ‘+’ present, ‘-’ absent or ‘Cj1340’  - transcript contains all genes up to and 
including Cj1340. 
b: expression ‘+’ present, ‘-’ absent. 
c: NssR binding ‘+’ present, ‘-’ absent.  
d: Cj1318 and Cj1336 are directly repeated genes, hence it is not possible to distinguish 
between these genes. 
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3.4.1 Transcriptional organisation of the flagellar modification region. 
 The first stage of the analysis of NssR activity in the FMR involved deducing 
the transcriptional organisation of the FMR. To that end, transcripts across the FMR 
were mapped by qualitative reverse-transcription PCR (RT-PCR) to determine the 
presence and extent of any transcripts in this region and to discover whether this region 
was transcribed discretely or together with the surrounding genes. Quantitative qPCR 
was also carried out to examine the levels of gene expression in this region, relative to 
the control gene gyrA. 
 These combined analyses indicated that the FMR is transcribed independently to 
the surrounding genes pseI (Cj1317) and pseE (Cj1337). Also evident was the fact that 
the region was expressed, not as a single long transcript from one promoter, but in 
several transcripts, some containing multiple genes, others only a single gene. The data 
from the RT-PCR and qPCR analyses are shown in table 3.12 together with the data 
gathered from both ChIP approaches, this data is generally in agreement upon the genes 
constituting each transcript, although there was a level of variation which can be 
explained by the limitations of each method. Transcriptional organisation was inferred 
from the qPCR data by comparing the expression levels of neighbouring genes; hence a 
gene which was expressed at a level less than the upstream gene would appear to form 
part of the preceding transcript, a gene which appeared to be expressed at a level greater 
than the preceding gene could be said to form a new transcript. The RT-PCR approach 
was limited by the activity of the reverse-transcriptase used to convert mRNA into 
cDNA, limiting the length of transcript which could be detected, and generally only 
transcripts less than 3kb were searched for. The combined results suggest that the FMR 
is expressed on different transcripts comprising 1) Cj1319, Cj1320 and Cj1321, 2) 
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ptmG, 3) ptmH and ptmC, 4) ptmD, ptmE and ptmF, 5) ptmB, ptmA and pseD and 6) 
Cj1334. It was impossible to analyse the expression levels or transcription of Cj1318 
and Cj1335/6 independently as these genes are direct repeats and hence are identical in 
sequence.  
No evidence of the transcription of Cj1322 or Cj1323 was observed, whether 
this was due to the actual level of expression being below the level of detection of the 
qPCR instrument or whether these genes are in fact not expressed in 11168-O WT it is 
impossible to determine. BLAST analyses of the predicted amino acid sequence of 
Cj1322 and Cj1323 showed no homology to any bacterial proteins. Expression of ptmF, 
which is thought to have a role in legionaminic acid biosynthesis (Logan et al., 2002), 
was confirmed by qPCR, although the expression was at a very low level, which could 
explain why its expression was not detected by RT-PCR transcript mapping.  
Analysis of the FMR by qPCR in the 11168-O 0466
-
 mutant indicated that 
transcription of the FMR was abrogated in this strain, supporting the conclusion that 
NssR is involved in FMR regulation. The surrounding genes, pseI and pseE, were 
expressed at levels comparable to the wild-type, indicating that these genes are unlikely 
to be subject to regulation by NssR. 
 
3.4.2 Location of potential promoter sequences in the FMR 
 Having determined the likely transcriptional organisation of the FMR, it was 
possible determine that FMR transcription does not originate from a single promoter at 
the start of the region, and to locate potential transcriptional start points within the 
FMR. Identification of transcript start points would, in addition to confirming the 
transcriptional organisation of the FMR, allow a search for the associated promoter 
sequences to be targeted. The combined data from the qualitative RT-PCR, quantitative 
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qPCR and combined ChIP approaches, shown in Table 3.12, is in largely in agreement 
upon the location and constituent genes of each transcript; the locations of potential 
transcript start points was inferred from his data. As the FMR was transcribed 
separately to the surrounding genes, it is likely that a promoter would be located in the 
first genes of the FMR. As it was difficult to assess the transcription of Cj1318, the 
upstream sequences of both it and Cj1319 were examined using 5’ RACE. Also 
examined were the upstream regions of ptmG, ptmH, ptmB as these genes were located 
at the start of the transcripts indentified above. No transcript start points for any so these 
genes were identified, despite multiple attempts. This failure is likely to be due to the 
fact that the primers designed to amplify the 5’-regions of these transcripts were 
incorrectly located. Primer extension is another popular technique for the exact 
identification of transcript start points, unfortunately this method also relies a correctly 
located primer to be successful. As all previous attempts to design primers for this 
purpose had been unsuccessful, the identification of transcript start points by primer 
extension was not attempted and it proved impossible to locate the transcriptional start 
points of the FMR.  
 
3.4.3 NssR binds DNA in vitro 
 NssR is the only member of the Crp-Fnr super-family of DNA binding proteins 
present in C. jejuni NCTC 11168. The promoter regions of genes regulated by members 
of the Crp-Fnr super-family generally contain distinctive recognition motifs (Korner et 
al., 2003). One such motif, with a consensus sequence of TTAAC-N4-GTTAA, was 
identified in the promoter regions of those genes in C. jejuni NCTC 11168 regulated by 
NssR, in the presence of externally applied nitrosative (NO) stress. These genes include 
the single-domain globin Cgb, which is involved in the scavenging and detoxification 
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response to NO stress (Elvers et al., 2004), and several other genes of uncertain 
function.  
The binding of NssR to DNA at the motif given above in the presence of 
nitrosative stress has been established (Elvers et al., 2005).  As part of this work, 
electrophoretic mobility shift assays were used to test for NssR binding in the absence 
of NO stress. Binding of NssR to radio-labelled DNA containing the consensus binding 
motif, in the absence of external NO stress was observed. The application of increasing 
concentrations of an unlabelled oligonucleotide, containing the consensus binding 
sequence, to the mixture of purified NssR and radiolabelled cgb DNA, produced a 
gradual decrease in the level, and eventually removal, of NssR binding. A large excess 
of salmon-sperm DNA was also applied to all reactions to ensure that non-specific 
binding would not produce a false positive result. Together, these results indicate that, 
at least in vitro, NssR is able to bind DNA at the consensus binding sequence, without 
the application of externally applied NO stress. Whether this binding also occurs in vivo 
can not be inferred from this data.  
If NssR is able to bind DNA and the sequence given above and if it were to act 
directly upon the FMR, binding motifs may also be visible in the promoter regions of 
FMR genes. However, a search of the entire FMR DNA sequence for the consensus 
binding sequence indentified no motifs with zero or one mismatches to the consensus 
and too many motifs with two or three mismatches to identify any specific motifs which 
could form part of a promoter sequence. 
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3.4.4 Chromatin immunoprecipitation (ChIP) to assess NssR binding 
 A ChIP method for the isolation of those genomic DNA fragments to which 
NssR binds in vivo in the 11168-O WT and a strain constructed in the11168-O 
background in which a FLAG-NssR fusion replaced wild-type NssR, was successfully 
developed. Initially the aim of this part of the work was to produce a genome-wide 
‘map’ of NssR binding by applying the DNA isolated by ChIP to a high-density DNA 
microarray (ChIP-chip) and identifying all genes to which NssR bound in the growth 
condition used. This ‘map’ could then be used to indentify any other genes regulated by 
NssR and to determine whether the action of NssR upon the genes of the FMR was 
direct, acting upon the genes themselves, or indirect, involving the modulation of 
expression of a second, unknown, regulatory gene.  
However, the failure of the DNA isolated by ChIP to label with the Cy-dyes 
necessary for detection on a microarray, meant that it was not possible, in the time 
available, to use the microarray to assess genome-wide NssR binding. Instead, the 
presence of a small subsection of genes, including those of the FMR, in the DNA 
isolated was tested for by PCR. The results generated from both ChIP approaches were 
in agreement and indicated that NssR bound to DNA in which the Cj1318/36, Cj1319, 
ptmG, ptmB and Cj1334 genes were present. As the DNA isolated from ChIP was 
sonicated to produce fragments of between approximately 500bp and 1kb it is possible 
that some DNA fragments were outside of this range and contained DNA from 
neighbouring genes. Hence it is possible that NssR binds only to one location where 
consecutive genes have been identified, for example in Cj1318 or Cj1319 and Cj1334 or 
Cj1335/6 not it both. Also, the identical sequence of Cj1318 and Cj1335/6 means that it 
is impossible to determine whether NssR binds to a sequence in both or only in one of 
these genes. 
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The failure of direct labelling with Cy-dyes was potentially due to the presence 
of protein, NssR or NssR-antibody, cross-linked to the DNA. Although several different 
methods of de-cross-linking and protease digestion were attempted, none removed the 
protein from the DNA to a point where the Exo-Klenow fragment polymerase was able 
to amplify DNA and allow labelling. The ability of the taq enzyme to amplify ChIP 
DNA may simply be due to the robustness of the enzyme in comparison to Exo-
Klenow. The retention of DNA on ChIP DNA is an acknowledged problem with this 
technique (Cho et al., 2008).  
 
3.4.5 Variation of homopolymeric tracts 
 To assess whether those FMR genes which contain homopolymeric sequences, 
Cj1318 and Cj1335/6, could be subject to phase variation by slipped strand mispairing, 
the homopolymeric tract located within Cj1318 was amplified from several separate 
cultures of 11168-O WT and 11168-GS WT and sequenced. None of the sequences 
generated from 11168-GS WT DNA showed any variation in the number of residues in 
the homopolymeric tract. Whilst the majority of 11168-O WT sequences examined also 
showed no variation in the sequence of this tract, one sequence showed variation 
between 10 and 11 G-residues; the population was divided approximately equally 
between the two states. This concurs with the findings of Parkhill et al. (2000) who, 
during the C. jejuni NCTC 11168 genome sequencing project, identified variation in 
this tract of between 10 and 11 G-residues, with the majority of the population being in 
the phase ‘off’ state with 10 G-residues. In order for the Cj1318 gene to be in the phase 
‘on’ state the tract must contain 11 G-residues.  
Cj1318 (maf1) is part of the maf (motility accessory factor) family of genes, 
which share considerable homology; some members of this group are involved in the 
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attachment (pseD/maf2) or assembly (pseE/maf5) of flagellar glycans. The exact 
function of Cj1318 is unknown, however, Karlyshev et al. (2002) demonstrated that a 
functional Cj1318 gene, with a homopolymeric tract containing 11 G-residues, could 
partially restore motility in an otherwise non-motile Cj1337 (maf5) mutant. Since this 
work was carried out, a homolog of Cj1337 (maf5) in C. jejuni 81-176 was found to 
have a role in the assembly or transfer of pseudaminic acid derived glycans to flagellin 
and was annotated pseE (Guerry et al, 2006). As a functional Cj1318 protein was able 
to partially restore the motility of a Cj1337 mutant, it is possible that Cj1318 may at 
least partially functionally substitute PseE and hence potentially have a similar function. 
 
3.4.6 Influence of NssR on the FMR 
Despite the fact that a complete map of NssR binding was not generated, the 
results generated by ChIP agree well with the interpretation of the transcriptional 
organisation of the FMR derived from RT-PCR and qPCR, which suggested that the 
FMR could be expressed in approximately six transcripts originating from Cj1319, 
ptmG (Cj1324), ptmH (Cj1325/6), ptmD (Cj1328), ptmB (Cj1331) and Cj1334. The 
ChIP data also supports the evidence of Section 3.4.3 that indicates that NssR binds 
DNA in the absence of external NO stress, although the whether the NssR binding motif 
is the binding sequence used in vivo can not be determined. Together, these results 
suggest that NssR is able to function in the absence of externally applied nitrosative 
stress and is likely to bind directly to certain undefined sequences, probably located in 
the promoter regions of Cj1318/36, Cj1319, ptmG, ptmB and Cj1334, to modulate the 
expression of these genes. As the transcript start points of these genes could not be 
identified it also proved to be impossible to identify a possible binding motif for NssR 
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under these conditions, whether the NssR binding motif identified by Elvers et al. 
(2005) or a novel sequence. 
It is also possible that NssR is not the only regulatory protein active in the FMR, 
as several genes, particularly ptmH and ptmD, which were not indentified by ChIP as 
being binding locations for NssR, show evidence of being transcribed independently of 
upstream genes. Carrillo et al. (2004) also identified σ28 promoter sequences upstream 
of ptmA and ptmB, which indicates that the flagellar associated σ-factor may also be 
involved in regulation of flagellar glycosylation.  
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3.4.7 Future work 
Whilst the failure of direct labelling meant that it was impossible to generate a 
genome wide map of NssR binding, the fact that DNA, corresponding to genes known 
to be directly regulated by NssR (cgb and nssR), as well as to genes not previously 
identified as being directly regulated by NssR (FMR genes), was isolated using the 
ChIP method developed as part of this work demonstrates the effectiveness of this 
method. The high throughput DNA sequencing technologies developed in recent years, 
such as the Illumina platform and the 454 technology of Roche, are capable of 
generating at least thousands of sequences from one run (Hall, 2007). The use of these 
high-throughput DNA sequencing technologies to sequence DNA isolated by ChIP 
(ChIP-seq) using anti-NssR antibodies, would allow a genome-wide map of NssR 
binding to be generated without the use of a microarray. The transcriptome of the nssR 
mutant could also be examined using RNA-seq, another high-throughput sequencing 
technique able to identify all of the mRNA transcripts present in a sample. The 
combination of NssR binding location mapping by ChIP-seq and transcriptome 
sequencing by RNA-seq would provide a very complete picture of the genome-wide 
activity of NssR. 
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Chapter IV: Motility and biofilm 
formation in C. jejuni 11168 
 
4.1 Introduction 
4.1.1 Motility in Campylobacter 
The characteristic rapid, darting motility of Campylobacter is mediated by a 
single polar unsheathed flagellum located at one or both ends of the cell (monotrichous 
or amphitrichous, respectively). This flagellar mediated motility is an essential part of 
the pathogenesis of Campylobacter, allowing cells to translocate through the viscous 
mucus of the intestine to colonise and establish an infection. Flagellar motility is also 
involved in the attachment to and invasion of cells, as shown by Wassenaar et al. (1991) 
and Grant et al. (1993) using polarised intestinal cell monolayers. 
 The flagella of Campylobacter jejuni are of the complex type, being composed 
of two species of flagellin monomer, as opposed to the single flagellin seen in E. coli. 
FlaA is the major flagellin in Campylobacter, expression of which is dependent on a σ28 
promoter, while the gene encoding the minor flagellin, FlaB, is located downstream of 
FlaA and is dependent on a σ54 promoter (Guerry et al., 1990; Nuijten et al., 1990). The 
two flagellins show considerable homology, approximately 95% in the sequenced strain 
of C. jejuni NCTC 11168 (11168-GS WT), with the majority of the variation occurring 
in the central region of the sequence. Mutants in flaA are poorly motile with short, 
truncated flagella, whilst mutants in flaB possess near normal flagella and motility but 
in certain experiments show a decrease in pathogenic potential (Guerry et al., 1991; 
Wassenaar et al., 1993). It has been suggested, by Kostrzynska et al. (1991) that in the 
closely related bacterium Helicobacter pylori FlaB forms the proximal part of the
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flagellum, while FlaA forms the distal part. However, as the two proteins in C. jejuni 
are antigenically indistinguishable, it is not possible to ascertain whether this is the case 
in this species. Flagellins in Campylobacter are also glycosylated, a modification which 
could have a role in processes as diverse as flagellar biogenesis and immune system or 
bacteriophage evasion. The exact extent of glycosylation in C. jejuni NCTC 11168 is 
unknown, but in the closely related strain C. jejuni 81-176, approximately 10% of the 
flagellar mass consists of carbohydrates (Thibault et al., 2001). Whilst the exact 
function(s) of flagellin glycosylation remain unclear, it is known that a variety of 
mutants in C. jejuni, where the flagellin lacks glycans or is glycosylated differently to 
the wild-type, are unable to assemble a full-length flagellum. Certain mutants have also 
been seen to accumulate unglycosylated flagellin monomers intracellularly (Goon et al., 
2003) and   other mutants do synthesise flagella but are non-motile. 
 C. jejuni strains also show the ability to move, reversibly and apparently 
spontaneously, between flagellate and aflagellate phenotypes. This indicates that C. 
jejuni has the capacity to modulate motility by variable expression of the flagella. 
Whether the variable expression of flagellin glycosylation genes is involved in this 
process is unclear (Caldwell et al., 1985). The sequenced strain of C. jejuni NCTC 
11168 (11168-GS WT) appears to be subject to some kind of flagellar phase switching, 
as many stocks of this strain are non-motile but still retain intact full-length flagella, 
including that used in this study. Motility of these stocks can be selected for in vitro 
using soft ‘motility’ agar as demonstrated by Karlyshev et al. (2002). This ability to 
modulate flagellar expression, function and/or flagellin glycosylation is understandable 
in light of the energetic cost of flagellar expression and the need for most pathogenic 
bacteria to adapt to the environmental changes encountered during the infection of a 
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host and exposure to the external environment, for those bacteria which are transmitted 
by the food chain. 
 The 11168-GS WT strain used in this study exhibits full-length flagella but is 
almost always non-motile; only rarely will an individual culture exhibit some motility, 
when approximately 50% of the cells move in a manner reminiscent of the 11168-O 
WT (Personal observation). The 11168-GS 0466
- 
and 11168-GS 0466C strains are both 
non-motile and exhibit full-length flagella. The 11168-O WT and 11168-O 0466C 
strains always exhibit the rapid darting motility characteristic of Campylobacter. 
However, the 11168-O 0466
-
 mutant does not consistently have full-length flagella 
when examined by electron microscopy and whilst the cells are still motile, they do not 
demonstrate the same type of movement as the parental strain. As the type of motility 
defect shown by the 11168-O 0466
-
 mutant has not previously been documented, this 
defective motility will be examined and quantified, for comparison with the wild-type.  
To ensure that the most suitable method(s) are used to examine motility several 
methods previously used to analyse and record bacterial motility will be tested and if 
necessary adapted and developed, to produce a method which allows repeatable and 
reliable quantification of bacterial motility and that yields results which can be easily 
presented. To aid in the development of a suitable method the motility of the other 
strains used in this study will also be examined, particularly that of the 11168-O WT, as 
due to its speed, it is likely to be the most challenging strain to analyse. The methods to 
be tested include the Hobson BacTracker imaging system which had been used by 
Karim et al. (1998) to measure and compare the motility of H. pylori, C. jejuni and E. 
coli. The second method is the ImageJ based video microscopy and manual tracking 
system which has been used to examine the motility of ΔflhF mutants in Pseudomonas 
aeruginosa and to produce images showing the paths of movements of individual 
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bacterial cells (Murray and Kazmierczak, 2006). The final method used involves growth 
of the strains on soft ‘motility’ agar, as demonstrated by Karlyshev et al. (2002) and 
used in the laboratory to isolate motile revertants from previously non-motile mutants. 
 
4.1.2 Biofilm formation 
Biofilms are multi-layered complex bacterial ecosystems encased in a 
polysaccharide matrix; they exist in many different ecological niches and are important 
considerations in many different industries, particularly those involved in food 
production, water treatment and also in medicine. Monospecies biofilms are of clinical 
importance and can be formed by several human pathogens; whilst C. jejuni has not 
been identified as one of these species, it has been found as part of certain multi-species 
biofilms (Trachoo et al., 2002). Biofilms can confer protection against a variety of 
stresses including desiccation, nutrient depletion and antibiotic exposure, hence the 
formation of or inclusion in biofilms may aid the survival of Campylobacter in the 
environment. Flagella appear to be involved in the initial attachment phase of biofilm 
formation as aflagellate mutants do not attach to other cells or surfaces (Joshua et al., 
2006; Kirov et al., 2004).  
Autoagglutination, which has been demonstrated in Campylobacter (Golden and 
Acheson, 2002), involves non-specific reactions which lead to clumping of bacterial 
cells, although it is unclear whether this has any role in biofilm formation or growth 
(Guerry et al., 2006). Autoagglutination in Campylobacter is at least party mediated by 
flagella and it is possible that flagellar glycans have some involvement in this process 
(Guerry et al., 2006). Several transposon mutants in genes thought to be involved in 
flagellin glycosylation have been found to be deficient in autoagglutination (Golden and 
Acheson, 2002).  
Motility and biofilm formation in C. jejuni 11168  Chapter IV 
 
  168 
 
Howard et al. (2009) have identified a livestock clade associated glycosylation 
island (Cj1321-Cj1325/6), which has a role in maintaining the ability of Campylobacter 
to colonise chickens. Deletion of this island, and particularly the Cj1324 gene, also 
annotated as ptmG, also caused an alteration in cell surface charge, a decrease in the 
ability of this strain to autoagglutinate and form biofilms, together with a loss of LegAm 
from flagellin. This flagellar glycan loss is thought to be responsible for the decrease in 
chicken colonisation seen in these mutants; both the complete island and Cj1324 
mutants remained motile and formed wild-type length flagella. This genetic island 
forms part of the FMR down-regulated in the 11168-O 0466
-
 mutant; hence it is 
possible that a decrease in autoagglutination and biofilm formation by the 11168-O 
0466
-
 mutant could be observed.  
 The formation of biofilms on glass surfaces by C. jejuni has been clearly 
demonstrated by Joshua et al. (2006). Autoagglutination in these strains has also been 
established and examined by Misawa and Blaser (2000). The ability of all 
Campylobacter strains used in this study to form biofilms on a glass surface, at the air-
liquid interface of a culture or in the body of the liquid, which would be 
indistinguishable from autoagglutination occurring independently of biofilm formation, 
will be tested. Any differences identified in biofilm formation or autoagglutination 
between these strains may aid the characterisation of any differences in flagellin 
glycosylation between these strains. 
Motility and biofilm formation in C. jejuni 11168  Chapter IV 
 
  169 
 
4.2 Methods 
4.2.1 Bacterial strains 
A list of bacterial strains and their relevant characteristics is given in Table 2.3 
(Section 2.3). All strains were grown under the culture conditions given in Section 2.4, 
unless otherwise stated. 
 
4.2.2 Plate assay of motility 
Motility assays of all strains from the 11168-O and 11168-GS backgrounds were 
carried out on soft agar plates made by combining Mueller-Hinton broth powder (Oxoid 
Basingstoke, UK) with 3.4g per litre of agar powder (Oxoid, Basingstoke, UK) to 
produce soft agar with a final agar concentration of 0.34% (w/v). An overnight broth 
culture of the strain to be tested was used to inoculate 10 ml MH broth to an OD600nm of 
0.08; this culture was then grown with shaking until mid-log phase was reached at an 
OD600nm of approximately 0.3. The log phase culture (2 µl) was then either dropped onto 
the centre of a soft agar plate and allowed to soak in, stabbed into the body of the agar, 
taking care not to pierce the agar entirely and allow the inoculum to reach the plastic of 
the petri dish, or dropped onto a sterile 5 mm diameter filter paper disk placed onto the 
surface of the agar. Plates were then incubated microaerobically at 37°C, facing 
upwards to avoid disturbing the agar, for 48h and the diameter of any growth measured 
and photographed, using a Sony Cyber-shot 7.2 Mp camera, every 12h. After 24h 
incubation, samples were taken from the edges of bacterial growth on plates of the 
11168-O WT and 11168-O 0466
-
 strains for examination by electron microscopy to 
attempt to identify any difference in cell or flagellar morphology. 
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4.2.3 Analysis of C. jejuni motility using the BacTracker  
The swimming behaviours of all of the C. jejuni 11168-O strains were measured 
using the Hobson Bac Tracker imaging system (Hobson Tracking Systems, Sheffield, 
UK; Karim & Logan, 1998), a computerised tracking system capable of measuring the 
mean velocity of a culture of motile bacteria from video footage of their movement. 
Video footage of motile, log-phase bacteria was prepared and sent to Dr Q. N. Karim at 
Imperial College, London for analysis. Footage was prepared by diluting an overnight 
broth culture to an OD600nm of 0.1 and growing the culture microaerobically at 37ºC for 
4h to obtain a log phase culture with an OD600nm of between 0.2-0.3; all strains were 
also grown on agar plates for 40h. A drop of log phase culture, or 40h plate culture 
emulsified into MH broth, was prepared for filming as quickly as possible after leaving 
the incubator, to avoid any loss of motility due to exposure to atmospheric oxygen 
concentrations or temperature changes. Microslides (100µm; Camlab, Cambridge UK) 
were filled with the culture to be filmed by capillary action and sealed at each end using 
Critoseal (Camlab, Cambridge UK). Cultures were filmed using a Leitz Laborlux 12 
microscope with a 40 x phase contrast objective. The camera used recorded directly to 
video tape, producing a field of view of approximately 25-35 cell lengths. The 
BacTracker software requires at least 2 minutes, and preferably 5 minutes, of recording, 
showing minimal drift, to make reliable measurements. Suitable recordings and repeats 
were made from each strain and growth condition. 
 
4.2.4 Analysis of motility by video microscopy and tracking. 
The swimming behaviours, in MH broth, of wild-type and ΔnssR bacteria from 
the C. jejuni 11168-O background were recorded then examined using the Image J 
software (Version 1.37, NIH; http://rsb.info.nih.gov/ij/) with the manual tracking plug-
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in, a method of analysis adapted from Murray & Kazmierczak (2006). Cultures were 
prepared by diluting an overnight broth culture to an OD600nm of 0.1 and growing 
microaerobically at 37ºC for approximately 4h to obtain a log phase culture with an 
OD600nm between 0.2- 0.3.  A drop of log phase culture was prepared for filming as 
quickly as possible after leaving the incubator to avoid any loss of motility due to 
exposure to atmospheric oxygen conditions or temperature changes. Microslides 
(Camlab, Cambridge, UK) were used to attempt to avoid drift in the footage taken. 
Bacteria were observed by phase contrast microscopy with a Leitz Laborlux 12 
microscope using a 40 x phase contrast objective, video clips were obtained with an 
Olympus SP-320 7.1 Mp camera. For each strain the movement, tracking on the centre 
of the cell, of six cells was followed for 60 consecutive images (2s). This was repeated 
for three separate films for each of three different biological replicates. 
 
4.2.5 Analysis of biofilm formation in C.  jejuni 
The ability of the strains of C. jejuni used in this study to form biofilms was 
tested. Growth by bacteria at the air-liquid interface at the surface of a broth culture 
produces a pellicle biofilm. Biofilms can also form when cells adhere to a surface or 
aggregate in liquid media to form flocs; the presence of any of these types of biofilm 
were recorded. A 10 ml overnight MH broth culture was diluted to an OD600nm of 0.1 
and 3 ml of the dilution aliquoted into sterile 30 cm glass test tubes. At least 15 tubes 
for each strain were prepared and incubated microaerobically without shaking at 37°C 
for up to seven days. Two tubes of each strain were removed for examination every 24h. 
The presence of a pellicle and/or flocs was recorded and the OD600nm of the liquid phase 
was measured; the morphology of cells in the liquid phase and in any biofilms formed 
was examined microscopically. The test tubes were then washed gently with water, 
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stained for a least 5 minutes using 3 ml of 1% (w/v) crystal violet in water and washed a 
further three times with water to remove any loose debris, allowing closer examination 
of the attached biofilm. 
 
4.3 Results 
4.3.1 Plate assay of motility 
4.3.1.1 Reproducibility of the assay varies with inoculation method 
 The results obtained from plates inoculated using the stab method were more 
reproducible than those from plates where the culture had been dropped directly onto 
the surface of the agar or onto a filter paper disk. Motile bacteria were also more likely 
to spread into the agar on the plates inoculated using the stab method, rather than grow 
on the surface of the agar at the inoculation point only. Contamination was also slightly 
less common on stab inoculated plates versus plates inoculated using the drop method 
(5.9 % of total plates inoculated as opposed to 14.3%). Contamination was considerably 
more common on plates using the filter paper disks (30%) possibly as the plates had to 
been opened twice prior to incubation to apply both the paper disk and the inoculum. 
Consequently the stab method was used to inoculate the motility plates used in this 
study. 
 
4.3.1.2 Growth of strains on motility agar 
The 11168-O background strains all grew and spread by growing into the body 
of the agar rather than on the surface of the plate, as no raised growth could be seen on 
the surface of the plate, suggesting that the cells were in fact moving through the soft 
agar itself. The C. jejuni 11168-O strain in which nssR (Cj0446) had been deleted, 
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11168-O 0466
-
, had covered significantly (P<0.05) less of the area of the soft agar 
plates after a 24h incubation when compared to both wild-type, 11168-O WT,  and 
complemented mutant bacteria, 11168-O 0466C. However, after 36h the difference was 
less pronounced but still statistically significant (P<0.05) and by 48h all strains had 
covered the surface of the soft agar plates. Representative plates are shown in Figure 4.1 
and the diameter of growth zone data summarised in Table 4.1. 
 
4.3.1.3 Examination of cells by electron microscopy 
After 24h and 48h incubation on soft agar plates, samples were taken from the 
edges of the zones of growth on the 11168-O WT and 11168-O 0466
-
 plates and 
prepared for electron microscopy to examine any differences in cell or flagellar 
morphology; representative images are shown in Figures 4.2 and 4.3. After 24h growth 
on soft agar cells of the 11168-O 0466
-
 strain did not possess the normal full length 
wild-type flagella seen on the 11168-O WT. Many cells had short flagella and on some 
cells the presence of short, asymmetric flagella was apparent; after 48h growth cells 
from both strains had full length, wild-type flagella. The appearance of short, 
asymmetric flagella was not observed when the 11168-O 0466
-
 strain was cultured on 
MH agar plates with a standard agar concentration for 24h, then examined by electron 
microscopy. When 11168-GS WT and 11168-GS 0466
-
 cells were examined no 
differences in flagellar morphology were observed. 
All of the 11168-GS background strains were repeatedly non-motile, although 
all of the strains from this background grew successfully on the agar. Growth remained 
confined to the central area of the plate in the area of inoculation and did not move 
across or into the agar. This method has also been used previously to select for motile 
derivatives of non-motile strains, such as the C. jejuni NCTC 11168 strain used by 
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Karlyshev et al. (2002) and also within our own laboratory to isolate motile revertants 
from previously non-motile mutants. These motile revertants appear on the agar as 
individual outgrowth sectors which grow from the central point of inoculation out 
towards the edge of the plate and which usually cover no more the one eighth of the 
surface of the plate. All plates inoculated with the non-motile 11168-GS background 
strains were examined for these outgrowths, but none were identified. 
 
 
Table 4.1 Mean diameters of zones of growth of 11168-O WT, 11168-O 0466
-
 and 
11168-O 0466C. Strains were grown on 0.3% agar (Mueller-Hinton), for 48 hours. 
Time (h) Diameter of growth (mean ± standard deviation) 
11168-O WT 11168-O 0466
-
 11168-O 0446C 
24 (n= 14) 42.57 ± 2.98mm 20.36 ± 3.34mm 46.57 ± 3.82mm 
36 (n= 10) 51.00 ± 5.19mm 45.40 ± 4.01mm 53.60 ± 3.03mm 
48 (n= 9) 75.56 ± 2.60mm 74.00 ± 2.24mm 77.00 ± 1.00mm 
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Figure 4.1 Defect in 11168-O 0466
-
 motility compared to the wild-type shown on 
motility agar. Growth of 11168-O WT, 11168-O 0466
-
 and 11168-O 0466C after 24, 
36 and 48h incubations on 0.3% MH agar plates. 
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Figure 4.2. Wild-type and short asymmetrical flagella of 11168-O WT and 11168-O 
0466
-
 strains. Electron micrographs of the 11168-O wild-type and ΔnssR mutant taken 
from the outer edge of bacterial growth on 0.3% MH agar plates after a 24h incubation. 
Bars represent 200 nm. 
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Figure 4.3. Wild-type flagella of 11168-O WT and 11168-O 0466
-
. Electron 
micrographs of the 11168-O wild-type and ΔnssR mutant taken from the outer edge of 
bacterial growth on 0.3% MH agar plates after a 48h incubation. Bars represent 400nm. 
 
Motility and biofilm formation in C. jejuni 11168  Chapter IV 
 
  178 
 
4.3.2 Video based measurement of motility in C. jejuni 11168-O background 
strains 
4.3.2.1 BacTracker 
The motility of all strains of the C. jejuni 11168-O background was examined in 
a liquid culture using the BacTracker image processing software to calculate the mean 
velocity of the motile culture (Karim et al., 1998). The ability of the software to track 
the movement of bacteria was found to be significantly impaired by even a small 
amount of drift (the current like movement of the growth medium across the slide), 
which made non-motile cells appear motile to the software and influenced the direction 
and speed of movement of motile cells, biasing the result. This was difficult to avoid 
when using conventional microscope slides and cover-slips as although leaving the 
slides for several minutes to allow the flow of liquid across the slide to stabilise 
decreased the amount of drift visible, it was not desirable to do this as Campylobacter 
cells quickly become less motile when exposed to atmospheric levels of oxygen and 
lower than optimal temperatures. Also, the measurement of velocity, which was 
calculated in this instance as an average value from all cells visible over the length of 
footage screened, was affected by the presence of non-motile cells in all of the cultures 
filmed. These cells may have been truly non-motile or simply stuck to the glass of the 
microscope slide or the cover slip, but all types of non-motile cells introduce error into 
the calculation of velocity, falsely lowering the average velocity of the culture. 
Microslides were used in an attempt to correct the drift, however this introduced an 
additional problem by increasing the depth of field visible on the video and so 
increasing the amount of non-motile and out of focus cells visible to the software, 
introducing yet more error for which the software was unable to compensate. 
Despite these difficulties the following results were obtained, in mid log phase 
11168-O WT bacteria had an average overall velocity of 26.68 ± 3.11 μm.S-1, 11168-O 
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0466
-
 bacteria had an average velocity of 13.04 ± 1.44 μm.S-1 and showed an increase in 
the numbers of spinning and tumbling cells, with fewer fast cells and an overall 
decrease in velocity, compared to the wild-type. 11168-O 0466C, complemented ΔnssR, 
bacteria had an average velocity of 37.99 ± 3.46 μm.S-1, showing a marked increase in 
velocity from the wild-type which agrees with previous ‘by eye’ assessment of the 
motility of this strain in the laboratory.  Due to the issues associated with drift, it was 
not possible to use this technology to gather any other information about motility in 
these strains, for example curvilinear and straight line velocities or linear displacement 
when spinning, which can be calculated by the software,  
 
4.3.2.2 Image J 
As an alternative to the BacTracker system the movement of individual 11168-O 
WT and 11168-O 0466
-
 bacterial cells was recorded, traced and analysed using the 
ImageJ software with the manual tracking plug-in (Murray and Kazmierczak, 2006). 
The camera used for recording uses the Quick Time Motion JPEG format, which the 
Image J software is unable to process; therefore files were converted to .avi format 
using the 3GP converter software (www.xilisoft.com). These .avi files had then to be 
converted to the uncompressed .avi format using VirtualDub 1.7.0 
(www.virtualdub.org/) and finally were analysed with the ImageJ 1.37v software, using 
the manual tracking plug-in. The movement of six randomly selected cells, which 
remained in frame and in focus for the entire two seconds of video, were tracked for 
three separate films taken from three biological replicates. 
As is evident from the representative tracking images shown in Figure 4.4, wild-
type bacteria mainly showed the straight ‘darting’ swimming behaviour, with occasional 
tumbling, typical of Campylobacter and were more motile than the mutant cells, this 
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was seen in all of the clips tracked. 11168-O 0466
-
 bacteria often appeared to spin 
around a fixed point and also to move in circular patterns with an increase in tumbling. 
Fewer cells in this strain appeared to move in straight lines compared to the wild-type 
and did not travel the same distance as wild-type cells, this was also observed in all of 
the footage of this strain tracked.  The mean velocities calculated manually for each 
strain from the tracks of individual bacteria are given in Table 4.2; again the 11168-O 
0446
-
 mutant is significantly less motile than the 11168-O WT. 
 
 
Table 4.2. Mean and range of velocity of 11168-O WT and 0466
-
 mutant cells as 
measured by manual tracking using the ImageJ software. Calculated from tracks of 
log-phase broth cultures generated using ImageJ with the manual tracking plug-in 
(n=54). 
 
Strain 
Mean Velocity 
(μm.S-1) 
Lower range 
(μm.S-1) 
Upper range 
(μm.S-1) 
11168-O WT 42 ± 14 33 61 
11168-O 0466
-
 27 ± 8 15 38 
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11168-O WT 
 
 
11168-O 0466
- 
 
 
Figure 4.4. Defect in 11168-O 0446- motility compared to the 11168-O wild-type 
shown by video microscopy and tracking. The movement of individual 11168-0 WT 
and 11168-O 0466
-
 cells was tracked for 60 frames (2s) in MH broth. Lines show the 
paths taken by a single cell during the 2s filming. Bar represent 5 μm. 
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4.3.3 Biofilm formation by C. jejuni 11168 strains is unaffected by nssR deletion. 
The ability of all strains from the 11168-O and 11168-GS backgrounds to form 
biofilms or autoagglutinate was tested. Biofilm formation at the surface of a static broth 
culture produces a pellicle biofilm. Cells can also adhere to the glass surface of the test 
tube to form an attached biofilm or adhere to each other in the liquid media producing 
flocs, which can appear similar to cells that have autoagglutinated; whether these two 
processes are interlinked is unclear. The presence or absence of all types of biofilm was 
recorded daily, as was the number of replicates in which biofilms were formed. 
All strains repeatedly formed flocs after 72h incubation, pellicles and attached 
biofilms were formed after 96h in all cultures and this was the identical in all replicates. 
In all strains cells in the liquid phase of the culture became coccoid after 48h of 
incubation, whereas cells from the attached biofilms (prior to staining), pellicles and 
flocs, remained curved (11168-O background) or straight (11168-GS background) 
throughout the experiment. No evident difference in the size of the biofilms or the time 
taken for them to form was observed; no significant difference (P<0.05) was observed 
in the OD600nm of the liquid phase of the cultures after any of the lengths of incubation 
tested. Representative images of the biofilms present after 4 and 6 day incubations are 
shown in Figures 4.5 and 4.6. It should be noted that during the development of this 
experiment various other conditions were tested, including the incubation of cells in the 
same manner as that of the final experiment but with shaking. In the liquid cultures with 
shaking at 100-120 r.p.m. no evidence of attached biofilm, pellicle, or aggregative floc 
formation was seen. The speed of shaking was decreased during testing until biofilm 
growth was first identified; in cultures which had been subjected to shaking at 40 r.p.m. 
no attached biofilms were observed, but flocs did form readily after incubation for 72h 
in the body of the culture in all strains; this could be attributed to either 
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autoagglutination or biofilm formation. Attached biofilms and pellicles were only 
observed when no shaking had taken place during incubation. 
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Figure 4.5. Biofilm formation in C. jejuni strains after 4 days of incubation, no 
defects in the ability of strain to form biofilms are evident. Cultures were incubated 
without shaking, the culture removed and the tube washed prior to staining with crystal 
violet.  
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Figure 4.6. Biofilm formation in C. jejuni strains after 6 days of incubation, no 
defects in the ability of strain to form biofilms are evident. Cultures were incubated 
without shaking, the culture removed and the tube washed prior to staining with crystal 
violet.  
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4.4 Discussion 
4.4.1 Evaluation of methods used to measure motility. 
4.4.1.1 Motility agar 
The results generated from the growth of strains on motility agar were most 
consistent when the inoculum was introduced directly into the medium, rather than 
dropped onto the surface of the agar and allowed to soak in; contamination was also 
reduced when using this variation. This method allows the easy identification of 
differences in the level of motility between strains, can provide quantifiable data, in the 
form of growth diameters, and also allows data to be presented visually. The major 
advantage of this technique is that further work can be carried out on a particular 
subsection of cells taken from the plate, i.e. from a hyper-motile out growth or from 
log-phase growth occurring at the edge of the zone of growth.  
Major disadvantages of use of motility agar are that the characteristics of 
movement of individual cells cannot be assessed as it is an average property of the 
population that results in colony spreading.  Furthermore the culture is not 
homogeneous and the activity of a particular subset of the population can not be 
examined. Also the motility of exponentially growing homogeneous cultures in liquid 
cannot be exactly modelled or assessed by the use of plates, as the change in medium 
unavoidably alters growth rate and introduces changes in environment, although the 
environment at the edge of a culture on a motility agar plate is thought to resemble that 
in a broth culture, at least to some degree.  It is not possible to identify any differences 
in the type of motility, i.e. increased spinning or tumbling of cells. For these reasons the 
methods described below were also used to determine the motility behaviour of cells in 
homogeneous conditions and ideally, that of individual cells.   
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4.4.1.2 The BacTracker 
This system has the potential to be very advantageous to those wishing to 
measure bacterial motility as it is possible to greatly reduce the amount of manual 
calculation needed, however, technical problems can mean that it is difficult to obtain 
meaningful results. The BacTracker software has been used by Karim et al. (1998) to 
measure and compare the motility of H. pylori, C. jejuni and E. coli. It is possible to 
automatically and simultaneously track 120 moving bacteria and calculate data such as 
direction of movement, curvilinear velocity (length travelled by a bacterium divided by 
time taken), straight line velocity and curvature rate; the software can also compensate 
for Brownian motion. 
In order to obtain reliable velocity data, it was necessary to obtain at least two, 
and preferably five, minutes of footage free of drift, which would alter the motion of the 
cells in a manner unconnected to their motility and so introduce error into the results. It 
proved impossible to obtain this length of footage using conventional microscope slides 
and cover-slips, as once the movement of liquid across the slide had ceased, the motility 
of the cells had decreased, possible due to too lengthy exposure to atmospheric 
concentrations of oxygen or room temperature. 
Microslides, thin-walled capillary tubes with a rectangular profile and an 
internal width of 100µm which can be viewed under a microscope in the same way as a 
conventional slide, were used and successfully countered the problem of ‘drift’ but also 
introduced another technical issue. The 20µm depth of the tube greatly increased the 
depth of sample present compared to that of a conventional microscope slide, hence the 
depth of view visible on the video taken from these slides was also increased; this 
caused the majority of motile cells to move out of focus or out of frame before the 
software was able to calculate their velocity. The number of non-motile cells present 
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also affected the results, as in this case bacterial velocity was calculated as an average 
result for all of the cells present in the field of view, and due to the increased depth of 
view when using Microslides, more non-motile cells were visible on the video footage. 
Whilst the BacTracker system has previously been used to calculate the 
velocities of several bacterial species (Karim et al., 1998) the difficulties in obtaining 
representative video footage of motile cultures suitable for analysis by this software and 
the inability of the software to compensate for any imperfections in the footage, mean 
that this system is not suitable for use in this study, although if it were possible to 
overcome the technical difficulties this system would be ideal. 
A system that could be used to analyse a shorter length of footage, so reducing 
the difficulties associated with obtaining the necessary amount of drift free footage and 
remove any decreases in motility associated with lengthy exposure to atmospheric 
concentrations of oxygen, would be preferable. It would also be advantageous for the 
user to be able to select manually which cells are tracked, a function which is performed 
automatically by the BacTracker software, so avoiding the loss of data that occurs when 
tracked cells move out of the field of view or out of focus and remove the error 
introduced by non-motile cells. 
 
4.4.1.3 Manual tracking using ImageJ 
The ImageJ software with the manual tracking plug-in has been used by Murray 
and Kazmierczak (2006) to measure the motility of ΔflhF mutants in P. aeruginosa. 
This method generates traces of the movements of each tracked cell, which can be 
overlaid onto the original footage, which can be used to manually make calculations of 
the velocity of individual cells or to display the data visually, to show differences in 
motility that are not conveyed by velocity measurements alone (i.e. circular vs. linear 
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motion). Although all of the tracking of individual bacteria, and the majority of the 
calculations, have to be done by hand and thus can be quite laborious, the method is 
more robust and able to deal with problems as it allows more user input. The user is 
able to decide which cells to track, so removing any error introduced into the data by 
cells which leave the field of view or move out of focus. It is also possible to entirely 
eliminate any error caused by the presence of non-motile cells by simply not tracking 
these cells and as the lengths of footage used are very short, it is easy to avoid the 
problems generated by drift, as any parts of the footage affected can simply be avoided. 
To avoid introducing bias into the results it is necessary first to identify all of the cells 
suitable for tracking, such as those that remain in frame and in focus for the duration of 
the clip, then either track all cells or select a proportion at random.  
Overall, manual tracking using the ImageJ system was found to be more suitable 
as a method of calculating bacterial velocity and visualising bacterial motility than the 
BacTracker system, for this application. Despite the lengthy manual calculations needed 
to obtain data, this data was less subject to error than that obtained from the BacTracker 
system and so more useful. 
 
4.4.2 Motility 
Analysis of motility by all of the methods used here demonstrated that the 
11168-GS background strains are not motile; this is consistent with the findings of 
Gaynor et al. (2004), who showed that the genome sequenced strain is non-motile, 
although this strain does retain full-length flagella. It was impossible to determine, from 
these experiments, whether there are any differences in motlity that may indicate 
differences in flagellin glycosylation between the strains examined.  
Motility and biofilm formation in C. jejuni 11168  Chapter IV 
 
  190 
 
The work carried out here demonstrated that the 11168-O 0466
-
 mutant has a 
significant defect in motility compared to the 11168-O WT, at least during exponential 
growth; this was evident in all of the methods used. In addition to being less motile the 
strain also moved in a different manner, with more circular movements and fewer long, 
fast runs than the wild-type. When the 11168-O 0466
-
 mutant was grown on motility 
agar, electron microscopy of cells taken from the edge of the growth on the plate after 
24h incubation appeared to show the growth of short, asymmetric flagella. Whilst 
neither flagellum had reached wild-type length, many cells had shorter flagella at one 
cell pole. Overall, spreading of the 11168-O 0466
-
 mutant across the soft agar at 24h 
was significantly retarded, probably due to these short flagella. The difference was still 
significant at 36h on soft agar, although by 48h both strains had grown enough to cover 
almost the entire surface of an agar plate. It is likely that the shorter flagella are present 
at the younger pole of the cell, which is formed after cell division. As bacteria at the 
edge of the growth on soft agar plates would be dividing rapidly it is possible that the 
11168-O 0466
-
 cells do not have sufficient time for the synthesis of a full length 
flagellum to occur before cell division occurs again, leading to an asymmetry in 
flagellar lengths. This potentially points to a deficiency in flagellar biosynthesis in this 
strain.  
Flagellin glycosylation is thought to have a role in flagellar formation, although 
this role has not yet been defined (Thibault et al., 2001; Guerry et al., 2006). As the 
11168-O 0466
-
 strain is believed to have alterations in flagellin glycosylation, it is 
possible that these alterations are affecting flagellar biosynthesis. The flagellar 
asymmetry may also be suggestive of a rate limitation in flagellar biogenesis which only 
becomes noticeable in rapidly growing cultures of the mutant strain. Cell division 
required the biosynthesis of a flagellum at the newly formed pole of the cell. Cells 
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growing at an increased rate, such as cells in the log-phase of growth, divide rapidly 
necessitating a fast rate of flagellar biosynthesis, if wild-type length flagella are to be 
produced. As such, any defect in the flagellar glycosylation machinery that decreases 
the speed of flagellar biosynthesis could lead to the presence of asymmetric flagella. 
The flagellum at the newer cell pole would be shorter in length than that at the older 
pole, as there would have been insufficient time between cell divisions for a wild-type 
length filament to form. When the rate of cell division slows the time between cell 
divisions increases, allowing longer flagellar filaments to be produced before the next 
division occurs. Once the rate of cell division decreases to the point where wild-type 
length filaments can be produced between cell divisions, or the rate limiting factor in 
flagellar biosynthesis is removed, the asymmetry in flagella disappears. The observation 
that full length flagella filaments were seen on 11168-O 0466
-
 cells after 48h incubation 
would fit this with hypothesis as by 48h, when the bacterial growth had reached the 
edges of the plates, the rate of cell division would have slowed considerably from that 
occurring at the edge of the zone of growth after 24h incubation. This decrease in 
growth rate would then allow the cell sufficient time to synthesise a full length flagellar 
filament at each pole before cell division occurred. 
 Whilst this hypothesis appears to fit the available data well, confirmatory 
evidence is difficult to obtain. It would first be necessary to define the mechanism of 
flagellin glycosylation in this strain, before identifying any defects present and 
determining whether these could be the limiting factor in flagellin glycosylation; this 
approach is beyond the range of this study. The changes in motility in the 11168-O 
0466
-
 mutant would appear to be due to the lack of expression of the FMR genes due to 
the deletion of the NssR transcriptional regulator. Although it is not possible to state this 
definitively, which would require genome wide NssR binding data from the ChIP-chip 
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work; it is not possible to say with any certainty whether this mutation has any other 
effects. The effects of mutation of the individual genes of the FMR alone in C. jejuni 
11168 are largely unknown. In the closely related strain C. jejuni 81-176, mutants in 
pseD and Cj1334 were made by Karlyshev et al. (2002) and both mutants were fully 
motile. pseD is involved in the attachment of acetamidino pseudaminic acid to flagellin 
(Guerry et al., 2006) and the function of Cj1334 is unknown. 
 Whilst it is clear that the 11168-O 0466
-
 mutant is defective in motility in 
comparison to the wild-type, it is not possible to say exactly why. It is very likely that 
the lack of expression of the FMR genes, due to mutation of nssR, is responsible, but it 
is not possible to define which gene or genes active at which stage(s) of the flagellin 
glycosylation process are the cause of this defective motility. 
 
4.4.3 Biofilm formation 
The aim of this part of the study was to establish whether there were any 
observable differences in the abilities of the strains used here to form biofilms or 
autoagglutinate. No differences in these abilities were noted, and all strains formed 
attached biofilms, pellicles and flocs in the body of the media in the same way, with the 
same level of efficiency and in the same amount of time. 
 The rationale for examining biofilm formation was that biofilms are often 
associated with stress tolerance and survival and as such may aid the survival of 
Campylobacter in both the environment and possibly in the host. Howard et al. (2009) 
identified a livestock clade associated glycosylation island (Cj1321-Cj1325/6) that was 
important in the colonisation of chicken and when mutated decreased the ability of the 
mutant to form biofilms and autoagglutinate. As campylobacters are microaerophilic, 
sensitive to desiccation and, in comparison to other foodborne pathogens, relatively 
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fragile, growth as a biofilm may be one of the mechanisms used by this bacterium for 
survival in otherwise lethal environments. The ability of Campylobacter to form 
biofilms in vitro has already been established (Trachoo et al., 2002; Reeser et al., 2007 
and Joshua et al., 2006), whilst monospecies biofilm formation by Campylobacter in 
vivo has not been observed, the presence of Campylobacter as components of multi-
species biofilm is established (Trachoo et al., 2002 and Keevil, 2003). Both flagella and 
quorum sensing components were found by Reeser et al. (2007) to be necessary for 
successful biofilm formation. Joshua et al. (2006) and Kalmokoff et al. (2006) also 
identified the flagellar filament as necessary for biofilm formation. Flagellin 
glycosylation has not been directly implicated in biofilm formation, other than that 
certain mutants that lack flagellin glycosylation and so are unable to synthesise a 
flagellar filament are unable to form biofilms. As the strains examined here show 
differences in flagellin glycosylation associated gene expression, but do not show any 
differences in biofilm formation, this work would appear to support the conclusion that 
flagellin glycosylation is not directly involved in biofilm formation. The finding that 
biofilms were not formed in the presence of shear forces, i.e. shaking, was also in 
agreement with the findings of Joshua et al. (2006).  
Autoagglutination occurs spontaneously between Campylobacter cells and may 
be a preliminary stage of micro-colony and biofilm formation. Autoagglutination also 
acts as a marker of virulence in several Gram negative bacterial pathogens, including 
Vibrio cholerae (Chiang et al., 1995) and Bordetella pertussis (Menozzi et al., 1994). 
Pilins and outer membrane proteins associated with virulence in these species have also 
been shown to be autoagglutinins (Skurnik et al., 1984). In C. jejuni 81-176 
autoagglutination has been associated with flagella (Guerry et al., 2002) and specifically 
with flagellar glycans (Guerry et al., 2006), as a mutant in pseD, which lacked 
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acetamidino pseudaminic acid flagellar glycans, did not autoagglutinate; this was also 
observed in C. coli VC 167. The transposon mutagenesis carried out in C. jejuni 480 by 
Golden and Acheson (2002) also identified pseD and Cj1318 mutants as unable to 
autoagglutinate. The glycosylation island (Cj1321-Cj1325/6) identified by Howard et 
al. (2009), in and particularly ptmG (Cj1324), one of the genes that make up the island, 
has a role in autoagglutination, biofilm formation and the colonisation of chickens. 
Given that the 11168-O 0466
-
 mutant shows no expression of either pseD, Cj1318 or the 
genes of the glycosylation island, it was hypothesised that these experiments would find 
a defect in autoagglutination in this strain, which would be consistent with previous 
work in other Campylobacter strains. Although the method used here could not 
distinguish between autoagglutination and biofilm formation in the body of the culture 
medium, any differences in the types of growth seen would have led to further work to 
determine whether this was due to biofilm growth or autoagglutination. As no 
differences in the growth of this or any other strain tested were seen, it can be concluded 
that either the method is unsuitable for this type of analysis, or that the hypothesis that 
the lack of expression of pseD, Cj1318 and Cj1321-Cj1325/6 would alter 
autoagglutination in this strain is incorrect. As the method used is similar in principle to 
that used by Guerry et al. (2002) and Joshua et al., (2006) to assess autoagglutination 
and biofilm formation respectively, it is reasonable to expect that this method would be 
able to detect any gross differences in biofilm formation or autoagglutination present. 
Another possible explanation is that, as the flagellin glycosylation locus in C. jejuni 
11168 is the largest and most complex yet identified in Campylobacter, the mutations 
which lead to loss of autoagglutination in other strains of Campylobacter are 
compensated for by differences in glycosylation in this strain. The C. jejuni 11168H 
strain in which the glycosylation island (Cj1321-Cj1325/6) was characterised by 
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Howard et al. (2009) is a hyper-motile derivative of the 11168-GS WT strain which is 
thought to be closely related to the 11168-O WT strain. Differences in flagellin mass 
and antigenicity, probably due to altered glycosylation profiles have been observed 
between the strains (Turner and Penn, 2005). It is possible that these differences may 
also account for the differences observed in AGG and biofilm formation.
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Chapter V: Analysis of C. jejuni 
11168 flagellar glycans 
 
5.1 Introduction 
A recent study by Logan et al. (2009) identified a series of glycosyl residues 
present on C. jejuni 11168 flagellin, which include the pseudaminic and legionaminic 
acid derivatives PseAc, PseAm, LegAm and MeLegAm which have previously been 
identified decorating C. jejuni 81-176 and C. coli VC67 flagellin. In addition to these 
previously recognised modifications two novel glycans, both di-O-methyl-glyceric acid 
derivatives of pseudaminic acid and its derivative acetamidino pseudaminic acid, were 
also discovered; these novel glycans were found to be the most common modifications 
present on C. jejuni 11168 flagellin. For more details of these glycans see Table1.1 
(Section 1.8). Whilst the different glycans found on C. jejuni 11168 flagellin were 
identified, no ‘map’, detailing the locations of the flagellar glycans on the amino acid 
backbone of the flagellin protein, has been published. Another interesting analysis that 
has yet to be undertaken would be a comparison of the flagellar glycans present in the 
two backgrounds of C. jejuni 11168, the ‘genome sequenced’ 11168-GS and ‘original’ 
11168-O strains. The flagellin glycosylation region of C. jejuni 11168 is the largest yet 
discovered in Campylobacter, whilst some genes thought to be associated with flagellin 
glycosylation have been assigned functions based upon their homology to genes 
characterised in other Campylobacter strains, there remain many genes which have no 
clear function, despite the evidence linking some to flagellar glycosylation or motility. 
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Hence there is still much regarding flagellar glycosylation in C. jejuni 11168 that 
remains unclear.  
Recent work by Howard et al. (2009) identified a glycosylation island (Cj1321 
to Cj1325/6) which was found to be important for several cellular processes including 
the biosynthesis of certain flagellar glycans and in the successful colonisation of 
chickens. In particular a ΔCj1324 mutant in the 11168H strain background, a hyper-
motile variant of the sequenced strain 11168-GS WT (Karlyshev et al., 2002), was 
found to lack a 315Da flagellar glycan which, because of their identical masses, could 
correspond to either PseAm or LegAm. Cj1324 has previously been found to have a role 
in legionaminic acid biosynthesis in C. coli VC167 and hence has been annotated ptmG; 
therefore it is likely that the glycan lost is the legionaminic acid derivative, LegAm. The 
loss of this glycan from 11168H flagellin caused a decrease in the ability of cells to 
autoagglutinate and a decrease in hydrophobicity, probably due to a change in cell 
surface charge caused by the changes in the flagellum; the ability of the strain to 
colonise chickens was also significantly reduced. The mutation of Cj1321 and Cj1325/6 
in this strain had no observable effect on autoagglutination or hydrophobicity and the 
functions of these genes, together with Cj1322 and Cj1323 the other genes of the 
glycosylation island, has yet to be deduced. Previous work in this thesis, detailed in 
Chapter 3, found that whilst Cj1321, Cj1324 (ptmG) and Cj1325/6 were transcribed; 
there was no evidence of expression of Cj1322 or Cj1323 in 11168-O WT. This study 
also identified several of the same flagellar glycans as the work by Logan et al. (2009) 
which used metabolomics analysis and mass spectrometry of flagellin. Work by Guerry 
et al. (2006) also used MS/MS to characterise a Cj1333 mutant in C. jejuni 81-176 and 
found that this mutant had lost the ability to decorate flagellin with PseAm. This work 
led to the conclusion that Cj1333 is somehow involved in the attachment of PseAm to 
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flagellin and hence Cj1333 was re-annotated as pseD, part of the pse family of 
pseudaminic acid associated genes. 
The FMR, the region of 17 genes, from Cj1318 to Cj1336, down-regulated in 
the nssR mutant in the original strain background of C. jejuni 11168, contains several 
genes known to be involved in flagellin glycosylation, including the ptmA-H genes, 
involved in legionaminic acid synthesis in C. coli VC167, and pseD which is implicated 
in the transfer of acetamidino pseudaminic acid to flagellin in C. jejuni 81-176; also 
present are other genes that are still to be characterised. Given the studies detailed 
before and work by others, it is possible to begin to predict the effects that the loss of 
expression of the FMR in the 11168-O 0466
-
 mutant should have on the flagellar 
glycans. However, as well as the potential loss of PseAm and the legionaminic acid 
derivative LegAm there may also be other glycosylation differences between this and 
the wild type strain, as many of the down-regulated genes remain uncharacterised. As 
such, one aim of this part of the study is to begin to map the glycans present on 11168-
O WT and 11168-O 0466
-
 flagellin by mass spectrometry. Any differences observed in 
the number, type or location of flagellar glycans may help to explain the deflective 
motility and altered flagellar structure of the 11168-O 0466
-
 mutant, as well as the 
decrease observed in 11168-O 0466
-
 flagellin mass in comparison to the wild-type when 
analysed by SDS-PAGE (Turner and Penn, 2005). The examination of 11168-O WT 
flagellin will also allow the mass spectrometry method, which has not previously been 
used for the analysis of flagellin glycopeptides, to be evaluated. The 11168-GS WT will 
also be examined, with the aim of identifying any differences in glycosylation between 
the wild-types of the two C. jejuni 11168 backgrounds.  
As detailed in Section 4.3.1, some 11168-O 0466
-
  mutant cells growing at the 
edge of a soft ‘motility’ agar plate developed short, asymmetric flagella after 
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approximately 24 hours of incubation, however, after incubation for 48 hours, the 
flagella of these cells reached wild-type length and no asymmetry was visible. A 
possible explanation of these observations is that the asymmetry of the flagella is due to 
a defect in flagellar glycosylation in this strain which decreases the rate of flagellar 
biosynthesis, and is made noticeable only because cells taken from the edge of the zone 
of growth of a soft agar plate are growing at a fast rate, possibly exponentially; this is 
discussed further in Section 4.4.2. A comparison of the type, number and location of the 
various glycans present on the flagellin of the 11168-O 0466
-
 mutant taken from cells in 
the exponential and stationary phases of growth should show whether this potential 
defect in flagellar biosynthesis is due to changes in glycosylation or to other unknown 
mechanisms. Therefore another aim of this part of the project is to begin to map the 
glycans present on 11168-O 0446
-
 flagellin isolated from exponential and stationery 
phase cells.  
To adequately describe glycosylation, three pieces of information are required. 
Firstly the identification of the glycosylated proteins and peptides, secondly the site(s) 
of the glycosylations on the peptides and thirdly the structure of the glycan(s).The use 
of mass spectrometry to indentify glycosylation sites has been previously described 
(Guerry et al., 2006; Thibault et al., 2001 and others) but can be very challenging, as the 
glycosyl modifications present can be heterogeneous and do not give the clearly defined 
mass shifts characteristic of other types of post-translational modifications, for example 
phosphorylation and acetylation; obtaining structural information from mass 
spectrometry analyses is also difficult. 
 Many studies which aim to identify flagellar glycans use a targeted 
metabolomics approach together with mass spectrometry to deduce the structure and 
location of flagellar glycans. This approach involves first extracting intracellular sugar-
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nucleotides from the strain to be examined, then probing these by mass spectrometry for 
those nucleotide-activated metabolites which are relevant to the biosynthesis of 
pseudaminic and legionaminic acids and their derivatives. Any metabolites of potential 
interest are then purified and analysed by nuclear magnetic resonance (NMR) 
spectrometry to determine their identity. Mass spectrometry is then used again to 
confirm the presence of these glycans on flagellin by the analysis of flagellin 
glycopeptides. The resulting mass spectra are searched for glycan residues, located on 
serine or threonine residues only, of identical mass to those indentified by the NMR 
spectroscopy. Studies of this type have been carried out on the flagellin of C. coli 
VC167 (McNally et al., 2007), C. jejuni 81-176 (McNally et al., 2006a), H. pylori 
(Schirm et al., 2003) and most recently C. jejuni 11168 (Logan et al., 2009 and Howard 
et al., 2009). Whilst a complete targeted metabolomics approach is beyond the range of 
this study, it is also unnecessary, as many glycans isolated from Campylobacter 
flagellin have already been identified by those studies detailed above, including those of 
C. jejuni 11168 (Logan et al., 2009). Hence, glycopeptides of C. jejuni 11168 flagellin 
will be examined for the presence of known flagellar glycans in a method similar to that 
used in the later stages of the above detailed metabolomics method. Collision-induced 
dissociation (CID) and electron-capture dissociation (ECD) mass spectrometry in 
particular will be used to locate flagellar glycans. 
Briefly, mass spectrometry involves firstly the digestion of the protein to be 
analysed with the protease trypsin, which cleaves protein at the carboxy termini of both 
arginine and lysine amino acid residues. As such, all cleaved peptides contain either a 
basic arginine or lysine residue and are therefore suitable for the positive ionisation 
which forms the next part of the process. Following this, the ions of the sample peptides 
are separated according to their mass (m) and charge (z) ratio, this separation is 
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recorded as a mass-charge (m/z) spectrum. For simple MS analysis this m/z spectrum 
can be used as a ‘protein fingerprint’ to identify the sample, as two different proteins are 
unlikely to fragment in the same way, hence a m/z spectrum is characteristic of a 
particular protein. In more complex tandem mass spectrometry (MS/MS), such as that 
carried out here, the individual groups of particular peptide species, which have been 
separated according to their mass and charge, are fragmented within the mass 
spectrometer. These fragment ions are separated according to their mass (m) and charge 
(z) ratios and this separation is again recorded as a mass-charge (m/z) spectrum. This 
spectrum of the resulting fragment ions can be used to generate structural information 
regarding the original, intact, sample molecule. For example, the sequence of amino 
acid residues within a protein can be determined by analysing the fragment ions 
generated from the fragmentation of its component peptides.  
Two different MS/MS methods are used in this study to attempt to locate glycan 
residues, the first method is collision-induced dissociation (CID) MS/MS, which is a 
technique used extensively for protein identification and is able, generally, to give good 
coverage of the peptides within a sample, to produce a relatively complete amino acid 
sequence. However, this technique preferentially cleaves glycan residues rather than the 
peptide backbone when analysis of glycopeptides is carried out, leaving the peptide 
backbone largely intact (Huddleston et al., 1993). As such, this technique is suitable for 
either the characterisation of unglycosylated peptides or glycans separately, but not the 
analysis of glycopeptides. It is not likely to be capable of determining which amino acid 
residues are glycosylated as it is unlikely to show the loss of a complete glycan from a 
peptide, together with the fragmentation of that peptide, which is necessary to identify 
the glycosylated residue (Alley et al., 2009). Due to the limitations of CID, another 
method, electron-capture dissociation (ECD) MS/MS, will also be employed. ECD 
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induces extensive fragmentation of the peptide backbone but only limited fragmentation 
of the glycan residues, which are retained largely intact on the amino acid residue, 
allowing the site of the modification to be located (Zubarev, 2004). However, due to the 
extensive fragmentation of the peptide backbone it can be difficult to obtain complete 
peptide sequence data using this method.  
Hence a mass spectrometry approach combining both CID, aiming to give good 
coverage of the amino acid sequence of the glycopeptides, with ECD, to provide the 
location and identification of any glycans present, will be used to attempt to map the 
locations and types of glycans present on C. jejuni 11168 flagellin, with the overall aim 
of linking differences in flagellin glycosylation between these strains to the motility, 
flagellin mass and gene expression differences observed.  
 
Figure 5.1. Fragmentation of a peptide precursor ion to generate, B’, C’, Y’ or Z’ 
ions. 
 
When peptide ions are subjected to CID mass spectrometry, which uses high 
pressure, energised helium gas to induce fragmentation, the OC-NH bonds of the 
peptide backbone are usually the first bonds to break, this generates B’ and Y’ ions, as 
indicated in red in Figure 5.1 above. If a singly charged peptide ion is fragmented the 
single charge can be retained on only one of the resulting fragments, if the charge is 
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retained on the N-terminal fragment it becomes a B’ ion, if the charge is retained on the 
fragment C-terminal of the breakage then the ion is named a Y’ ion. The B’ and Y’ ions 
are numbered based upon location of the bond which has been broken. The fragment 
which does not retain the charge from the precursor becomes invisible to the mass 
spectrometer as it can no longer be manipulated. A multiply charged ion can generate 
both B’ and Y’ ions, or a single, multiply charged, ion. When CID of glycopeptides is 
carried out the C-C bonds of the glycan may fragment before the peptide bonds, which 
can hinder the assignment of a modifying glycan to a particular residue. 
  ECD mass spectrometry uses a stream of electrons to induce fragmentation of 
the peptide backbone, as electrons are used all ions subjected to ECD must have 
multiple positive charges. In ECD the HN-CH bonds are usually broken preferentially 
to produce C’ and/or Z’ ions, indicated in Figure 5.1 above in green. ECD preferentially 
produces C’ ions resulting from the charge being retained on the N-terminal fragment, 
the mechanism for this is unknown. When the charge is retained on the C-terminal 
fragment the resulting ion is termed the Z’ ion, numbering is again based on the location 
of the broken bond, counting from either the N- or C- terminus depending on the type of 
ion and hence the terminus upon which the charge was retained after fragmentation. 
Again, multiply charged precursor ions can generate both C’ and Z’ ions.  
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5.2 Methods 
5.2.1 C. jejuni flagella purification 
5.2.1.1 Growth conditions 
Campylobacter strains 11168-GS WT, 11168-O WT and 11168-O 0466
-
 were 
grown in MH broth or on MH agar at 37ºC in a microaerobic environment as previously 
described. Over-night cultures were used to inoculate 400 ml MH broth to an OD600nm 
of 0.05; this culture was then grown until an OD600nm of approximately 0.3 was reached. 
The 11168-O 0466
-
 strain was also grown on MH agar for 24 hours and colony material 
was then removed from the plates using a sterile loop and emulsified into 5 ml Tris-
NaCl (10mM TrisHCl 0.85% (w/v) NaCl pH 7.4). 
 
5.2.1.2 Flagella filament isolation 
This was adapted from the method of Power et al. (1994).  24h broth cultures 
were centrifuged at low-speed, 6 000 x g for 10 minutes at 4ºC to pellet cells. The pellet 
was then resuspended in Tris-NaCl (10mM TrisHCl- 0.85% (w/v) NaCl, pH 7.4) to a 
calculated OD600nm of 20. The resulting suspension was homogenised for 3 minutes 
using an Ultra-Turrax T-25 high speed homogeniser (IKA Labortechnik) at a speed of 
20,500 revolutions.min
-1
. Whole cells and cell debris were then removed by two low-
speed centrifugations at 6 000 x g for 20 minutes at 4ºC in a total volume of 20ml. The 
resulting supernatant was subjected to ultracentrifugation at 100 000 x g for 60 minutes 
at 5ºC. The pellet was then resuspended in 1% (w/v) SDS in distilled water, incubated at 
37°C with gentle agitation for 2h and again subjected to ultracentrifugation as above. 
The SDS washing was repeated three times, after which the flagella fragments were 
checked for purity by Coomassie blue-stained SDS-PAGE gels and electron 
Analysis of C. jejuni 11168 flagellar glycans  Chapter V 
  205 
 
microscopy. The final pellet was then washed by resuspension and centrifugation three 
times in distilled water and stored in distilled water at 
-
20ºC until required. 
 
5.2.2 Mass spectrometry 
5.2.2.1 Excision of the flagellin bands 
 Flagellar proteins isolated from C. jejuni strains were separated by 
polyacrylamide gel electrophoresis. Bands with a molecular mass of approximately 
60kDa were cut out of the gel with clean, sharp scalpel blades, using a separate blade 
for each band and taking care not to cross contaminate gel slices. The slices were 
collected in a 48-well plate and stored at -20°C until required for trypsinisation. 
 
5.2.2.2 Trypsinisation 
 Modified trypsin is an enzyme used for the cleavage of proteins prior to analysis 
by mass spectrometry. It is used to generate peptides that are within the mass range of 
the spectrometer and which can be fragmented efficiently. Modified trypsin cleaves the 
peptide bonds in proteins on the c-terminal side of both lysine and arginine residues; the 
enzyme is modified to reduce non-tryptic activities and prevent autolysis. Trypsinisation 
was carried out in 48 well v-shaped plates using a MWGAG BIOTECH Robo Seq 4204 
S liquid handling robot. The following reagents and protocols were used. 
Reagents: 
Digestion buffer  100mM ammonium bicarbonate 
Destain solution  50% (v/v) acetonitrile in 0.5 x digestion buffer 
Reduction buffer  10mM DTT in digestion buffer 
Alkylation buffer  55mM iodoacetamide in digestion buffer 
Trypsin solution 6 ng.μl-1 modified trypsin (Promega, Madison, USA) in 
0.5 x digestion buffer 
Extraction buffer  1% (v/v) formic acid 
    2% (v/v) acetonitrile in water 
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Protocols 
Program one - Trypsinisation 
Dehydration  Dispense 80 μl acetonitrile, wait 5 minutes, aspirate 160 μl. 
Destain Dispense 50 μl digestion buffer, dispense 50 μl acetonitrile, wait 
10 minutes, aspirate 120 μl, wait 5 minutes. 
Dehydration Dispense 50 μl acetonitrile, 5 minutes, aspirate 70 μl, wait 5 
minutes. 
Reduction  Dispense 50 μl reduction buffer, wait 30 minutes. 
Alkylation Dispense 50 μl alkylation buffer, wait 20 minutes, dispense 100 
μl acetonitrile, wait 5 minutes, aspirate 200 μl. 
Wash Dispense 50 μl digestion buffer, wait 10 minutes, dispense 50 μl 
acetonitrile, wait 15 minutes, aspirate 100 μl 
Dehydration Dispense 50 μl acetonitrile, wait 5 minutes, aspirate 70 μl, wait 5 
minutes 
Trypsin digestion Dispense 25 μl trypsin solution 
 
The lid of the 48-well plate was sealed with parafilm and the plate incubated at 37°C for 
2.5h, 15 μl HPLC grade water was then added to each well and the plate incubated at 
37°C overnight. The wells were checked periodically to ensure that the gel slices had 
not dried out. Following the incubation peptide extraction was carried out. 
 
Program two - Peptide extraction 
The processed gel slices from program 1 were returned to the robot in the 48-well plate, 
and the following program was then carried out: 
Extraction one   Dispense 30 μl extraction buffer, wait 30 minutes 
Peptide removal one  Aspirate 23 μl and dispense into final plate 
Extraction two Dispense 12 μl extraction buffer and 12 μl acetonitrile, 
wait 30 minutes. 
Peptide removal two Aspirate 23 μl from each well and dispense in final plate 
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5.2.3 Liquid Chromatography  
Samples were injected using an online Micro AS auto-sampler and Surveyor MS 
pump (Thermo Fisher Scientific, Epsom, UK). Peptides were separated using a binary 
solvent system consisting of solvent A: comprising 0.1% formic acid (J.T. Baker, 
Holland) in water (J.T. Baker, Holland) and solvent B comprising acetonitrile (J.T. 
Baker, Holland) and 0.1% formic acid. A linear 40 min gradient, which increased the 
composition of (B) from 5% to 40%, was used together with an Integrafrit (New 
Objective, USA) C8 resolving column with a length of 10 cm and an internal diameter 
of 75 µm. The peptide was introduced into the mass spectrometer using a Triversa 
Nanospray source (Advion Biosciences, NY) with an elution in a flow rate of ~ 300 nL 
min
-1
; the typical nanoelectrospray voltage was +1.7 kV.  
 
5.2.4 Mass spectrometry  
A 7-T LTQ FT mass spectrometer (Thermo Fisher Scientific, Epsom, UK) was 
used to perform a data-dependent scanning. Data acquisition was controlled by the 
Xcalibur 2.0 software.  
 
5.2.4.1 Collision-induced dissociation (CID)  
The mass spectrometer alternated between a full FT-MS scan (m/z 380 – 2000) 
and subsequent CID MS/MS scans of the three most abundant ions. Survey scans were 
acquired in the ion cyclotron resonance (ICR) cell with a resolution of 100 000 at m/z 
400. Precursor ions were isolated and subjected to CID in the linear ion trap, the product 
ion was acquired with a resolution of 25 000 at m/z 400. Automatic gain control (AGC) 
target values for full scan acquisition was maintained at 1e
6
 counts for detection in the 
ICR cell and 5e
5
 counts for detection in the linear ion trap. Collision activation for the 
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experiment was performed using helium gas at collision energy normalized to precursor 
m/z of 35% and qexcite = 0.25. The width of the precursor isolation window was m/z 2 
and only multiply charged precursor ions were selected for MS/MS. Dynamic 
exclusion, which prevents reanalysis of a precursor ion, was 180 s. 
 
5.2.4.2 Electron-capture dissociation (ECD)  
The mass spectrometer alternated between a full FT-MS scan (m/z 380 – 2000) 
and subsequent ECD MS/MS scans of the first most abundant ions. Survey scans were 
acquired in the ICR cell with a resolution of 100 000 at m/z 400. Precursor ions were 
isolated in the ion trap and transferred to the ICR cell. Isolation width was 6 m/z and 
only multiply charged precursor ions were selected for MS/MS. Dynamic exclusion 
used was 180 s. AGC target values for full scan and ECD acquisition was maintained at 
1e
6
 counts for detection in the ICR cell. In the ICR cell the ions were subjected to ECD, 
which the product ion was acquired with a resolution of 25 000 at m/z 400. The 
electrons for ECD were produced by an indirectly heated barium tungsten cylindrical 
dispenser cathode (5.1 mm diameter, 154 mm from the cell, 1 mm off-axis). The current 
across the electrode was ~1.1 A. Ions were irradiated for 60 ms at 5% energy 
(corresponding to a cathode potential of -2.775 V). Each ECD fragmentation was 
performed using 6 microscans. 
 
5.2.5 Data analysis  
CID and ECD MS/MS data were searched against the NCBI non-redundant 
database using the SEQUEST algorithm within Bioworks 3.3.1 (Thermo Electron 
Corp., Bremen, Germany). The search used the monoisotopic values 315.293 
(acetamidino pseudaminic acid), 316.3394 (pseudaminic acid), 329.1164 (legionaminic 
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acid derivative, LegAm), 315.1324 (legionaminic acid derivative, MeLegAm), 
390.1270 (dimethylglyceric acid derivative of PseAc) and finally 389.1274 
(dimethylglyceric acid derivative of PseAm; Logan et al., 2009) to attempt to identify 
potential glycan modifications of the serine and threonine amino acid residues only. 
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5.3 Results 
5.3.1 Isolation of flagella filaments. 
It was found to be impossible to isolate enough flagellin from 11168-O 0466
-
 
cells taken from the outside of the zone of growth on motility agar for the sample to be 
identified as flagellin when analysed by MS/MS. Therefore cells isolated from early 
log-phase broth cultures were used as an alternative, to provide flagellin for analysis 
from exponentially growing cells of this strain. Whilst this change of growth medium 
and conditions will affect the growth rate, and potentially the flagellar glycans present 
in this strain, it is the best approximation of soft agar growth conditions available. 
Flagellar filament pieces were also isolated from log-phase broth cultures of 11168-O 
WT, 11168-GS WT and plate grown cultures of 11168-O 0466
-
, to provide flagellin 
from stationary phase cells of this strain. All flagellar pieces were purified to 
homogeneity by an adaptation of the method given of Power et al. (1994).  
Figure 5.2 shows an SDS-PAGE gel of the isolated, purified flagella fragments, 
which indicates that this method allows for the purification of flagellin to apparent 
homogeneity. The flagellin band in lane seven, corresponding to the flagellar pieces 
isolated from 11168-O 0466
-
 mutant cells grown in broth, contains a relatively small 
amount of protein, this is potentially due to the presence of short flagella on 11168-O 
0466
-
 mutant cells. Another feature of this gel is the the breadth and diffusion of the 
flagellin bands themselves, which could potentially indicate the presence of a greater 
heterogeneity in flagellin mass from an individual strain than would perhaps be 
expected. As the flagellin proteins themselves should be of an identical mass, it is likely 
that there are differences in the number and/or nature of the glycosylation residues 
present. It is possible that this heterogeneity is due to either the loss of glycans during 
the purification process or to natural variability in the numbers or types of glycans 
Analysis of C. jejuni 11168 flagellar glycans  Chapter V 
  211 
 
applied to the flagellin during the glycosylation process. If the later is the case, it is 
possible that the same variation could be visible in native material extracted directly 
from cells. To test this, 10μl of whole cell lysate of 11168-O WT and 11168-O 0466- 
mutant cells, taken from Muller-Hinton broth cultures with an OD600nm of 0.2, was 
analysed by SDS-PAGE, the resulting gel is shown in Figure 5.3. The decreased mass 
of the 11168-O 0466
-  
flagellin band is evident, in comparison to its parent. As the FlaA 
and FlaB sequences of these strains are identical it is likely that this difference in mass 
is due to differences in glycosylation. However, whilst the amount of material applied to 
the gel was relatively small, the flagellin band, indicated by the arrow, is very sharp. If 
variation in flagellin glycosylation were occurring naturally within a strain it is likely 
that this band would be broader and more diffuse. 
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Figure 5.2. SDS-PAGE analysis of isolated flagellar pieces. 12.4% SDS-PAGE gel, 
stained with Coomassie blue, 4μl of purified flagellar pieces were applied to each lane. 
Lanes 1 & 4 –molecular weight markers, Mr values given. Lane 2- 11168-GS WT. Lane 
3- 11168-O WT, Lane 5- whole cell protein extract from 11168-O WT, for comparison. 
Lane 6- 11168-O 0466
- 
grown on agar. Lane 7- 11168-O 0466
-
 grown in broth.  
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Figure. 5.3. SDS-PAGE gel showing the difference in mass between 11168-O WT 
and 11168-O 0466
-
 mutant flagellin. Lane 1, 10μl 11168-O WT cell lysate. Lane 2, 10 
μl 11168-O 0466- cell lysate. The arrow indicates the flagellin band.  
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5.3.2 Mass Spectrometry (MS) 
When analysed by MS/MS the flagellar fragments tested, from 11168-O WT, 
11168-GS WT and 11168-O 0466
-
 grown in broth or on agar, were all identified as C. 
jejuni NCTC 11168 FlaA, the major flagellin protein, indicating that flagellin was 
present in all samples. It was impossible to tell whether the minor flagellin protein, 
FlaB, was also present, due to the high sequence similarity of the two flagellins (93% in 
11168-GS WT); although there was no evidence of the presence of FlaB specific 
peptides in any of the samples. Tables 5.1 and 5.2 show the percentage of peptide 
coverage in all samples when analysed by CID and ECD respectively.  
  
Table 5.1. Peptide coverage of C. jejuni NCTC 11168 Flagellin analysed by CID 
MS/MS 
 
Sample Protein identification Coverage (%) 
11168-O WT Flagellin (flaA) [Campylobacter  jejuni NCTC 11168] 48 
11168-GS WT Flagellin (flaA) [Campylobacter  jejuni NCTC 11168] 52 
11168-O 0466
-
 
(Broth grown) 
Flagellin (flaA) [Campylobacter  jejuni NCTC 11168] 49 
11168-O 0466
-
 
(Agar grown) 
Flagellin (flaA) [Campylobacter  jejuni NCTC 11168] 43 
 
Table 5.2. Peptide coverage of C. jejuni NCTC 11168 Flagellin analysed by ECD 
MS/MS 
 
Sample Protein identification Coverage (%) 
11168-O WT Flagellin (flaA) [Campylobacter  jejuni NCTC 11168] 52 
11168-GS WT Flagellin (flaA) [Campylobacter  jejuni NCTC 11168] 34 
11168-O 0466
-
 
(Broth grown) 
Flagellin (flaA) [Campylobacter  jejuni NCTC 11168] 
 
43 
 
11168-O 0466
-
 
(Agar grown) 
Flagellin (flaA) [Campylobacter  jejuni NCTC 11168] 
 
41 
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When analysed by both the CID MS/MS and ECD MS/MS methods, no glycans 
were identified on flagellar peptides from 11168-GS WT or the 11168-O 0466
-
 mutant, 
grown either on agar or in broth. Despite several repetitions of MS/MS analysis, using 
material from two separate flagellin isolations, no glycans could be indentified. 
However, one glycan, a di-O-methyl-glyceric acid derivative of acetamidino 
pseudaminic acid was identified in two places on 11168-O WT flagellin.  
One of the modified peptides was 174- FETGGRISTSGEVQFTLK-191 which 
is located in the central region of FlaA; the serine residue bearing the modification is 
underlined. The glycan was identified as the dimethylglyceric acid derivative of 
acetamidino pseudaminic acid (PseAm), which was first identified as a major 
glycosylation of C. jejuni 11168 flagellin by Logan et al. (2009). Figure 5.4 shows the 
fragments obtained from CID of the FETGGRISTSGEVQFTLK peptide. As only three 
b-fragment ions and no y-fragment ions were identified, it is impossible to determine 
the sequence of this peptide from this data, nor can any information regarding the 
location of the glycan can be derived. The unfragmented glycan, which has been 
released from the glycopeptide is visible in the form of its oxonium ion, is visible at m/z 
390.28. The intact doubly charged peptide is visible at m/z 979.53, indicating that the 
peptide backbone was not fragmented during CID, which is in agreement with the lack 
of fragment ions. Figure 5.5 shows the fragments generated by ECD of the 
FETGGRISTSGEVQFTLK peptide. The large number of C- and Z-fragment ions 
indicate that the peptide backbone has been fragmented and allows the peptide sequence 
to be determined. By comparing the experimental masses of the fragment ions obtained 
here to the values expected without glycosylation, it is possible to locate the 
glycosylated residue. 
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The second modified peptide identified in 11168-O WT flagellin was 203- 
VVISTSVGTGLGALADEINK-222; the amino acid residue bearing the modification is 
underlined. This peptide is also located in the central region of the C. jejuni 11168 FlaA 
protein and was modified with the same dimethylglyceric acid derivative of acetamidino 
pseudaminic acid as the first peptide. Again, too few b-fragment ions were generated by 
CID to deduce the peptide sequence or locate the glycosyl-modification, as shown in 
Figure 5.6. The intact peptide minus the glycan was identifiable, as was the oxonium 
ion of the intact glycan at m/z 390.24. The ECD spectrum shows the large number of C- 
and Z-fragment ions which together allow the peptide sequence and the location of the 
glycosyl modification to be deduced, see Figure 5.7.
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Figure 5.4. CID fragments of the FETGGRISTSGEVQFTLK peptide. The three b fragment ions arising from fragmentation of the peptide 
bonds are shown, as is the oxonium ion of the glycan residue at m/z 390.28 and the doubly charged peptide minus the glycan at m/z 979.53.
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Figure 5.5 ECD fragments of the FETGGRISTSGEVQFTLK peptide. Showing the C- and Z-fragment ions arising from fragmentation of 
the peptide bonds, lines dividing the peptide sequence show the locations of the breakages of the peptide backbone which produced these ions. 
The peptide fragmentation allows the peptide sequence to be determined and the glycan to be located to the serine residue highlighted in red.
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Figure 5.6. CID fragements of the VVISTSVGTGLGALADEINK peptide. The six b-fragment ions arising from fragmentation of the peptide 
bonds are shown, as is the glycan residue at m/z 390.24 and the doubly charged peptide minus the glycan at m/z 972.8.
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Figure 5.7. ECD fragments of the VVISTSVGTGLGALADEINK peptide. Showing the C- and Z-fragment ions arising from fragmentation 
of the peptide bonds and the locations of peptide bond breakage. This allows the peptide sequence to be determined and the glycan to be located 
to the serine residue highlighted in red.
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5.4 Discussion 
5.4.1 Variation in flagellin glycosylation 
Flagellar pieces isolated using a variation on the extensively used method of 
Power et al. (1994) were examined by SDS-PAGE (Figure 5.1). The 11168-O 0466
-
 
flagellin isolated from exponential phase broth grown cells gave a considerably less 
dense band than that of the same strain grown on agar. This reflects the difficulty of 
isolating sufficient amounts of flagellar pieces from this strain as, under these growth 
conditions, only short, truncated flagella are produced. Also apparent in Figure 5.2 is 
the breadth of the flagellin bands which are diffuse and not as sharp and compact as 
would be expected from SDS-PAGE of a single protein. It is possible that this is an 
artefact of the SDS-PAGE analysis or the flagellin isolation procedure; alternatively it 
could be indicative of variation in the mass of the flagellin isolated.  The variation could 
potentially be due to natural variation in the types and locations of glycans applied to 
the flagellin proteins by the cell. Variation in flagellin mass due to gene and gene 
expression differences has been described (Thibault et al., 2001; Turner and Penn, 
2005); whether this type of can occur within a single population of cells is unclear. This 
variation could also be generated by the loss of flagellar glycans during the purification 
process or otherwise be due to natural variation in the types and locations of glycans 
applied to the flagellin proteins by the bacterial cell. When whole cell lysates were 
examined by SDS-PAGE, see Figure 5.3, the flagellin bands of both 11168-O WT and 
11168-O 0466
-
 appeared to be sharp and did not suggest that there was any large 
variation in flagellin glycosylation within these strains. This gel does however show the 
variation in mass between 11168-O WT and 11168-O 0466
-
 flagellins. This suggests 
that any apparent variation n flagellin mass seen within a particular strain may actually 
be artefactual. 
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Studies which have used isoelectric focusing to characterise flagellins from C. 
jejuni wild-type strains (including 11168-GS WT) and defined mutants have provided 
some evidence of variation in flagellar glycans, by demonstrating the separation of 
flagellins into multiple ‘glycoforms’ in both wild-type and mutant flagellins (Doig et 
al., 1996; Guerry et al., 2006). However, the majority of these studies also use the 
method of flagellar isolation developed by Power et al. (1994), it therefore remains 
difficult to determine whether the presence of multiple glycoforms of flagellin is due to 
natural variation in the number and nature of the glycans attached to flagellin proteins or 
simply due to the loss of glycans during the isolation process. 
 The identification and location the flagellar glycans of C. jejuni 81-176 by 
Thibault et al. (2001) provides evidence to suggest that there is little natural variation in 
flagellin glycosylation as it was shown that, although there was a certain amount of 
micro-heterogeneity in the natures of the O-linked glycans attached to flagella, all of the 
19 identified glycosylation sites were occupied on each flagellin monomer. Hence it is 
probable that the potential variation in flagellin mass seen here is due not to natural 
variation in flagellin glycosylation caused by alterations in the number and type of 
glycans applied to flagellin by the cell, but instead to the method of isolation used.  This 
is also supported by evidence that at least a certain level of flagellin glycosylation is 
required for flagellar assembly, as mutants in certain PseAc biosynthesis genes which 
do not glycosylate flagellin do not produce flagella (Goon et al., 2003; Guerry et al., 
1996). 
 
5.4.2 Mass spectrometry 
 The aim of this part of the study was to begin to map the type and locations of 
flagellar glycans present on the flagellins of the11168-O WT, 11168-O 0466
-
 mutant 
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and 11168-GS WT isolated from log-phase broth and 11168-O 0466
-
 flagellin isolated 
from cells grown on agar. Any differences observed in the glycans present on the 
flagellins could be used to help to explain the differences in flagellin mass between the 
strains, as observed by SDS-PAGE, and potentially the presence of short, asymmetric 
flagella in the 11168-O 0466
-
 mutant when grown on soft motility agar.  
 
5.4.2.1 Glycosylation of 11168-O WT flagellin 
Analysis by mass spectrometry carried out as part of this work indicated that the 
major flagellin protein, FlaA, of C. jejuni 11168-O WT was glycosylated in two places 
with a dimethylglyceric acid modification of acetamidino pseudaminic acid (PseAm) 
which was recently discovered by Logan et al. (2009). Another novel glycan, a 
dimethylglyceric acid modification of pseudaminic acid (PseAc), was also identified by 
Logan et al. (2009) and the presence of other previously detailed flagellar glycans in the 
metabolome of C. jejuni 11168 was confirmed; these glycans included PseAc, PseAm 
and two derivatives of legionaminic acid. The two novel glycans were found to be the 
most common modifications present on C. jejuni 11168 flagellin. 
Although no information concerning the overall level of glycosylation of C. 
jejuni 11168 flagellin or the locations glycans across the flagellin exists, the difference 
in FlaA mass when predicted from the amino acid sequence and observed by SDS-
PAGE analysis suggests that slightly less than 10% of flagellin mass will consist of 
glycans. In C. jejuni 81-176, 10% of flagellin mass comprises carbohydrate, which 
corresponds to 19 glycans. Hence it is very probable that C. jejuni 11168 flagellin is 
glycosylated at considerably more locations that the two identified here, or those 
detailed by Logan et al. (2009).  
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It is unclear why no other glycans were identified by the MS/MS analysis 
carried out here; it is possible that the flagellar isolation process caused the loss of some 
flagellar glycans before MS/MS analysis was carried out. If specific modifications were 
particularly subject to loss during the isolation process, the fact that CID and ECD 
fragmentation was carried out on only the most abundant ions present in each scan, the 
top three ions in each scan were subjected to CID and only the most abundant ion from 
each scan was selected for ECD, could help to explain why these modifications were 
not detected.  
The incomplete peptide coverage, 48% for CID MS/MS of 11168-O WT 
flagellin and 52% for ECD MS/MS of 11168-O WT flagellin, will also have contributed 
to the lack of flagellar glycans identified. Whilst peptides corresponding to those known 
to be glycosylated in C. jejuni 81-176 (Thibault et al., 2001) were identified during 
thisMS/MS analysis, several did not carry glycan residues. However not all of these 
corresponding glycosylated peptides were identified, with or without glycans, 
suggesting that could be present on peptides which were not identified in this work. 
Other reasons for the lack of glycans discovered could be more intrinsic to the samples 
analysed as glycopeptides can be subject to poor ionisation during the initial stages of 
MS/MS analysis, peptides which fail to ionise are eluted from the mass spectrometer 
prior to MS/MS analysis and hence are not detected. Low stoichiometric abundance of 
particular types of modifications can also prevent the identification of glycan 
modifications. The two novel dimethylglyceric acid modifications of PseAc and PseAm 
were identified by Logan et al. (2009) as the prevalent modifications of C. jejuni 11168 
flagellin, the failure to detect other modifications, including PseAc, PseAm and 
legionaminic acid derivatives, could simply be due to the fact that these modifications 
were not present in sufficient amounts. 
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The multiple alignment shown in Figure 5.8 indicates that the locations of 
glycosylation are quite well conserved between C. coli VC167 and C. jejuni 81-176, 
although the actual types of glycan applied are not. Also evident is the level of sequence 
conservation between the flagellins of these strains, particularly at the N- and C-
terminal regions, which are thought to be involved in flagellar subunit interactions and 
flagellar assembly (Yonekura et al, 2003). The majority of glycans appear to be located 
in the central region of the flagellin, which is also the most diverse region in terms of 
sequence. Although, despite the differences in sequence, the relative locations of the 
glycan modifications appear to be well conserved. 
It is impossible to determine whether glycosylation in C. jejuni 11168 also 
follows the pattern established from C. jejuni 81-176 and C. coli VC167 flagellin, until 
a more complete map of flagellar glycosylation in this strain is available. However, 
given the flagellin sequence similarities and the importance of flagellin glycosylation to 
flagellar filament formation (Goon et al., 2003), it is probable that C. jejuni 11168 will 
show a similar pattern of glycosylation to C. jejuni 81-176 and C. coli VC167, although 
there is clearly significant variation in the nature of the glycans applied. The large 
flagellin glycosylation locus of C. jejuni 11168 contains approximately 50 genes in 
comparison to the 23 genes of C. jejuni 81-176 and 14 of C. coli VC167, suggesting that 
the modifications present on C. jejuni 11168 flagellin will be more diverse than those of 
other strains; the discovery of two novel modifications by Logan et al. (2009) supports 
this. As many genes in the C. jejuni 11168 flagellin glycosylation locus do not yet have 
defined functions, it is possible that yet more glycans remain to be discovered.  
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C.jejuni_11168    MGFRINTNVAALNAKANADLNSKSLDASLSRLSSGLRINSAADDASGMAIADSLRSQANT 
C.jejuni_81176    MGFRINTNIGALNAHANSVVNSNELDKSLSRLSSGLRINSAADDASGMAIADSLRSQAAT 
C.coli_VC167      -GFRINTNVAALNAKANSDLNSRALDQSLSRLSSGLRINSAADDASGMAIADSLRSQANT 
 
C.jejuni_11168    LGQAISNGNDALGILQTADKAMDEQLKILDTIKTKATQAAQDGQSLKTRTMLQADINRLM 
C.jejuni_81176    LGQAINNGNDAIGILQTADKAMDEQLKILDTIKTKATQAAQDGQSLKTRTMLQADINKLM 
C.coli_VC167      LGQAISNGNDALGILQTADKAMDEQLKILDTIKTKATQAAQDGQSLKTRTMLQADINRLM 
 
C.jejuni_11168    EELDNIANTTSFNGKQLLSGNFINQEFQIGASSNQTVKATIGATQSSKIGLTRFETGGRI 
C.jejuni_81176    EELDNIANTTSFNGKQLLSGNFTNQEFQIGASSNQTVKATIGATQSSKIGVTRFETGAQS 
C.coli_VC167      EELDNIANTTSFNGKQLLSGGFTNQEFQIGSSSNQTIKASIGATQSSKIGVTRFETGSQS 
 
C.jejuni_11168    STSGEVQFTLKNYNGIDDFQFQKVVISTSVGTGLGALADEINKNADKTGVRATFTVETRG 
C.jejuni_81176    FTSGVVGLTIKNYNGIEDFKFDNVVISTSVGTGLGALAEEINKSADKTGVRATYDVKTTG 
C.coli_VC167      FSSGTVGLTIKNYNGIEDFKFQNVVISTSVGTGLGALAEEINRNADKTGIRATFDVKSVG 
 
C.jejuni_11168    IAAVRAGATSDTFAINGVKIGKVDYKDGDANGALVAAINSVKDTTGVEASIDANGQLLLT 
C.jejuni_81176    VYAIKEGTTSQDFAINGVVIGQINYKDGDNNGQLVSAINAVKDTTGVQASKDENGKLVLT 
C.coli_VC167      AYAIKAGNTSQDFAINGVVIGKVDYSDGDENGSLISAINAVKDTTGVQASKDENGKLVLT 
 
C.jejuni_11168    SREGRGIKIDGNIGGGAFINADMKENYGRLSLVKNDGKDILISGSNLSSAGFGATQFISQ 
C.jejuni_81176    SADGRGIKITGDIGVGSGILANQKENYGRLSLVKNDGRDINISGTNLSAIGMGTTDMISQ 
C.coli_VC167      SADGRGIKITGSIGVGAGIL--HTENYGRLSLVKNDGRDINISGTGLSAIGMGATDMISQ 
 
C.jejuni_11168    ASVSLRESKGQIDANIADAMGFGSANKG----VVLGGYSSVSAYMSSAGSGFSSGSGYSV 
C.jejuni_81176    SSVSLRESKGQISATNADAMGFNSYKGGG-KFVFTQNVSSISAFMSAQGSGFSRGSGFSV 
C.coli_VC167      SSVSLRESKGQISAANADAMGFNAYNGGGAKQIIFA--SSIAGFMSQAGSGFSAGSGFSV 
 
C.jejuni_11168    GSGKNYSTGFANAIAI-SAASQLSTVYNVSAGSGFSSGSTLSQFATMKTTAFGVKDETAG 
C.jejuni_81176    GSGKNLSVGLSQGIQIISSAASMSNTYVVSAGSGFSSGSGNSQFAALKTTAANTTDETAG 
C.coli_VC167      GSGKNYSAILSASIQIVSSAASISSTYVVSTGSGFSAGSGNSQFAALRISTVSAHDETAG 
 
C.jejuni_11168    VTTLKGAMAVMDIAETAITNLDQIRADIGSVQNQVTSTINNITVTQVNVKAAESQIRDVD 
C.jejuni_81176    VTTLKGAMAVMDIAETAITNLDQIRADIGSVQNQLQVTINNITVTQVNVKAAESTIRDVD 
C.coli_VC167      VTTLKGAMAVMDIAETAITNLDQIRADIGSVQNQITSTINNITVTQVNVKSAESQIRDVD 
 
C.jejuni_11168    FAAESANYSKANILAQSGSYAMAQANSVQQNVLRLLQ 
C.jejuni_81176    FASESANFSKYNILAQSGSYAMSQANAVQQNVLKLLQ 
C.coli_VC167      FASESANYSKANILAQSGSYAMAQANSSQQNVLRLLQ 
 
 
 
Figure 5.8. Alignment of FlaA from C. jejuni NCTC 11168, C. jejuni 81-176 and C. 
coli VC167. Those residues modified with glycans are indicated.  C. jejuni 81-176 
modifications are taken from Thibault et al. (2001), C. coli VC167 modifications are 
taken from Logan et al. (2002). C. jejuni 11168 modifications shown are those 
identified in this work. (The sequences were obtained from CampyDB at 
http://xbase.bham.ac.uk/campydb/ and aligned using the ClustalW2 tool available from 
EBI at http://www.ebi.ac.uk/Tools/clustalw2/index.html, accessed August, 2009). 
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5.4.2.2 Flagellin glycosylation in C. jejuni 11168-O 0466
-
 and 11168-GS WT 
No flagellar glycans were identified on flagellin from 11168-GS WT or 11168-
O 0466
-
 . The aim of this part of the analysis was to identify and ‘map’ the locations and 
types of glycans present on flagellin from these strains. This information would then be 
compared to the map of glycosylation for 11168-O WT flagellin to begin to elucidate 
some of the observed differences between these strains. The flagellin of 11168-GS WT 
has a lower mass than that of 11168-O WT (Turner and Penn, 2005) which is likely to 
be due to a decrease in the amount of glycosylation of flagellin in 11168-GS WT; 
although it is probable that this flagellin is still glycosylated to some degree as 
glycosylation appears to be necessary for flagellar filament formation (Goon et al., 
2003). Likewise the flagellin of 11168-O 0466
-
 also has a lower mass than that of 
11168-O WT. These ‘maps’ could also have been used to determine whether differences 
in flagellin glycosylation were responsible for the inability of 11168-O 0466
-
 cells, 
growing at fast rates, to form full length flagella. 
Potential reasons for the failure of MS/MS analysis to locate flagellar glycans 
could include many of those reasons detailed above (Section 5.4.2.1), such as the 
possible loss of glycans prior to MS/MS analysis, incomplete peptide coverage and poor 
peptide ionisation, which can affect MS/MS of glycopeptides (Alley et al., 2009). The 
possibility of low abundance of particular modifications could also be responsible, as 
the MS/MS method used here to locate the flagellar modifications, ECD, is known to be 
less sensitive than other MS/MS methods (Zubarev, 2004). It is also possible that the 
dimethylglyceric acid modifications of acetamidino pseudaminic acid located on 11168-
O WT flagellin are not present on the flagellin of the other strains. Whether this is the 
case or not is difficult to predict as the biosynthetic process of the dimethylglyceric acid 
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PseAm is not known and so it is not possible to identify which changes in gene 
expression could be responsible for loss of these glycans.  
 
5.5 Conclusions and future work 
 
From this work it is possible to conclude that 11168-O WT flagellin is 
glycosylated in at least two, and probably more, locations and that one of the glycans is 
present as a dimethylglyceric acid derivative of acetamidino pseudaminic acid. This 
information agrees with the published data (Logan et al., 2009), but is not as complete. 
The failure of MS/MS to generate glycosylation mapping information for 11168-GS 
WT and  11168-O 0466
-
, from both growth conditions, makes it impossible to link 
changes in flagellin glycosylation in these strains to observed changes in flagellin mass, 
flagellar structure and motility. It is also impossible to link any potential glycosylation 
changes to alterations in gene complement or expression. There is, from other work, 
evidence to suggest that the 11168-O 0466
-
 could be lacking flagellar glycans including 
LegAm and PseAm (Howard et al., 2009; Guerry et al., 2006). However there is also 
evidence to suggest that flagellin glycosylation is necessary for flagellar formation and 
function in Campylobacter (Goon et al., 2003; Guerry et al., 1996), and as the strains 
used in this study all produce flagella, although of varying lengths, they are likely to be 
glycosylated. Although, as this work was carried out in several different strains of 
Campylobacter, it is necessary to more fully map the flagellar glycans present in these 
strains before attempting to draw comparisons. 
To that end, other approaches to the task of identifying and locating flagellar 
glycans could involve the focused-metabolomics based approach adopted during several 
studies of Campylobacter flagellin (Logan et al., 2009; McNally et al., 2006a and 
McNally et al., 2007). This approach has been very successful in identifying the glycans 
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themselves, although their mapping to particular amino acid residues still relies on mass 
spectrometry based approaches, which have had varied levels of success. Another 
approach could be to attempt to improve the quality of the starting material by 
improving the method used for the isolation and enrichment of flagellar pieces, as it is 
possible that glycans are being lost from flagellin at this stage. Although many isolation 
methods rely on the generation of shear-forces within a sample to separate pieces of 
flagella from bacterial cells, other methods, such as glycine extraction, are available 
(Nilsson et al., 2000).
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Chapter VI: General Discussion  
 
Protein glycosylation was once considered to be a strictly eukaryotic phenomenon; 
however, there is now an increasing awareness of prokaryotic glycoproteins, particularly of 
surface proteins, including flagella. Flagellin was the first glycoprotein identified in 
Campylobacter and remains the best characterised. The majority of research in the area of 
flagellin glycosylation in Campylobacter has focused on identifying the glycans applied to 
flagella, the functions of the genes responsible for glycan biosynthesis and attachment, and 
the elucidation of the pathways of glycan biosynthesis (Guerry et al., 1996; McNally et al., 
2006a; Thibault et al. 2001, and others). This has led to the identification of a large and 
growing array of glycans which decorate Campylobacter flagellin and many groups of genes 
involved in glycan biosynthesis including the pse, pseudaminic acid and related derivative 
biosynthetic genes and the ptm genes, responsible for legionaminic acid synthesis.  
The regulation of flagellin glycosylation is not well understood. Given that at least a 
certain level of glycosylation is required for filament formation (Goon et al., 2003), it is 
possible that at least some flagellin glycosylation genes will be co-ordinately regulated with 
the flagellar structural genes. In support of this hypothesis, σ28 has been implicated in the 
regulation of a small number of flagellin glycosylation genes (Carrillo et al., 2004). However, 
the mechanisms of regulation for the majority of flagellar glycosylation genes remain unclear. 
This study investigates the action of the nitrosative stress response regulator in C. jejuni, 
NssR, upon a subset of 17 flagellin glycosylation genes, the FMR. NssR was found, by 
chromatin immunoprecipitation analysis, to bind to at least four sites within the FMR. 
Analysis of the transcriptional organisation of the FMR identified six possible transcripts 
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beginning in the region, three of which potentially started ahead of a gene in which NssR 
binding had been identified. Hence it is likely that NssR binds to the promoter regions of a 
certain subset of FMR genes to modulate gene expression in this region. Further work would 
be required to confirm this as it was not possible to identify either the transcript start points of 
the genes involved or the NssR binding motifs within the FMR. 
The deletion of nssR causes changes to the flagella of the mutant which include a 
decrease in flagellin mass, probably associated with uncharacterised changes in glycosylation. 
The motility of the ΔnssR mutant is also altered it demonstrates a significant decrease in speed 
in comparison to the wild-type and looses the darting motility typical of Campylobacter, 
acquiring a more circular, spinning type of motion. When the flagella of ΔnssR mutant cells, 
taken from a rapidly dividing culture, were examined by EM, short, asymmetric flagella were 
observed. It is possible that the inability of this mutant to form full length flagella could be 
due to a defect in flagellar biosynthesis, potentially caused by changes in glycosylation. 
Attempts to create a complete map of the flagellar glycans present in the original strain wild-
type and mutant by mass spectrometry were unsuccessful. 
It remains unclear why NssR is involved in the regulation of a group of genes 
associated with flagellin glycosylation. NssR is a member of the Crp-Fnr superfamily of 
transcriptional regulators which are involved in regulating the response to a broad spectrum of 
intracellular and exogenous signals, including oxidative and nitrosative stress, nitric oxide, 
carbon monoxide, 2-oxoglutarate, anoxia, cAMP, redox state and temperature (Korner et al., 
2003). These regulators can modulate the activity of a large range of genes, it is possible that 
NssR is acting in response to an unknown signal to modulate expression of the FMR and 
consequently flagellin glycosylation and so potentially motility and flagella filament 
formation. Oxygen, by a largely unknown mechanism, together with NssR, has been found to 
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positively regulate Cgb, a globin protein involved in NO detoxification, which was previously 
thought to be regulated by NssR alone (Monk et al., 2008). It is also possible that oxygen 
availability is a factor which influences NssR regulated gene expression; the repertoire of 
signals which modulate nssR expression remains to be determined. 
Further work is required to better understand the action of NssR, not only in the FMR 
but across the entire C. jejuni genome. The chromatin immunoprecipitation method developed 
in this work could be used to isolate DNA which could then be sequenced using high-
throughput DNA sequencing technologies; this would provide a genome-wide map of NssR 
binding. Identification of the glycans present on wild-type and mutant flagella could be very 
useful in explaining some of the phenotypic differences between these strains, and in 
identification of those genes involved in glycan biosynthesis. The mass spectrometry 
approach used here had some success in this area, but to generate a complete map of flagellin 
glycosylation, improvements in the method of flagella isolation would be needed. A 
metabolomic analysis, to identify flagellar glycan precursors present in the ΔnssR mutant, 
could also be useful to begin to determine the pathways of glycan synthesis in this strain.  
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Appendix I - Sequence of the pDex_Fcc plasmid 
 
    0  GACGAAAGGGCCTCGTGATACGCCTATTTTTATAGGTTAATGTCATGATAATAATGGTTT 
   60  CTTAGACGTCAGGTGGCACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTGTTTATTTT 
  120  TCTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAAT 
  180  AATATTGAAAAAGGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTT 
  240  TTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATG 
  300  CTGAAGATCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCGGTAAGA 
  360  TCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGC 
  420  TATGTGGCGCGGTATTATCCCGTATTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATAC 
  480  ACTATTCTCAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATG 
  540  GCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGCCA 
  600  ACTTACTTCTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGG  
  660  GGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACG 
  720  ACGAGCGTGACACCACGATGCCTGTAGCAATGGCAACAACGTTGCGCAAACTATTAACTG 
  780  GCGAACTACTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAAG 
  840  TTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTG 
  900  GAGCCGGTGAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCT 
  960  CCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGAC 
 1020  AGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAAGTTTACT   
 1080  CATATATACTTTAGATTGATTTAAAACTTCATTTTTAATTTAAAAGGATCTAGGTGAAGA 
 1140  TCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGT 
 1200  CAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCT 
 1260  GCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGC 
 1320  TACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCC 
 1380  TTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACC 
 1440  TCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCG 
 1500  GGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTT 
 1560  CGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTG 
 1620  AGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCG 
 1680  GCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTT 
 1740  ATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAG 
 1800  GGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTT 
 1860  GCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTA 
 1920  TTACCGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGT 
 1980  CAGTGAGCGAGGAAGCGGAAGAGCGCCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGC 
 2040  CGATTCATTAATGCAGCTGGCACGACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCA 
 2100  ACGCAATTAATGTGAGTTAGCTCACTCATTAGGCACCCCAGGCTTTACACTTTATGCTTC 
 2160  CGGCTCGTATGTTGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGCTATG 
 2220  ACCATGATTACGCCAAGCTCTAGGGATAACAGGGTAATCGATGAATTCAAGCTTGGATCC        
 2280  CGGGTACCGACTACAAAGACCATGACGGTGATTATAAAGATCATGATATCGACTACAAAG 
 2340  ATGACGACGATAAATAGTAATGTAGGCTGGAGCTGCTTCGAAGTTCCTATACTTTCTAGA 
 2400  GCTGCTCGGCGGTGTTCCTTTCCAAGTTAATTGCGTGATATAGATTGAAAAGTGGATAGA 
 2460  TTTATGATATAGTGGATAGATTTATGATATAATGAGTTaTCAACAAATCGGAATTTACGG 
 2520  AGGATAAATGATGCAATTCACAAAGATTGATATAAATAATTGGACACGAAAAGAGTATTT 
 2580  CGACCACTATTTTGGCAATACGCCCTGCACATATAGTATGACGGTAAAACTCGATATTTC 
 2640  TAAGTTGAAAAAGGATGGAAAAAAGTTATACCCAACTCTTTTATATGGAGTTACAACGAT 
 2700  CATCAATCGACATGAAGAGTTCAGGACCGCATTAGATGAAAACGGACAGGTAGGCGTTTT 
 2760  TTCAGAAATGCTGCCTTGCTACACAGTTTTTCATAAGGAAACTGAAACCTTTTCGAGTAT   
 2820  TTGGACTGAGTTTACAGCAGACTATACTGAGTTTCTTCAGAACTATCAAAAGGATATAGA 
 2880  CGCTTTTGGTGAACGAATGGGAATGTCCGCAAAGCCTAATCCTCCGGAAAACACTTTCCC 
 2940  TGTTTCTATGATACCGTGGACAAGCTTTGAAGGCTTTAACTTAAATCTAAAAAAAGGATA 
 3000  TGACTATCTACTGCCGATATTTACGTTTGGGAAGTATTATGAGGAGGGCGGAAAATACTA 
 3060  TATTCCCTTATCGATTCAAGTGCATCATGCCGTTTGTGACGGCTTTCATGTTTGCCGTTT 
3120 TTTGGATGAATTACAAGACTTGCTGAATAAATAAAATCCCAGTTTGTCGCACTGATAAAA 
 3180  ACCCTTTAGGAACTAAAGGGCGCAGCTCGAGCTCATATGCTAGCGTCGACTAGTAGGGAT 
 3240  AACAGGGTAATGAGCTTGGCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCT 
 3300  GGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTAATAGC 
 3360  GAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGAATGGCGA 
 3420  GCTTGGCTGTTTTGGCGGATGAGAGAAGATTTTCAGCCTGATACAGATTAAATCAGAACG 
 3480  CAGAAGCGGTCTGATAAAACAGAATTTGCCTGGCGGCAGTAGCGCGGTGGTCCCACCTGA 
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 3540  CCCCATGCCGAACTCAGAAGTGAAACGCCGTAGCGCCGATGGTAGTGTGGGGTCTCCCCA 
 3600  TGCGAGAGTAGGGAACTGCCAGGCATCAAATAAAACGAAAGGCTCAGTCGAAAGACTGGG 
 3660  CCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCCTGAGTAGGACAAATCCGCCGG 
 3720  GAGCGGATTTGAACGTTGCGAAGCAACGGCCCGGAGGGTGGCGGGCAGGACGCCCGCCAT 
 3780  AAACTGCCAGGCATCAAATTAAGCAGAAGGCCATCCTGACGGATGGCCTTTTTGCGTTTC 
 3840  TACAAACTCTTTTTGTTTATTTTTCTAAATACATTCAAATATGCATGCGCCTGATGCGGT 
 3900  ATTTTCTCCTTACGCATATCGACATCCGCCCTCACCGCCAGGAACGCAACCGCAGCCTCA 
 3960  TCACGCCGGCGCTTCTTGGCCGCGCGGGATTCAACCCACTCGGCCAGCTCGTCGGTGTAG 
 4020  CTCTTTGGCATCGTCTCTCGCCTGTCCCCTCAGTTCAGTAATTTCCTGCATTTGCCTGTT 
 4080  TCCAGTCGGTAGATATTCCACAAAACAGCAGGGAAGCAGCGCTTTTCCGCTGCATAACCC 
 4140  TGCTTCGGGGTCATTATAGCGATTTTTTCGGTATATCCATCCTTTTTCGCACGATATACA 
 4200  GGATTTTGCCAAAGGGTTCGTGTAGACTTTCCTTGGTGTATCCAACGGCGTCAGCCGGGC 
 4260  AGGATAGGTGAAGTAGGCCCACCCGCGAGCGGGTGTTCCTTCTTCACTGTCCCTTATTCG 
 4320  CACCTGGCGGTGCTCAACGGGAATCCTGCTCTGCGAGGCTGGCCGGCTACCGCCGGCGTA 
 4380  ACAGATGAGGGCAAGCGGATGGCTGATGAAACCAAGCCAACCAGGAAGGGCAGCCCACCT 
 4440  ATCAAGGTGTACTGCCTTCCAGACGAACGAAGAGCGATTGAGGAAAAGGCGGCGGCGGCC 
 4500  GGCATGAGCCTGTCGGCCTACCTGCTGGCCGTCGGCCAGGGCTACAAAATCACGGGCGTC 
 4560  GTGGACTATGAGCACGTCCGCGAGCTGGCCCGCATCAATGGCGACCTGGGCCGCCTGGGC 
 4620  GGCCTGCTGAAACTCTGGCTCACCGACGACCCGCGCACGGCGCGGTTCGGTGATGCCACG 
 4680  ATCCTCGCCCTGCTGGCGAAGATCGACTCTAGCTAGAGGATCGATCCTTTTTAACCCATC 
 4740  ACATATACCTGCCGTTCACTATTATTTAGTGAAATGAGATATTATGATATTTTCTGAATT 
 4800  GTGATTAAAAAGGCAACTTTATGCCCATGCAACAGAAACTATAAAAAATACAGAGAATGA 
 4860  AAAGAAACAGATAGATTTTTTAGTTCTTTAGGCCCGTAGTCTGCAAATCCTTTTATGATT 
 4920  TTCTATCAAACAAAAGAGGAAAATAGACCAGTTGCAATCCAAACGAGAGTCTAATAGAAT 
 4980  GAGGTCGAAAAGTAAATCGCGCGGGTTTGTTACTGATAAAGCAGGCAAGACCTAAAATGT 
 5040  GTAAAGGGCAAAGTGTATACTTTGGCGTCACCCCTTACATATTTTAGGTCTTTTTTTATT 
 5100  GTGCGTAACTAACTTGCCATCTTCAAACAGGAGGGCTGGAAGAAGCAGACCGCTAACACA 
 5160  GTACATAAAAAAGGAGACATGAACGATGAACATCAAAAAGTTTGCAAAACAAGCAACAGT 
 5220  ATTAACCTTTACTACCGCACTGCTGGCAGGAGGCGCAACTCAAGCGTTTGCGAAAGAAAC 
 5280  GAACCAAAAGCCATATAAGGAAACATACGGCATTTCCCATATTACACGCCATGATATGCT 
 5340  GCAAATCCCTGAACAGCAAAAAAATGAAAAATATCAAGTTCCTGAGTTCGATTCGTCCAC  
 5400  AATTAAAAATATCTCTTCTGCAAAAGGCCTGGACGTTTGGGACAGCTGGCCATTACAAAA 
5460 CGCTGACGGCACTGTCGCAAACTATCACGGCTACCACATCGTCTTTGCATTAGCCGGAGA 
 5520  TCCTAAAAATGCGGATGACACATCGATTTACATGTTCTATCAAAAAGTCGGCGAAACTTC 
 5580  TATTGACAGCTGGAAAAACGCTGGCCGCGTCTTTAAAGACAGCGACAAATTCGATGCAAA    
 5640  TGATTCTATCCTAAAAGACCAAACACAAGAATGGTCAGGTTCAGCCACATTTACATCTGA 
 5700  CGGAAAAATCCGTTTATTCTACACTGATTTCTCCGGTAAACATTACGGCAAACAAACACT 
 5760  GACAACTGCACAAGTTAACGTATCAGCATCAGACAGCTCTTTGAACATCAACGGTGTAGA 
 5820  GGATTATAAATCAATCTTTGACGGTGACGGAAAAACGTATCAAAATGTACAGCAGTTCAT 
 5880  CGATGAAGGCAACTACAGCTCAGGCGACAACCATACGCTGAGAGATCCTCACTACGTAGA 
 5940  AGATAAAGGCCACAAATACTTAGTATTTGAAGCAAACACTGGAACTGAAGATGGCTACCA 
 6000  AGGCGAAGAATCTTTATTTAACAAAGCATACTATGGCAAAAGCACATCATTCTTCCGTCA 
 6060  AGAAAGTCAAAAACTTCTGCAAAGCGATAAAAAACGCACGGCTGAGTTAGCAAACGGCGC 
 6120  TCTCGGTATGATTGAGCTAAACGATGATTACACACTGAAAAAAGTGATGAAACCGCTGAT 
 6180  TGCATCTAACACAGTAACAGATGAAATTGAACGCGCGAACGTCTTTAAAATGAACGGCAA 
 6240  ATGGTATCTGTTCACTGACTCCCGCGGATCAAAAATGACGATTGACGGCATTACGTCTAA 
 6300  CGATATTTACATGCTTGGTTATGTTTCTAATTCTTTAACTGGCCCATACAAGCCGCTGAA 
 6360  CAAAACTGGCCTTGTGTTAAAAATGGATCTTGATCCTAACGATGTAACCTTTACTTACTC 
 6420  ACACTTCGCTGTACCTCAAGCGAAAGGAAACAATGTCGTGATTACAAGCTATATGACAAA 
 6480  CAGAGGATTCTACGCAGACAAACAATCAACGTTTGCGCCTAGCTTCCTGCTGAACATCAA 
 6540  AGGCAAGAAAACATCTGTTGTCAAAGACAGCATCCTTGAACAAGGACAATTAACAGTTAA 
 6600  CAAATAAAAACGCAAAAGAAAATGCCGATTATGGTGCACTCTCAGTACAATCTGCTCTGA 
 6660  TGCCGCATAGTTAAGCCAGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGC 
 6720  TTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTG 
 6780  TCAGAGGTTTTCACCGTCATCACCGAAACGCGCGA
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Appendix II - Buffers and Solutions 
 
Section 2.20.1. SDS-PAGE reagents 
 
2 x Resolving gels (12.5% acrylamide) 
 40% Acrylamide mix (Sigma, Gillingham, UK)   3.0 ml 
 1.5M Tris (pH 8.8)       2.5 ml 
 Sterile distilled water       4.4 ml 
 10% SDS        100 µl 
 10% Ammonium Persulphate      50 µl 
 TEMED        5 µl 
 
2 x Stacking gels (4.0% acrylamide) 
 40% Acrylamide mix (Sigma, Gillingham, UK)   490 µl 
 0.5M Tris (pH 6.8)       1.25 ml 
 Sterile distilled water        3.2 ml 
 10% SDS        50 µl 
 10% Ammonium Persulphate      50 µl 
 TEMED        5 µl 
 
Sample buffer 
 Laemmli sample buffer (BioRad, Hemel Hempstead, UK)  950 µl 
 Β-mercaptoethanol (Sigma, Gillingham, UK)   50 µl 
 
10 x SDS-PAGE running buffer 
 Tris-HCl        30.3 g.l
-1
 
 Glycine        144 g.l
-1
 
 SDS         10 g.l
-1 
 
Sterile distilled water       to 1l 
 
 
 
Buffers and Solutions  Appendix II  
 
  236 
 
Coomassie stain 
 Coomassie blue R-25       0.1% (w/v) 
 Methanol        45% (v/v) 
 Glacial acetic acid        10% (v/v) 
 Sterile distilled water       to 100% 
 
Destaining solution 
 Methanol        200 ml  
 Acetic acid        75 ml 
 Sterile distilled water       725 ml 
 
 
Section 3.2.8 - Purification of the NssR protein. 
 
8 x binding buffer (pH 7.9) 
4M NaCl 
160mM Tris-HCl 
40mM Imidazole 
 
1 x wash buffer (pH 7.9) 
0.5M NaCl 
20mM Tris-HCl 
60mM Imidazole 
 
1 x elute buffer (pH 7.9) 
0.5M NaCl 
20mM Tris-HCl 
1M Imidazole 
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Section 3.2.10 - Western Blotting 
 
Western blot running buffer 
Glycine      14.4 g 
Tris       3.0 g 
Methanol      200 ml 
Sterile distilled water     to 1l  
 
10 x Tris buffered/saline (TBS, pH 7.6) 
Trizma HCl      24.23 g 
NaCl       80.06 g 
Sterile distilled water     to 1l 
 
1 x Tris buffered saline tween 20 buffer (TBST) 
10 x TBS      100 ml 
Tween 20      1 ml 
Sterile distilled water     to 1l 
 
Blocking solution 
 Fat-free dried milk powder    5 g 
 1 x TBST      to 100 ml 
 
Section 3.2.12 Chromatin immunoprecipitation (ChIP). 
 
Lysis buffer 
10mM Tris (pH 8.0) 
20% Sucrose 
50mM NaCl 
10mM EDTA (pH 8.0) 
Lysozyme to final concentration (20 mg.ml
-1
) as needed 
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IP buffer 
50mM HEPES-KOH (pH 7.5) 
150mM NaCl 
1mM EDTA 
1% Triton X-100 
0.1% Sodium deoxycholate 
0.1% SDS 
 
IP salt buffer 
50mM HEPES-KOH (pH 7.5) 
500mM NaCl 
1mM EDTA 
1% Triton X-100 
0.1% Sodium deoxycholate 
0.1% SDS 
 
Wash buffer 
10mM Tris HCl (pH 8.0) 
250mM LiCl 
1mM EDTA 
0.5% Nonidet P-40 
0.5% Sodium deoxycholate 
 
Elution buffer 
100mM NaHCO3 (pH 9.0) 
1.0% SDS 
 
TBS buffer (pH 7.6) 
10mM Tris HCl 
150mM NaCl 
Buffers and Solutions  Appendix II  
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Section 3.2.13.4 - Electrophoretic mobility shift  assay 
 
10 x Binding buffer 
1M Potassium Glutamate 
10mM EDTA 
100mM Potassium Phosphate (pH 7.5) 
500µM DTT 
 
Mobility gel mix 
30% Acrylamide Mix (Protogel, Geneflow)  14 ml 
Glycerol      1.4 ml 
5 x TBE      3.5 ml 
Sterile distilled water     51.1 ml 
10% APS      400 µl 
TEMED      70 µl 
 
5 x TBE 
Tris-HCl      54 g 
Boric acid      27.5 g 
0.5M EDTA (pH8.0)     20 ml 
Sterile distilled water     to 1L 
 
2 x Loading dye (10 ml) 
1% bromophenol blue     1 ml 
50% glycerol      6 ml 
1M Tris (pH 8.0)     100 μl 
0.5M EDTA (pH 8.0)     20 μl 
Sterile distilled water     2.88 ml 
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Appendix III - Campylobacter growth data 
To determine whether there were are any differences in the growth rates of the 
strains used here, growth curves were constructed for all strains. Muller-Hinton broth 
was inoculated with the appropriate strain and grown overnight at 37°C in a 
microaerobic atmosphere containing 5% (v/v) O2, 10% (v/v) CO2 and 85% (v/v) N2, 
with shaking at ~220 rpm. The following day 50 ml of pre-warmed Muller-Hinton broth 
was inoculated with the overnight culture to an OD600nm of 0.1 and grown for 24h. 
Readings of the OD600nm were taken every 1.5h for the first 15h and finally at 24h. 
Measurements for all strains were repeated three times and the data combined to 
generate the graphs shown below. 
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